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ABSTRACT OF DISSERTATION

METHODS DEVELOPMENT IN QUALITATIVE AND QUANTITATIVE
PROTEOMICS
Proteomics based on liquid chromatography coupled to mass spectrometry has
developed rapidly in the last decade and become a powerful tool for protein mixtures
analysis. LC-MS based proteomics involves four steps, sample preparation, liquid
chromatography, mass spectrometry and bioinformatics. Improvements in each step have
extended its applications to new biological research areas. This dissertation mainly
focuses on method developments in both qualitative and quantitative proteomics.
The first part of this dissertation focuses on qualitative analysis of T. gondii
Parasitophorous Vacuole Membrane (PVM) proteins, which is very important for T.
gondii’s survival. The hypothesis of this study is that proteomic approaches coupled with
immunoprecipitation using polyclonal antisera as affinity reagents can successfully
characterize the proteome of the T. gondii PVM. The “Three-layer Sandwich Gel
Electrophoresis” (TSGE) protocol, was developed to contend with efficient salt removal
and protein concentration from challenging samples. Furthermore, the TSGE coupled to
2D-LC-MS/MS was proven to be effective with the proteomic analysis of complex
protein mixtures like T. gondii whole cell lysate, allowing for high-throughput protein
analysis from complex samples. By using the TSGE-2D-LC-MS/MS methodology, we
successfully identified 61 proteins from the PVM samples and constructed the PVM
proteome.
The second part of this dissertation describes a novel method for selecting an
appropriate isocyanate reagent for potential quantitative proteomics application. Our
hypothesis is alteration of isocyanate structure will change fragmentation pattern and ESI
property of isocyanate modified peptides. The CID property of N-terminal modified
peptides by phenyl isocyanate (PIC), phenethyl isocyanate (PEIC) and pyridine-3isocyanate (PyIC) was systematically studied using LC-ESI-MS/MS. We observed that
adjustment of isocyanate structure changed both ESI and fragmentation characteristic of
modified peptides. We rationalized the decrease of protonation of PIC and PEIC
modified peptides results from the neutral property of the both reagents. The electron-

withdrawing feature of PyIC leads to significant reduction of fragments during CID.
Therefore, we designed a new isocyanate reagent, 3-(isocyanatomethyl) pyridine
(PyMIC). The results revealed that PyMIC modified peptides had more suitable ESI
properties and generated more sequence-useful fragments compared to PIC, PyIC and
even unmodified peptides. PyMIC is a more appropriate labeling reagent for quantitative
proteomics applications.

KEYWORDS: Mass Spectrometry, Toxoplasma gondii Parasitophorous
Vacuole Membrane (PVM), Three-layer Sandwich Gel
Electrophoresis, Isocyanate, ESI and Fragmentation
Characteristics.
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CHAPTER ONE
INTRODUCTION
Proteomics Background
Bottom-Up Proteomics
Proteomics is defined as the analysis of complete complements of proteins,
including not only the identification and quantification of proteins, but also the
determination of their localizations, modifications, interactions and functions. There are
four components to a proteomic approach: sample preparation, chromatography, mass
spectrometry and proteomic informatics. In the most commonly used bottom-up
approaches, purified proteins or complex protein mixtures are generally subjected to
proteolytic cleavage prior to mass spectrometric analysis. Bottom-up proteomics can be
carried out in two basic schemes (Figure 1.1). One scheme is called as peptide
fingerprinting1, 2. Protein mixtures are first resolved by two-dimensional polyacrylamide
gel electrophoresis (2D-PAGE)3, 4, in which proteins are separated by isoelectric focusing
(IEF) in the first dimension based on their isoelectric point (pI) difference and followed
by SDS-PAGE separation in the second dimension based on their size difference. Then
the two-dimensional electrophoresis gels are visualized and analyzed by gel image
analysis softwares so that proteins of interest can be localized on the gel. Selected
proteins are cut from the gel for further enzymatic digestion. Then the resultant peptides
are extracted from the gel pieces and introduced into a mass spectrometer for MS
analysis. Proteins are identified by searching the experimental peptide masses against
calculated peptide masses generated by in silico cleavage of the protein using the same
enzyme employed in the experiment. One disadvantage of peptide mass fingerprinting is
the requirement for pure proteins or simple protein mixtures. Protein separation and
purification steps therefore are crucial and limit the efficiency of the peptide mass
fingerprinting approach. Also, multiple peptides are required for unique identification of
a protein.
The other scheme used for bottom-up proteomics is via peptide fragmentation5.
In this scheme, protein mixtures are initially enzymatically digested to the peptide level.
1

The resulting digests are separated by on-line chromatography coupled to electrospray
mass spectrometry (ESI–MS). Since the digest may contain thousands of peptides, two
chromatographic dimensions have been used for efficient separation before MS analysis.
After MS analysis is performed for each isolated peptide, the instrument automatically
swiches to MS/MS analysis to obtain product ion fragments. The amino acid sequence of
each analyzed peptide can be deduced from the masses of the fragment ions via de novo
peptide sequencing6 (peptide sequencing performed without prior knowledge of the
amino acid sequence). Alternatively, tandem MS data can be correlated to computerpredicted MS/MS spectra to obtain the peptide sequences and further identify proteins.
One of the most common mass spectrometers used for tandem MS analysis is the
quadrupole ion trap. It is the earliest developed instrument for multiple stage
fragmentation and has the ability to generate high-quality MS2 and MSn spectra (n≤12)7.
Compared to the peptide fingerprinting scheme, the peptide fragmentation is capable of
analyzing complex protein mixtures, especially when coupled to high-resolution
chromatographic techniques such as 2D-HPLC8, 9, 10. Also, peptide fragmentation has the
ability to identify an intact protein based on elucidation of one unique peptide amino acid
sequence. Furthermore, strategies like stable isotope affinity tags11, 12 have been
developed and added to the peptide fragmentation scheme, making it capable to
determine up- and down-regulated proteins in expression proteomics.
In the remaining part of the introduction, components of bottom-up proteomics
will be described in detail.
Gel Electrophoresis
Electrophoresis can be used to separate biomolecules in an electric field. By
applying an electric potential, the biomolecules trapped in a matrix will move through the
matrix at different rates based on their size. When the molecules have positive charge,
they will be drawn toward the negative anode. If they are negatively charged, they will
be repelled by the anode and move toward the positive cathode.

2
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Figure 1. 1: two basic schemes for performing bottom-up proteomics: A: peptide
fragmentation scheme. B: peptide fingerprinting scheme.
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Electrophoresis Theory
Electrophoretic separations are based upon the fact that a charged particle in an
electric field (E) experiences an electric force (F) that is proportional to the particle’s
charge (q)13, (Eqn.1.1):

F = qE

(Eqn. 1.1).

The velocity (v) of a charged molecule in an electric field is dependant on both electric
force (F) and the frictional force:

ν=

qE

f

(Eqn. 1.2)

where f represents frictional coefficient. The frictional coefficient relates to both size and
shape of the particle.
The electrophoretic mobility of a molecule (µ) is defined as the migration of the
charged particle in the electric field. It is expressed as the velocity per unit field strength
as follows (Eqn. 1.3)

µ =ν E = q f

(Eqn. 1.3)

where v is the velocity of the charged particle and f is the frictional coefficient. Since the
frictional coefficient is proportional to both viscosity of the medium and size of the
molecule, from Equation 1.3, it can be seen that electrophoretic mobility decreases for
larger particles and increases with higher charge.
Factors that affect gel electrophoresis
Matrix
Depending on the targeted biomolecules to be separated, different matrices are
chosen for gel electrophoresis. The most commonly used matrix for protein separation is

4

polyacrylamide gel. Agarose is another common matrix for gel electrophoresis. It usually
is used for larger biomolecule separation.
Polyacrylamide gel14 is prepared by adding free radical initiators to an aqueous
solution of the monomer mixture, which typically includes acrylamide monomer and
crosslinking agent N,N’-methylene bisacrylamide (bis). The most common free radical
initiator system used is ammonium persulfate and N,N,N’N’-tetramethylethylenediamine
(TEMED). The structures of all reagents employed in the polymerization reation and the
polyacryamide product are shown in Figure 1.2. Compounds that may act as a free
radical trap will inhibit polymerization. As one of the inhibitors, oxygen is usually
removed from gel solution via degassing process prior to the addition of free radical
initiator to the monomer solution.
The effective pore size of polyacrylamide gels is an inverse function of “the total
acrylamide concentration” (T %), which is defined as the sum of the concentrations of
acrylamide and Bis in the polymerization mixture15. The proportion of crosslinker Bis
also affects the pore size of gel. The effective pore size decreases as crosslinker Bis
concentration increases and reaches a minimum at a concentration of Bis of 5%. With
higher concentration of Bis, the polymer chain becomes crosslinked into large bundles.
The spaces between these bundles become larger, which directly leads to the increase of
effective pore size. Pore size reproducibility depends on the accuracy and purity of
monomer stock solution. The polymer formed will not be reproducible unless the
polymerization yield reaches over 95%.
Agarose is obtained from the agar-bearing seaweeds from the class Rhodophyta,
or red algae. Agarose is an alternating 1,3 linked beta-D-galactopyranose and 1,4-linked
3,6-anhydro alpha-L-galactopyranose. Agarose gel has the characteristic of large pore
size, which allows it to separate larger complex or molecules like DNA, RNA and
nucleoproteins.

5

Buffer Systems
Buffer systems are classified as continuous and discontinuous buffer systems. If
the same buffer ions are present throughout the sample, gel and electrode reservoirs at
constant pH, it is referred as continuous buffer systems. In contrast, if different buffer
ions are used in the gel compared to those in the electrode reservoirs, it is called as
discontinuous buffer systems. Both buffer composition and pH factors are applied in
most discontinuous buffer systems. The major advantage of discontinuous buffer systems
is that good resolution of sample components can be obtained even for large volumes of
dilute protein samples. The most commonly used SDS-Discontinuous system described
by Laemmli16 consists of Tris-glycine buffer pH 8.3 in both upper and bottom electrode
reservoir, Tris-HCl buffer pH 6.7 in stacking gel and Tris-HCl buffer pH 8.8 in resolving
gel. An anionic detergent, sodium dodecyl sulphate (SDS), which is the most common
dissociating agent, is present in the entire buffer system. SDS can bind to hydrophobic
portions of a protein (one SDS anion to two amino acids) in a constant weight ratio (1.4g
SDS per gram of polypeptides). The natural charges of the polypeptide are insignificant
compared to the negative charges provided by the SDS, so the SDS bonded polypeptides
have identical charge densities and migrate in gels according to polypeptide size.
Polyacrylamide gel electrophoresis (PAGE) can be carried out at a pH anywhere between
2.5 and 1115. In SDS-PAGE, the SDS-polypeptides are negatively charged over a wide
range so the pH of the buffer systems is not critical.
Two-dimensional Gel Electrophoresis (2D-SDS-PAGE)
Traditionally, two-dimensional gel electrophoresis (2D-SDS-PAGE) coupled with
MS is used for differential protein expression studies3. As described previously, 2D-SDSPAGE is involved in resolving proteins by isoelectric focusing (IEF) using immobilized
pH gradient (IPG) strips in the first dimension followed by further protein separation
using SDS polyacrylamide gel17 in the second dimension. For comparative proteomic
studies, practically two protein samples from control and tested samples are dissolved in
loading buffer and loaded onto two IPG strips, respectively. The proteins are absorbed
into the IEF strips with the aid of low voltage and further resolved by increasing the

6

Figure 1. 2: Mechanism of acrylamide polymerization 14. Polyacrylamide gel is
prepared by adding free radical initiators like ammonium persulfate and N,N,N’N’tetramethylethylenediamine (TEMED) to an aqueous solution of the monomer mixture,
which typically includes acrylamide monomer and crosslinking agent N,N’-methylene
bisacrylamide (bis).
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voltage. Once the first dimension separation is finished, the IPG strips are transferred to
the top of 1D-SDS-PAGEs and gel electrophoresis is carried out under voltage. The
resolved proteins are visualized by conventional staining techniques, such as Coomassie
Blue18, SYPRO Ruby19 or silver staining20. Among these staining techniques, the
sensitivity of SYPRO Ruby and silver staining can reach 1ng, which are more sensitive
than Coomassie Blue. SYPRO Ruby has better linear dynamic range (1-1000ng)
compared to silver staining (1-100ng). Relative quantities of each pair of interested
proteins can be obtained by comparing the densities of stained spots from control sample
with the tested sample via gel image analysis softwares like PDQuest21 22.
High-Performance Liquid Chromatography (HPLC)
Since HPLC was developed in 1970’s23, it has been extensively applied to
separate a variety of mixtures including biological, environmental and industrial samples.
The HPLC instrument consists of reservoirs of mobile phase, a pump, an injector, a
separation column and a detector23. The separation is performed by pumping mobile
phase at high pressure through the column followed by introduction of the sample to be
analyzed onto the column. The sample is then forced to flow through the column by
continuously running mobile phase and eventually detected by the detector while eluting
from the column. HPLC comprises all liquid chromatographic techniques that require the
use of high pressure to force the liquid through a packed bed of the stationary phase.
Among these liquid chromatographic techniques, reversed-phase chromatography and ion
exchange chromatography are typically used for peptide separation prior to MS analysis
in proteomics and therefore will be discussed in detail.
Reversed-Phase Chromatography
Reversed-phase chromatography (RP-HPLC) is a very popular HPLC tecnique
and accounts for about 90% of small molecule separations HPLC 24. RP-HPLC is
characterized as comprising a non-polar stationary phase and a polar mobile phase. The
hydrophobic stationary phases for RP-HPLC are to a large extent based on long-chain
hydrocarbons attached to supports. For peptide separation, Silica-based C18 packing
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materials have been commonly used. This type of packing materials is prepared by
treating silica support with RMe2SiCl, where R is a straight chain alkyl group: C18H3725.
A typical mobile phase for RP-HPLC contains mixtures of water with polar organic
solvents like methanol or acetonitrile. RP-HPLC operates on the principle of
hydrophobic interactions between the analytes and nonpolar stationary phases. Many
models have been developed to explain retention in reversed-phase chromatography26-29.
According to the liquid-crystalline hydrocarbon partition model developed by Martire
and Boehm30, the properties of the stationary phases, which directly influence the
retention behavior in RPC, will change dramatically with mobile phase conditions. The
bonded hydrocarbon chains on the surface of the silica support are extended and oriented
at organic-rich mobile phase. The brush-like configuration allows complete penetration
of solvent and solute molecules. However, as mobile phase increases aqueous
composition, the alkyl chains behaves as a quasi-liquid layer that allows solute
penetration but not solvent. Martire and Boehm concluded that the retention process in
RPC approaches the classic liquid-liquid partitioning model. As known in partitioning
model, the equilibrium generated during analytes partition between the stationary phase
and the mobile phase23 can be described as Eqn. 1.4.

Amobile ↔ Astationary

Eqn. 1.4

The equilibrium constant (K) is defined as the ratio of the molar concentration of analyte
in the stationary phase and the molar concentration of the analyte in the mobile phase
(Eqn.1.5):

K=

Cs
Cm

Eqn. 1.5

Hydrophobic peptides have higher equilibrium constants (K) and stay on the
stationary phase longer than relatively hydrophilic peptides. When mobile phase passes
through the column, peptides move in and out of the stationary phase and migrate toward
the direction of the column outlet. When enhancing the hydrophobicity of the mobile
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phase, the partition equilibrium can be shifted toward the mobile phase. Theoretically,
the most polar component elutes first, and the most nonpolar component elutes last25.
Column Efficiency
A fundamental disadvantage of HPLC is the broadening of the sample component
band during migration through the separation system, which seriously affects column
efficiency of the chromatographic separation. The column efficiency is usually measured
by plate count (N), which is related to the length of the separation column and the
theoretical plate height (H), as shown in Eqn.1.6:
N=

L
H

Eqn. 1.6

L: length of the separation column;
H:

theoretical plate height

The theoretical plate height is used as a measure of relative peak dispersion in distillation
technology. The relationship of the theoretical plate height with linear velocity can be
described by the Van Deemter equation31 (Eqn. 1.7):
H=A+

B
+ Cu
u

Where

Eqn. 1.7

u = the linear velocity of the mobile phase
A= the eddy diffusion
B= the longitudinal diffusion coefficient
C= Resistance to mass transfer in the stationary (Cs) and
mobile (Cm) phases

The eddy diffusion term (A) relates to the various pathways, by which a component finds
its way through the column. It is independent of the flow velocity but dependent on the
size of the packing particles, the distribution of the inter-particle channels and other nonuniformities in the packed bed. The longitudinal diffusion term, B/u, describes the
molecular diffusion in the axial direction. It is inversely related to the mobile phase
10

velocity. Cu represents all terms related to mass transfer between mobile and stationary
phase. It is associated with the time needed for establishing dynamic equilibrium of an
analyte between the mobile and stationary phases and directly proportional to the linear
velocity. At high mobile flow rates there is less time for this equilibrium to take place,
therefore a higher Cu value is observed.
A plot of plate height versus linear velocity is shown in Figure 1.3, which
indicates the optimum flow rate of a given column. As shown in Figure 1.3, at mobile
phase velocities below the optimum, the overall column efficiency is mainly affected by
eddy diffusion term A. At the optimum velocity, the longitudinal diffusion term (B/u)
plays an important role on increase of the theoretical plate height. When velocities
become higher than the optimum, the resistance to mass transfer term (Cu) contributes
more for the decrease of column efficiency. Column efficiency takes into account only
peak dispersion. The higher values of theoretical plate height, are the lower column
efficiencies obtained, which implies broad chromatographic peaks are observed. In order
to obtain high column efficiency for peptide separation, RP-HPLC running condition
needs to be optimized.
Challenges in LC-MS/MS-Based Bottom-up Proteomics
The proteomes of mammalian cells, tissues and biologic fluids are complex and
consist of thousands proteins. For peptide fragmentation, protein mixtures are subjected
to tryptic digestion prior to LC-MS/MS analysis, which makes the sample more
complicated. Therefore, it is very important to evaluate the peak capacity of the
chromatographic column to see if it can overcome the sample complexity for
comprehensive analysis. Peak capacity (nc) represents the number of peaks that can be
separated from one another by a specific chromatographic column, which is defined by
the equation31 (Eqn. 1.8):

nc =

L
4σRs

Eqn. 1.8
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Plate height, H

H = A + B/u + Cu
Cu

A
B/u
Linear velocity, u
Optimum u
Figure 1. 3: The van Deemter plot 31. H is the plate height, A is the Eddy diffusion term,

B is the longitudinal diffusion term, C is the resistance to mass transfer term and u is the
mobile phase velocity.
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where L is the column length, σ is the standard deviation and Rs is the resolution of
separated peaks. The equation is based on the assumption that all the peaks are separated
from one another by four standard deviations of the Gaussian peak profile, which is far
beyond actual situation. Therefore, the peak capacity ideally reflects the maximum
number of resolved peaks that can fit within the column length. For best-case scenario,
considering that a reversed-phase chromatography column has a peak capacity of 250 32
and no more than 10-20 peptides can be analyzed simultaneously in electrospray
ionization mass spectrometers, theoretically, the peptides that can be separated and
analyzed using LC-MS might reach103 at most, which is still orders of magnitude lower
than the peptide number generated in a proteome (for example, about 4000 predicted
proteins from E. coli genome)33. Therefore, additional fractionation steps are needed to
deal with a sample’s complexity. Furthermore, the abundance differences from protein to
protein in most proteomes, which are far beyond the dynamic range of most mass
spectrometers, seriously challenges the LC-MS/MS analysis. The coelution of high and
low abundance peptides due to the limited peak capacity of RP-HPLC columns
compounds this problem. The ionization of low abundance peptides can be suppressed
and their spectra are masked by high abundance species, making it very difficult to
analyze all species.
In order to analyze low abundance proteins or as many proteins as possible in a
proteome, further sample purification steps such as removal of high abundance proteins
from samples or sample simplification via affinity selection methods34 35 are widely
employed. Another effective way is the application of multidimensional HPLC
separations36-38 to increase HPLC peak capacity, therefore reducing the number of
coeluting peptides. The most commonly used two-dimensional HPLC system involves
the combination of strong cation exchange (SCX) chromatography with reversed-phase
HPLC chromatography.
Strong Cation Exchange Chromatography

Strong cation exchange chromatography (SCX)39 is based on the electrostatic
attraction between opposite charges on the stationary-phase and the molecules. The
typical strong cation exchange column has sulfonic acid groups on the surface of the
13
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Figure 1. 4: Schematic representation of a surface-sulfonated cation exchange material.
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stationary phase. Since the sulfonic acid functional group can be ionized at all pH values
and has negative charges, it has wide applications23. Figure 1.4 schematically depicts a
representative cation exchange material. Typically, the SCX column is equilibrated using
low ionic strength buffers (e.g. 0.1% formic acid, 95% aquious solution, 5% acetonitrile).
Under these conditions, all sulfonate groups in the stationary phase are associated with
protons. Then, the sample is applied to the stationary phase. Only species carrying
positive charges will be retained by the negative charged stationary phase. Species
having negative charge or no charge will simply flow through without binding. The ion
exchange matrix is washed with additional low ionic strength buffer to completely
remove any remaining unbound species from the SCX column. The exchange reaction of
a cation M+ with a cation exchanger on the stationary phase can be expressed as
follows39:
Resin-SO3-H+ + M+A- ↔ Resin-SO3-M+ + H+AThe separation of cations is determined by their different affinities towards the stationary
phase. The bound peptides are eluted by increasing the salt concentration of the mobile
phase. As the ionic strength of the mobile phase increases, salt cations compete with the
peptides for binding to the charges on the ion exchange matrix. Peptides with weaker ion
interactions will be released at lower salt concentrations. Peptides with higher charge
will have a higher affinity towards the stationary phase and will stay on the column
longer. The effectiveness of displacement for cations39 commonly used in mobile phase
is: Ca2+ > Mg2+ > Na+ > K+ >NH4+. Ammonium acetate is usually employed for peptide
separation in proteomics. The elution is expressed as follows:
Resin-SO3-M+ + NH4+AC- ↔ Resin-SO3-NH4+ + M+ACElectrospray Ionization-Ion Trap Mass Spectrometry
Electrospray Ionization

One challenge for LC-MS is the introduction of species eluted from a HPLC
column to a mass spectrometer. The difficulty is to transform a solute in solution into a
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gas-phase ion. Currently electrospray is the most popular technique for ion introduction
approach. John Fenn demonstrated the use of ESI for the ionization of high mass
biological compound 40, 41, over 20 years ago and won the 2002 Nobel Prize in chemistry
for his contribution to the development of electrospray ionization 42.
Electrospray ionization takes place at atmospheric pressure. It is considered to be
a soft ionization method since little or no fragmentation takes place during this process.
The full MS spectrum provides mainly molecular weight information of analytes.
Practically, the HPLC effluent is directly connected to the electrospray probe, which is
shown in Figure 1.5. A typical voltage between 500 V to 4.5 kV is applied to the ESI
probe tip. When the HPLC effluent passes through the electrospray needle, the high
voltage leads to charged droplets spraying out of the probe tip. Those droplets have the
surface charge identical to the electrospray needle. Thus the droplets are repelled from
the needle and fly toward the counter electrode on the atmospheric pressure ionization
(API) sources. The droplets generated from this process contain both solute and solvent
molecules. Solvent evaporation starts to take place as soon as the droplets form and fly
towards to the API stack. Then the droplets are drawn into a heated capillary located in
the API stack from atmospheric pressure region to vacuum region by a decreasing
pressure gradient. The high temperature of the heated capillary assists solvent
evaporation process of the charged droplets. Ultimately, all solvent molecules evaporate
and gas-phase ions are formed.
ESI can be operated in either positive mode (positive potential is applied to the
electrospray needle) or negative mode (negative potential is applied to the electrospray
needle)43. The produced ions are dependent on the species present in eluent buffers. In
positive mode, typical ions produced by ESI include [M+H] +, [M+Na] +, [M+K] + and
[M+CH3CN+H] +, etc. In negative mode, ions like [M-H] - and [M+HCOO -] - are easily
generated. Considering properties of peptides, the positive mode is usually used during
the ESI for bottom-up proteomics. The typical buffer used for peptide elution from
HPLC is 0.1% formic acid in water or 0.1 % formic acid in water-acetonitrile solvent
which has an approximate pH of 3. Under this condition, multiple positive charged
peptide ions can be easily formed.
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Figure 1. 5: A schematics of electrospray probe. The HPLC effluent is directly

connected to the electrospray probe. A typical voltage between 500 V to 4.5 kV is
applied to the ESI probe tip. When the HPLC effluent passes through the electrospray
needle, the high voltage leads to charged droplets spraying out of the probe tip.
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Mechanisms of Electrospray Ionnization
The first step of ESI is production a stream of charged droplets at the capillary
needle tip. The high potential applied at the electrospray capillary needle leads to a
partial separation of positive ions from negative ions in the solution. In the positive
mode, positive ions are forced to move to the surface of the liquid at the capillary needle
tip while negative ions are forced to move back forward the inside of the capillary needle.
The repulsion of the positive ions at the surface overcomes the surface tension of the
liquid, causing the formation of a Taylor cone at the the capillary needle tip (Figure 1.6).
The tip of the Taylor cone breaks up into individual charged droplets. The occurrence of
the whole process requires at least 10-5 molar electrolytes present in the liquid. Since ESI
is a continuous process, series of droplets form and move toward the counter electrode,
which forms the total droplet current (TDC) between the electrospray capillary needle
and the negative counter electrode. An electrochemical oxidation reaction, which
removes negative ions, occurs at the metal capillary44. Correspondingly, an
electrochemical reduction reaction, which removes positive ions, occurs at the negative
counter electrode (Figure 1.6).
Once the droplets form, solvent evaporation starts and eventually gas-phase ions
are formed. This process can be explained by two mechanisms. One is called the
charged residue model (CRM), originally proposed by Dole 45, 46, and the other one is the
ion evaporation model (IEM), which is proposed by Iribarne and Thomson47-50 .
According to charged residue model, as solvent evaporation occurs, the droplet keeps
shrinking until the Rayleigh limit is reached. This implies the surface tension can not
hold the charges in the droplet any longer. A "Coulombic explosion" occurs to break up
the droplet into smaller droplets. The whole process repeats until the droplets are so small
that only one analyte molecule is present. Then the gas-phase ions will be produced by
evaporating all solvent in the droplets. The ion evaporation model (IEM) proposes a
different scheme. In brief, the initial droplet shrinkage is via solvent evaporation and
Coulomb droplet fissions. However, when the process has reduced the size of the
charged droplets to a certain point, direct emission of ions to the gas phase begins to
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Figure 1. 6: A schematic of the mechanism of ion formation in ESI. *: Adapted from
http://www.chm.bris.ac.uk/ms/theory/esi-ionisation.html
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occur. Since the charge density on the droplet required for this ion-emission is lower
than that required for the Coulomb fission, ion emission replaces Coulomb fission until a
naked charged ion is formed.
Electrospray ionization has several features. First of all, it is characterized as a
soft ionization technology since very little residual energy is retained by the analyte.
Therefore, ESI does not damage non-covalent interactions during the process of
transferring the analytes into gas phase, which is crucial for biological studies involved in
protein-protein interactions. Second, it is well-known that ESI is able of producing
singly or multiply charged ions depending on the chemical structure of the analyte. For
peptide analysis, since both N-terminal amino groups and basic side-chains of peptides
can be protonated at low pH value, multiple positively charged ions are easily formed
during the ESI process, which is critical for analyzing high molecular weight peptides
using mass spectrometers with limited mass range detection such as quadrapole ion trap
mass spectrometers. Also, since very little fragmentation is produced during the ESI
process, tandem mass spectrometry is needed to fragment analytes for structural
elucidation studies.
Quadrupole Ion Trap Mass Spectrometry

In the early 1950s, Wolfgang Paul and co-workers invented both the quadrupole
mass analyzer and the quadrupole ion trap mass spectrometer (QIT-MS)51. For the
invention of the ion trap, Dr. Paul won the 1989 Nobel Prize in Physics. His work builds
the foundation of the present-day quadrupole ion trap instruments. However, because of
limited performance of the ion trap at that time, it was primarily restricted to the physics
community. In 1983, breakthroughs in ion trap design were fulfilled by George Stafford
and co-workers at Finnigan MAT52 which significantly simplified the operation of the ion
trap and simultaneously improved the mass resolution of the instrument. All these
improvements led to the successful development of a commercial ion trap mass
spectrometer. Today, the QIT-MS has been widely applied to chemical, biochemical and
forensics areas and has become one of the most common instruments in various
laboratories. A schematic of the basic setup of a quadrupole ion trap is shown in Figure
1.7. The core of quadrupole ion trap consists of three hyperbolic electrodes: a ring and

20

two end-caps. These electrodes form a small trapping volume with a dimension of r0 and
z0 as shown in Figure 1.7. A gating lens located in front of the entrance end-cap
electrode pulses positive or negative voltages to repel or inject ions into the ion trap. The
gating lens open time is optimized so that maximum signal and minimum space-charge in
the ion trap can be obtained. Ions injected into the ion trap collide with helium gas
molecules present in the trap (1 mtorr). The collisions dampen the kinetic energy of the
ions and make these ions move toward the center of the ion trap53, 54. The fundamental rf
(1.1 MHz), which creates a saddle-shaped quadrupole field in the ion trap, is applied onto
the ring electrode for further focusing the ions toward the center of the trap7. The
oscillation of the fundamental rf causes a periodic inversion of the quadrupole field,
which leads to the ion staying at the center of the trap. The potential values at any point
of the quadrupole field can be described by the following equation55, 56 (Eqn. 1.9):

φr,z =

(U − V cos Ωt )  r 2 − 2 z 2  (U − V cos Ωt )

+
2
2
2
r
0



Eqn. 1.9

where, U = dc potential applied to ring electrodes
V = rf amplitude applied to ring electrode (fundamental rf)
Ω = oscillating frequency of rf (V), typically 1.1 MHz

r0 = distance between the center of QIT and the ring electrode
r = closest distance between the ion and the ring electrode
z = closest distance between the ion and the end-cap electrode
The solutions to the equation can be expressed in the form of a second order differential
equation, the Mathieu equation7. Two dimensionless Mathieu parameters az and qz,
derived from the Mathieu equation (Eqn. 1.10 and Eqn.1.11), are used to describe ion’s
stable motion in the trap:
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Figure 1. 7: A schematic of quadrupole ion trap. The core of quadrupole ion

trap consists of three hyperbolic electrodes: a ring and two end-caps. These electrodes
form a small trapping volume with a dimension of r0 and z0. A gating lens located in
front of the entrance end-cap electrode pulses positive or negative voltages to repel or
inject ions into the ion trap. Ions injected into the ion trap collide with helium gas
molecules present in the trap (1 mtorr) and get trapped in the trap, or move out of the trap
by adjusting amplitude of RF on the ring electrode.
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qz =

2eV
mr02 Ω 2

az =

4eU
mr02 Ω 2
where,

Eqn. 1.10

Eqn. 1.11

e = electronic charge
m = the mass of the ion

Mathieu Stability Diagram

A plot of az vs qz is called Mathieu stability diagram,7 and represents radial and
axial stability overlap. Depending on the values of the dc potential (U) and rf amplitude
(V) placed on the ring electrode, an ion of a given m/z will have an az and a qz value. If
the values fall within the boundaries of the stability diagram, the ion will be trapped. If
the values fall outside of the boundaries of the stability diagram, the ion will hit the
electrodes and be lost. By changing both dc potential (U) and rf amplitude (V) on the
ring electrode, we can control the movement of an ion with a given mass-to-charge ratio
in the ion trap so that the ion of interest can either stay within the boundaries of the
stability diagram and be trapped in the trap, or move out of the boundaries and be
expelled from the trap.
Mass Selective Instability Scan

Mass spectra are normally recorded by means of the “mass selective instability
scan” mode 52. In this mode of operation, the dc potential (U) on the ring electrode is not
employed and the ion motion is constrained to the az = 0 axis. The rf potential (V) applied
to the ring electrode is raised to “move” ions along the qz axis. When qz values approach
0.908, ions reach the boundary of the stability diagram, become unstable, and eventually
are ejected from the ion trap (shown in Figure 1.8). A well-defined low-mass cutoff is
created for a given value of the fundamental rf (V). Theoretically, ions with mass larger
than mmin will be trapped in the trap. But ions with large m/z values ions have low
trapping efficiency compared to ions with small m/z values. As amplitude of the
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fundamental rf potential (V) is raised, ions of increasing m/z are sequentially ejected
from the ion trap through the holes in the end-cap electrode and detected by an external
electron multiplier detector. Therefore, a mass spectrum is produced.
Resonance Ion Excitation and Ejection

The other way to eject ions from ion trap is resonance ejection57. Ions oscillate
with a frequency, the secular frequency (fz), when they are trapped in the QIT. The
secular frequency (fz) is lower than angular frequency ( Ω ) of the fundamental rf and
decreases with increasing mass. It is determined by the values for az, qz and Ω . When a
supplemental potential which has frequency that matches the secular frequency fz of an
ion is applied on the end-cap electrode of the ion trap, the ion’s kinetic energy is
increased and its axial trajectory is exaggerated until the ion is ejected from the trap. So
resonance ejection can expel ions from the trap at a qz value below normal value (0.908).
For example, qz values as low as 0.01 instead of 0.908 can be used to eject ions in this ion
ejection method, therefore, extending the mass to charge ratio range that can be scaned in
normal scan mode.
MS/MS Experiments

Tandem mass spectrometry in an ion trap can be carried out in three steps: the
isolation of the ions of interest, the fragmentation of ions via collision-induced
dissociation (CID) and the scan of resultant product ions out of the trap. Resonance
ejection57 as described above can be employed to isolate an ion with particular m/z, while
ejecting all others. Another approach to ion isolation is reverse-then-forward scanning55.
A supplemental rf is applied to the endcap electrodes to create an ejection hole at low qz.
Ions bigger than the ion of interest are first moved to the ejection hole and are ejected out
of the trap by scanning the findermental rf amplitude (V) on the ring electrode in the
reverse direction. Then the ions smaller than the interest ion are ejected by changing the
supplemental rf to form an ejection hole at high qz. The rf amplitude on the ring electrode
(V) is then scanned forward, thus ejecting all ions of lower m/z 7. Once
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Figure 1. 8: Mathieu stability diagram for a 3D quadrupole ion trap. The az

parameter is proportional to dc and the qz parameter is proportional to rf. In “mass
selective instability scan” mode, the dc potential (U) on the ring electrode is not
employed and the ion motion is constrained to the az = 0 axis. The rf potential (V) applied
to the ring electrode is raised to “move” ions along the qz axis. When qz values approach
0.908, ions reach the boundary of the stability diagram, become unstable, and eventually
are ejected from the ion trap.
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the ions of interest are isolated, the low-energy collision-induced dissociation (CID)
fragmentation is performed by the application of a supplemental potential (ac) with a
low-amplitude to the endcap electrodes, which causes excitation of the ion and the
increase of the ion kinetic energy. The amplitude of the applied supplemental potential is
controlled to a reasonable level so that the ion will not be ejected from the trap. The
excited ions in the trap collide with the damping gas helium and fragment to from
product ions. The last step of the MS/MS experiment is to sequentially eject product ions
from low m/z to high m/z by a gradual change in the fundermental rf amplitudes (V).
Ions are ejected through holes in the endcap electrode and detected using an electron
multiplier.
Quadrupole ion trap mass spectrometers have become one of the most popular
instruments and have been widely used in bottom-up proteomic studies due to their
unique features. First of all, QIT is very amenable to soft ionization techniques like ESI
ionization, making it suitable for biological molecule analysis. Also the QIT instruments
have the ability to perform MSn experiments58. The QIT has been used to perform up to
12 stages of tandem mass spectrometry (MS12), greatly increasing the amount of
structural information obtainable for a given molecule. These characteristics make the
ion trap extensively applied to bottom-up proteomics.
In order to meet the needs of full automation and high through-put analysis of a
numbers of proteins in bottom-up proteomics, QIT mass spectrometers are usually
coupled with HPLC via electrospray ionization techniques. Data-dependent algorithms
have been used to obtain both MS and MS/MS data during the course of a single LC/MS
run. In the data-dependent mode, the instrument first acquires full scan mass spectra,
then the most intensive precursor ions from previous full scan spectra are automatically
chosen for following MS/MS experiments. The switch from MS mode to MS/MS mode
takes place once a signal threshold is exceeded. With dynamic exclusion enabled, once
one ion is analyzed by MS/MS, it is put on an exclusion list. The ion is not analyzed
further for a pre-selected time window. Then the instrument proceeds with the analysis
of other ions present in the full scan.
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Proteomic Bioinformatics

Peptide CID fragmentation is usually carried out by cleaving amide bonds along
the peptide backbone, producing six possible types of fragments: a,b,c ions (when the
charge is retained on the N-terminal fragment), and x, y, z ions (if the charge is retained
on the C-terminus)59. Under low-energy collision-induced dissociation conditions,
peptides typically form b, y, and occasionally a ions (structure showed in Figure 1.9).
Peptide sequences can be elucidated by using database searches or de novo sequencing6.
The database-searching approach is convenient and important for high through-put
protein identification technology such as 2D-LC-MS/MS. However, when the
corresponding sequences are not included in the databases, de novo sequencing will play
an important role in its identification. Since no preliminary information about the peptide
is necessary for de novo sequencing approach, continuous y ions or b ions are required
for complete sequence elucidation.
The Mascot database search engine60 is used for protein identification in this
dissertation. As one of the commonly used database searching algorithms, the Mascot
database search engine is developed based on MOWSE algorithm.1 Mascot adds a
probability-based algorithm to the Mowse algorithm. Protein identification is based on
the calculation of the probability (P) that the observed match between the experimental
data and theoretical value is a random event. Therefore, the best match directly
corresponds to the lowest probability value. In order to easily interprete search results,
the calculated probability values are converted into Mowse scores using the
equation − 10 * log 10 * ( P) , thus giving a high score for a good match. Using Mascot

score allows the peptide or protein which best matches the data to be identified.
Since Mascot is derived from MOWSE algorithm, the detail of MOWSE
algorithm is discussed. At first, the calculated peptide masses in the sequence database is
generated and used to compare with the experimental data set. If one calculated value
falls within a given mass range of an experimental value, it counts as a match. Each
individual peptide match is statistically evaluated by Mowse using empirically
determined factors. A matrix of weighting factors is created using a frequency factor
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matrix (F). In this matrix, each row represents an interval of 100 Da in peptide mass, and
each column stands for an interval of 10 kDa in intact protein mass. As each calculated
peptide mass is compared, the appropriate matrix element fi,j for each match is obtained.
Then each element in the matrix is normalized via dividing individual fi,j value by the
largest fi,j value in the same column to give the Mowse factor matrix mi,j (Eqn. 1.12):
mi , j =

f i, j
f i, j

Eqn. 1.12

max incolumnj

After finishing the search of the experimental mass values against a calculated peptide
mass database, the score for each peptide is obtained based on Eqn.1.13:
score =

50,000
M Pr ot × ∏ mi , j

Eqn.1.13

n

where Mprot is the molecular weight of the entry and

∏m

i, j

is the product of distribution

n

factors for each match between the experimental data and peptide masses calculated from
the entry.
Compared to the MOWSE algorithm, Mascot not only can support peptide mass
fingerprint search, but is also used for MS/MS Ion Searches. For an MS/MS Ions Search,
the analysis begins with the conversion of MS/MS spectra into mascot generic format
(MGF), which is a list of pairs of mass and intensity values, delimited by BEGIN IONS
and END IONS statements for each MS/MS dataset. Then theoretical peptide mass or
fragment ion masses are calculated based on the pre-selected parameters such like
proteolytic enzyme used to cleave protein, potential modification and database used to be
searched. The generated MGF files are searched against the computer-calculated peptide
mass or fragment ion masses in a database entry. Eventually, Mascot scores are
generated and used to indicate if the match is a good match or not.
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Figure 1. 9: Illustration of the fragments formed through bond cleavages along the
backbone of protonated peptides. Peptide CID fragmentation is usually carried out by

cleaving amide bonds along the peptide backbone. Under low-energy collision-induced
dissociation conditions, peptides typically form b, y.
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Statement of Research

This chapter is mainly focused on the introduction of background knowledge that
involves the following chapters. It includes the definition of proteomics, the
development of bottom-up proteomics and methodologies used for bottom-up
proteomics. Tools employed in bottom-up proteomics, such as HPLC, ionization
techniques, mass spectrometer and data analysis, have been discussed in detail.
The remaining part of this dissertation mainly focuses on discussion of the
research that has been conducted on method development and application in proteomics.
Two parts, which involves the method developments in qualitative and quantitative
proteomics, will be presented in detail. Part one is method development for qualitative
proteomic analysis and its application on qualitative analysis of the T. gondii
Parasitophorous Vacuole Membrane (PVM). Part two is regarding a novel methodology
for selection of an appropriate labeling reagent for potential application on quantitative
proteomics.
Chapter two focuses on qualitative analysis of the T. gondii PVM proteins (part
one). In order to do this, a novel protein concentration and clean up method for
challenging protein samples like PVM sample, “Three-layer Sandwich Gel
Electrophoresis” (TSGE) was developed. Its performance was compared with other
available protein concentration and salt removal methods. By coupling with MuDPIT,
the application of TSGE method to proteomic analysis of whole T. gondii lysate was also
discussed to prove that the new methodology can correctly reflect the composition of
protein sample and is suitable for global proteomics. Finally, application of the novel
methodology on proteomic analysis of T. gondii PVM proteins is presented. The
identified PVM proteins were further analyzed and discussed.
Chapter three describes the systematic study of mass spectrometric properties of
N-terminal labeled peptides with various isocyanates using LC-ESI-MS/MS (part two).
Stable isotope labeling strategies used for quatititive proteomics was introduced. Then
the effect of peptide labeling on peptide ESI properties and peptide fragmentations was
explained. Three commercially available isocyanates were chosen and their mass
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spectrometric properties were systematically studied. Eventually a new isocyanate
reagent for better fragmentation was designed and evelated.
Chapter four is the general conclusion of the dissertation, which provides some
concluding remarks and highlights the significance and future direction of this work.

Copyright © Ting Liu 2008
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CHAPTER TWO

METHOD DEVELOPMENT FOR QUALITATIVE PROTEOMICS AND ITS
APPLICATION ON ANALYSIS OF THE T. GONDII PARASITOPHOROUS
VACUOLE MEMBRANE (PVM)
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Chapter 2.1
Introduction

High through-put bottom-up proteomics has been widely applied to the
identification and characterization of proteins in various biological systems. However,
reliable identification and analysis of the targeted proteins still remains a key challenge in
the study of sub-proteomes and protein interactomes which can play important roles in
our understanding specific protein functions and biological pathways. One main reason
is the difficulty of obtaining high quality protein samples for subsequent well-established
proteomic analysis. It is still hard to isolate low abundance target proteins from high
abundance interfering proteins, especially for organelles that are not capable of being
purified by traditional biochemical methods. Therefore, it is critical to develop efficient
isolation and purification methods for challenging biological samples. Recently,
numerous isolation, purification and enrichment strategies based on affinity pull-down
and immunoprecipitation for different target system have been developed35, 61, 62. These
strategies successfully solved the biological sample preparation problem. However, since
these strategies utilize a variety of reagents such as salts, detergents and other small
molecule additives for the purpose of obtaining the highest amount of target proteins and
simultaneously removing interfering proteins at most, those reagents can either inhibit
protein digestion or impede subsequent MS analyses. Therefore, sample cleanup prior to
proteomic analysis is inevitable.
In this part of the dissertation, we developed a novel proteomic methodology for
qualitative analysis of a sub-proteome, the parasitophorous vacuole membrane (PVM) of
Toxoplasma gondii. The new methodology includes the development of new biological

sample preparation methods for isolation and purification of the PVM organelle
(described in chapter 2.3), the development of the PVM sample concentration and
cleanup methods (described in chapter 2.2), and analysis of the PVM proteins using a
combination of the biological sample preparation and cleanup methods with
multidimensional protein identification technology (MudPIT) (described in chapter 2.3).
In the following part of this chapter, the background on Toxoplasma gondii PVM, gel
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electrophoresis and multidimensional protein identification technology (MuDPIT), will
be introduced.
Toxoplasma gondii and the Parasitophorous Vacuole Membrane (PVM)

Toxoplasma gondii is an obligate intracellular parasite in the phylum

Apicomplexa with a worldwide distribution63. It is a type of parasitic protozoa whose
definitive host is cats. But it also can be found in the majority of warm blooded animals,
including humans. It is estimated that 1/3 of the human population, world wide, is
infected with T. gondii64. As shown in Figure 2.1.1, T. gondii has three forms though its
life65: tachyzoites, which are the rapidly multiplying forms, the quiescent bradyzoites,
which is slow multiplying stage in tissues or non-feline hosts and the oocysts shed in
feces of cats. When a cat ingests uncooked meat containing tissue cysts, the bradyzoites
are released into the small intestine. One part of the bradyzoites first initiates the
formation of several asexual generations. Then the sexual cycle begins with the formation
of the male and female gametes. The male gamete fertilizes the female to produce the
oocyst which is subsequently excreted in the feces. Other bradyzoites begin to multiply as
tachyzoites. Within a few hours of infection, tachyzoites may either enter extra intestinal
tissues or spread to any host cell and multiply. Parasite growth results in an immume
response. This immune response forces the parasite into the quiescent bradyzoite stage.
T. gondii may cause a disease known as toxoplasmosis, which can be most severe

in certain “high risk” groups of individuals whose immunity is impaired63. As shown in
Figure 2.1.2, The T. gondii tachyzoite possesses all the organelles of a typical eukaryotic
cell including the nucleus (N), endoplasmic reticulum (E), Golgi apparatus (G), and
mitochondrion (Mt). In addition to these organelles, the parasite also contains a set of
unique secretory organelles including micronemes (M), club shaped rhoptries (R), and
dense granules (D) that are critical for establisment and maintainence of infection.
Additionally, the apicoplast (A), a unique four-membraned organelle, and an apical
complex including the conoid, the polar ring complex, subpellicular microtubules, and
secretory organelles are also found in the parasite66, 67. Within host cells, T. gondii
resides and multiplies in a specialized compartment called the parasitophorous vacuole
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Figure 2.1. 1: Life cycle of Toxoplasma gondii. T. gondii has three forms though its

life65: tachyzoites, which are the rapidly multiplying forms, the quiescent bradyzoites,
which is slow multiplying stage in tissues or non-feline hosts and the oocysts shed in
feces of cats. When a cat ingests uncooked meat containing tissue cysts, the bradyzoites
are released into the small intestine. One part of the bradyzoites first initiates the
formation of several asexual generations. Then the sexual cycle begins with the formation
of the male and female gametes. The male gamete fertilizes the female to produce the
oocyst which is subsequently excreted in the feces. Other bradyzoites begin to multiply as
tachyzoites. Within a few hours of infection, tachyzoites may either enter extra intestinal
tissues or spread to any host cell and multiply. Parasite growth results in an immume
response. This immune response forces the parasite into the quiescent bradyzoite stage.
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Figure 2.1. 2 : Structure of T. gondii tachyzoite. (Scale bar = 1 µm). The T. gondii

tachyzoite possesses all the organelles of a typical eukaryotic cell including the nucleus
(N), endoplasmic reticulum (E), Golgi apparatus (G), and mitochondrion (Mt). In
addition to these organelles, the parasite also contains a set of unique secretory organelles
including micronemes (M), club shaped rhoptries (R), and dense granules (D) that are
critical for establisment and maintainence of infection. Additionally, the apicoplast (A),
a unique four-membraned organelle, and an apical complex including the conoid, the
polar ring complex, subpellicular microtubules, and secretory organelles are also found in
the parasite
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(PV)68, which is delimited by the parasitophorous vacuole membrane (PVM). The PVM
is derived from host cell plasma membrane. It acts as interface between the growing
parasite and the host cell. As such, the PVM plays many important roles in acquiring
nutrients from the host cell69, 70, in signaling to and from the host cell71, 72, and in
maintaining the structure of the vacuole73. Nutrients required by the parasite must pass
through the vacuole membrane in a controlled fashion. Proteins in the PVM are likely to
have crucial functions that are essential to the survival of the parasite, so they are
attractive targets for potential novel vaccines and drugs.
T. gondii host-cell invasion and the PVM generation is a successive event74;

taking place in 10 s75. The whole process includes gliding motility to reach a host cell,
binding to host receptors and actively penetrating into the host cell. During infection, T.
gondii secretory organelles including microneme, rhoptry and dense granule secrete

proteins to help with parasite invasion and PVM formation. As shown in Figure 2.1.3,
first, microneme proteins are discharged from the anterior end of the parasite when they
attach to the surface of the host cell76-78. Then microneme and rhoptry proteins are
released to form a moving junction with the host-cell plasma membrane that drives the
parasite into the developing PV79. Once it penetrates into the host cell, T. gondii modifies
the host-cell plasma membrane and forms the parasitophorous vacuole membrane
(PVM)80. Soon after penetration, a tubulovesicular membranous network (TMN)
develops within the PV81. Some of the TMN membranes are connected to the
parasitophorous Vacuole membrane (PVM)81. The dense granule proteins are secreted
into the PV and the PVM continuously during the intracellular residence of the parasite
80

. As such, many proteins from the three secretory organelles are likely located in the

PVM. Another striking feature of T. gondii is the morphologically intimate interactions
between the PVM and host cell mitochondria and endoplasmic reticulum (ER)82, 83.
Figure 2.1.4 shows an electron micrograph of a T gondii infected host cell. It can be seen
that the PVM intimately associates with both host mitochondria and ER. Studies indicate
that the maintenance of the organelle associations does not need the viability of
parasites84. Killing the parasite does not affect the established organelle associations.
Also, the extent of mitochondrial-PVM association stays constant as the vacuole grows,
while the extent of ER-PVM association decreases84.
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Figure 2.1. 3: T. gondii host cell invasion. The whole process includes gliding motility

to reach a host cell, binding to host receptors and actively penetrating into the host cell.
First, microneme proteins are discharged from the anterior end of the parasite when they
attach to the surface of the host cell76-78. Then microneme and rhoptry proteins are
released to form a moving junction with the host-cell plasma membrane that drives the
parasite into the developing PV79. Once it penetrates into the host cell, T. gondii modifies
the host-cell plasma membrane and forms the parasitophorous vacuole membrane
(PVM)80. The dense granule proteins are secreted into the PV and the PVM continuously
during the intracellular residence of the parasite 80. *: used with permission from a
presentation by A.P. Sinai, 2006
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Figure 2.1. 4 : The association of the PVM with both host mitochondria and
endoplasmic reticulum ER. *: used with permission from a presentation by A.P. Sinai,

2006
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Multidimensional Protein Identification Technology (MuDPIT)

In order to deal with the complex protein mixtures, John Yates and coworkers85
developed a new protein separation and identification technology: Multidimensional
Protein Identification Technology (MudPIT), which has been widely applied to bottomup proteomics. Rather than use traditional two-dimensional gel electrophoresis to
separate proteins, MudPIT peptides generated from protein proteolytic digests in 2D
liquid chromatography, which allows the direct interfacing with a mass spectrometer. The
approach is demonstrated in Figure 2.1.5. MudPIT online couples fused silica capillary
strong cation exchange (SCX) column with a reversed-phase C18 column. Ammonium
acetate is chosen as the salt to elute peptides from the SCX column due to its high
volatility. Water with 0.1% formic acid and acetonitrile with 0.1% formic acid are
chosen as mobile phases for reversed-phase C18 chromatography. First, the protein
complex is subjected to proteolytic digestion, and then the resultant peptide mixture is
loaded onto a SCX column. Peptides with little net charge will pass through the SCX
column and reach reversed- phase C18 column where they are separated by enhancing
the hydrophobicity of the mobile phase and eventually identified by MS/MS once eluted
from the column. Then the elution cycles start. Each cycle contains an isocratic salt
elution followed by C18 reversed phase gradient elution. Low salt concentrations are
used in initial cycles to elute peptides that have weak interactions with the SCX column.
Increased salt concentrations in the following cycles are used to fractionally "bump"
peptides off the SCX followed by a gradient of increasing hydrophobicity to
progressively elute peptides from the RP column into the ion source. The advantage of
MuDPIT is that by online coupling the SCX column with RP-HPLC, the peptide
separation capacity is significantly increased. Also, since the separation can be interfaced
directly with the ion source of a mass spectrometer, sensitivity of the detection is
maximized.
Study Rationale

The PVM acts as an interface between the growing parasite and the host cell.
Nutrients required by the parasite must pass through the vacuole membrane in a
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Figure 2.1. 5: Schematic illustrating the MuDPIT. Protein mixtures are directly

subjected to enzymatic digestion. The generated peptides are resolved by strong cation
exchange (SCX) column coupled with a reversed-phase C18 column followed by mass
spectrometric analysis using tandem MS. The resultant spectra are eventually searched
against database and the corresponding proteins are identified.
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controlled fashion. Proteins in the PVM are likely to have crucial functions that are
essential to the survival of the parasite, so they are attractive targets for potential novel
vaccines and drugs. In spite of its importance, the PVM is understudied due to inherent
challenges. First, since the PVM is formed and found only within infected cells68, it is
very difficult to obtain PVM protein samples in large quantities. In addition, since the
PVM intimately associates with host mitochondria and endoplasmic reticulum,
biochemical methods cannot isolate it from the host mitochondria and ER86. The problem
is the amount of the PVM proteins is very low compared to that of the host mitochondria
and ER, seriously affecting the characterization of the PVM proteins. These unique
structural characteristics of the PVM impede thorough study of its composition and
biochemical analysis of its functions in spite of its importance as an interface between the
host cell and the parasite. To date, the PVM composition and PVM proteins responsible
for activities are largely unknown.
Study Goals

Since parasitophorous vacuole membrane (PVM) plays important roles in the
survival of T.gondii, identification of proteins in the PVM can establish the foundation
for the characterization of activities associated with the T. gondii PVM and contribute to
the discovery of potential novel vaccines and drugs. The purpose of this study is to
develop a proteomic method for high throughput identification of proteins isolated from
immunoprecipitation by using multidimensional protein identification technology
coupled with mass spectrometry. We then applied the developed methodology to PVM
proteomic analysis and characterize of the PVM proteome of T. gondii.
Study Hypothesis

The hypothesis of this study is that proteomic approaches coupled with
immunoprecipitation using polyclonal antisera as affinity reagents can successfully
characterize the proteome of the T. gondii PVM.
A.P. Sinai and coworkers developed a novel PVM purification method based on
the use of two polyclonal rabbit antisera raised against PVM-enriched cell fractions of
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infected rabbit fibroblasts; by matching the species, reactivity to host proteins was
minimized and specificity to parasite proteins was maximal. The PVM proteins were
extracted from infected host cells using the PVM antibodies crosslinked to protien A
magnetic beads and eventually eluted from the magnetic beads for the subsequent
proteomic analyisis.
However, the protein samples obtained from immunoprecipitaiton had the
characteristics of small amount of proteins, large volume and contain various
contaminants including salts, other small molecules, and more severely, non-ionic
detergent triton-X 100 in the protein sample. All these factors lead to low yield of
enzymatic digestion and interfered with mass spectrometric analysis. Therefore the
sample must be concentrated and purified prior to mass spectrometric analysis. In the
following chapters, a new protein concentration and purification method is introduced.
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Chapter 2.2
Method Development of Salt Removal and Protein Concentration for Challenging
Protein Samples
Introduction

Bottom-up proteomics has been successfully applied to global protein profiling8789

and protein-expression profiling90-93. In addition, bottom-up proteomics is also a

powerful approach for the study of sub-proteomes94-96, protein interactomes97, 98 and
protein posttranslational modifications99, 100 which can play important roles in our
understanding specific protein functions, biological pathways and disease. However,
reliable identification and analysis of the targeted proteins still remains a key challenge in
the study of proteomes. Targeted proteomes are accessible via numerous isolation,
purification and enrichment strategies, including the affinity pull-down approach35, 61, 101,
immunoprecipitation62 and subcellular fractionation102. In these strategies, a variety of
reagents such as salts, detergents and other small molecule additives are utilized that can
either inhibit protein digestion or impede subsequent MS analyses. Multiple enrichment
steps are typically needed for particularly low abundant proteins in biological samples.
These enrichment steps can lead to a large volume of tremendously diluted protein
sample. Therefore, development of an efficient concentration and cleanup methods for
these challenging samples is critical before successful analysis of targeted proteins in
proteomics can be realized.
One of the most frequently used methods for sample cleanup and buffer exchange
is dialysis103. However, instead of reducing sample volume, dialysis can actually
increase sample volume and result in serious sample loss from dilution and binding to
dialysis membranes and vessels. Various commercially available microcentrifugation
devices (spin filters) have been used for protein concentration and contaminants removal.
These devices can usually deliver rapid sample concentration and cleanup, and
simultaneously provide high protein recoveries. But for samples containing low protein
concentrations, high concentration of salts, detergents or other contaminants, significant
protein losses can take place. Arnaud et al.104 developed a new salt removal method
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referred to as the “Off-Gel technology”, which is based on Off-Gel electrophoresis105, 106.
Unfortunately, this method is only useful for removal of charged species and is not
suitable for nonionic contaminants like detergent Triton X-100, which are often used in
the preparation of biological samples. Additionally, the sample volume is limited by the
dimensions of the flow-chamber in Off-Gel devices and cannot be practiced on large
volume samples or used to concentrate samples during operation. Recently, another new
method was reported, the Tube-Gel digestion protocol107. The Tube-Gel protocol directly
incorporates protein samples into the acrylamide monomer solution prior to gel
polymerization. Contaminants present in the sample are removed by washing gel pieces
before in-gel digestion. The advantage of this method is that various MS-incompatible
detergents can be used for sample preparation and removed prior to mass spectrometry.
Unfortunately, this method is not suitable for large volume samples. Additionally,
acrylamide can react with amino acid residues in proteins, such as His, Lys, Tyr, Cys or
the N-terminus under appropriate pH conditions108. The addition of proteins into
acrylamide monomer prior to gel polymerization can lead to modification and/or
crosslinking of proteins. Most damaging would be protein dependant modifications that
could lead to losses of specific proteins during purification. Acrylamide modified
proteins can significantly reduce digestion efficiency and sequence coverage during
enzymatic digestion, and consequently affect the overall proteomic analysis.
In this part, we combined the properties of agarose gels, and low and high
percentage acrylamide gels to develop a new protein concentration and cleanup method,
the “Three-layer Sandwich Gel Electrophoresis” (TSGE). In this three-layer system, a
high percentage acrylamide gel was employed as the bottom or sealing layer. The middle
or concentration layer was 100-150µL of a 12% acrylamide gel. Protein samples were
directly mixed with a stock agarose solution to make the top agarose layer. Therefore, in
practice, proteins are first trapped in the top, adjustable volume agarose layer and then
forced to move to the middle layer under voltage. Because of the obstacle presented by
the high percentage sealing layer, all proteins will eventually concentrate in the middle
layer and be available for subsequent in-gel digestion and analysis. In addition, most of
the salts, detergents and other contaminants in the protein sample, which are not
compatible with subsequent trypsin digestion and/or mass spectrometric analysis, will be
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removed during electrophoresis. Any remaining contaminants in the concentration layer
are easily removed by washing the concentration layer prior to in-gel digestion.
Compared to other methods, the TSGE method not only efficiently removed solvents and
contaminants, but also produced significantly improved protein recoveries. Furthermore,
the TSGE method in combination with 2D-LC-MS/MS can be applied to complex
proteomic analysis as evidenced by our proteomic interrogation of the intracellular
protozoan parasite, Toxoplasma gondii. Valuable insights obtained from this study
highlight the utility of the TSGE method for high through-put protein analysis.
Experimental
Materials

SDS-PAGE low range protein standards, Laemmli sample buffer, Coomassie
Brilliant Blue G-250, Tris base, SDS, acrylamide, N,N-methylene-bis-acrylamide (Bis),
ammonium persulfate (APS), N,N,N,N-tetramethylethylenediamine (TEMED), glycine
and Agarose (Standard Low-mr) were obtained from BioRad (Hercules, CA).
Ammonium sulfate was obtained from EMD Chemicals (Gibbstown, NJ). Hydrochloric
acid, o-phosphoric acid, formic acid, methanol, HPLC grade acetonitrile, and HPLC
grade water were purchased from Fisher Scientific (Chicago, IL). Sequencing grade
modified trypsin was supplied by Promega (Madison, WI). Buffers involved include:
PBS (137mM NaCl, 2.7mM KCl, 10mM NaH2PO4, and 1.8mM KH2PO4 adjusted to pH
7.4) and RIPA buffer (10mM Tris-HCl (pH 8.0), 140 mM NaCl, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% SDS and 0.025% sodium azide). 2% agarose stock gel was
made by mixing agarose powder with water, and then the mixture was heated in a
microwave oven until completely melted.
Equipment

A model 422 Electro-Eluter (BioRad) coupled with a power PAC 1000 power
supply (BioRad) was used to perform three-layer “sandwich” gel electrophoresis. A Mini
PROTEAN II electrophoresis cells (BioRad) was used for SDS-PAGE. A Finnigan LCQ
Deca ion trap mass spectrometer (San Jose, CA) coupled with LC Packings ULtimate
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quaternary capillary LC system (San Francisco, CA) was used for mass spectrometric
analysis.
Standard Protein Solution Preparation

SDS-PAGE low range protein standards were used for method evaluation and
optimization. Two buffer systems, PBS and 100mM glycine-HCL (pH 1.8), were
employed to dilute the standard proteins. Standard proteins (1µL, 2ug/µL) were added to
either 2.7 mL PBS buffer or 2.4 mL 100mM glycine-HCL (pH 1.8) buffer.
Neutralization of the glycine system was carried out by addition 220 µL of 1M Tris
solution.
Cell Culture and T. gondii Parasite Infection

Vero cell lines were maintained in α-Minimal Essential Medium (α-MEM)
supplemented with 7% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100
U/mL penicillin, and 100 µg/mL streptomycin. The RH∆HX strain of Toxoplasma
gondii (obtained from the NIH AIDS Research and Reference Program) was maintained

in Vero cells by serial passage as previously described 69. For proteomic analysis,
parasite pellets were obtained by infecting confluent Vero monolayers with 2x107
parasites for 24 hours. The plates were then washed with sterile PBS, scraped and
centrifuged at 2000 rpm for 10 minutes. Parasite containing cells were selectively lysed
by passage through in a 27 gauge needle. An intact parasite pellet was obtained by low
speed centrifugation. The resulting parasite pellet was washed three times by sequential
centrifugation and re-suspended in 10 mL sterile PBS and finally pelleted by a 2000 rpm
10 minute spin.
Toxoplasma gondii Lysate Preparation

Toxoplasma gondii pellets were lysed in 400 µL RIPA buffer (10mM Tris-HCl

(pH 8.0), 140 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS and
0.025% sodium azide) for 30min on ice. The resulting sample solution was centrifuged
at 16000 x g for 5 min. The supernatant was transferred and diluted with 2.3mL glycine-
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HCl (pH 1.8) buffer. The resulting protein sample was neutralized by adding 210 µL of
1M Tris.
The “Three-layer Sandwich Gel Electrophoresis”

A “Three-layer sandwich” gel, generated in a 4 mL Electro-Eluter glass tube,
consisting of an acrylamide sealing layer (bottom), an acrylamide concentration layer
(middle) and an agarose loading layer (top). Before gel casting, a model 422 ElectroEluter frit was first placed at the bottom of the glass tube. The glass tube was sealed with
an Electro-Eluter stopper to prevent liquid leakage during the gel casting process.
Recipes for casting the sealing layer and the concentration layer gels are given in Table
2.2.1. Once the monomer solution was loaded, 200 µL of a 1-butanol overlay was
applied immediately. Each acrylamide gel layer was allowed to polymerize for 30
minutes. The agarose loading layer was prepared using the following steps: 11µL of a
10% SDS solution per milliliter protein sample was transferred to the protein sample and
incubated at 60°C for 10 min. A 2% agarose gel was melted by heating in a microwave
for 1min and added to the protein sample at a ratio of 110 µL agarose per milliliter
sample. After mixing, the sample/agarose solution was quickly transferred to the top of
the acrylamide concentration layer and allowed to cool at 4°C for 10 min. Finally, 10 µL
of 0.5% agarose with 1% Bromphenol Blue was overlaid on the gel to monitor
electrophoresis. The running buffer preparation for the TSGE followed Laemmli’s
protocol16. The gel was run at 15V for 30min, 5V overnight and at gradually increased
voltage to 150V until the dye front moved to the concentration layer.
Microcon 3K Membrane Concentration and Tube-Gel Method

To facilitate evaluation of the Tube-Gel method, samples were dissolved in
minimum volume of H2O and mixed with acrylamide (40%, 29:1) solution, 1%
ammonium persulfate, and TEMED at a ratio of 14:5:0.7:0.3. The resulting solution was
immediately transferred to a well of pre-cast small-format gel. After 30 min, the Tube-
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Table 2.2. 1: Protocols used for the concentration layer and the sealing layer preparation
The sealing layer:

Reagents

Amount

Acrylamide

0.389g

Bis-acrylamide

0.0205g

1.5M Tris (pH 11)

250µL

10% (w/v) SDS stock

10µL

Deionized water

360µL

10% freshly made ammonium persulfate

5µL

TEMED

0.5µL

total amount loaded onto electro-eluter glass tube

1mL

The concentration layer:

Reagents

Amount

Acrylamide/Bis (30% stock)

400µL

0.5M Tris-HCl (pH 6.8)

250µL

10% (w/v) SDS stock

10µL

Deionized water

335µL

10% freshly made ammonium persulfate

5µL

TEMED

0.5µL

total amount loaded onto electro-eluter glass tube

250µL
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Gel solution polymerized in the well effectively crosslinks with the stacking gel section
of the mini gel. The entire mini gel with Tube-Gel in the wells was fixed in fixing
solution (40% methanol, 10% acetic acid) overnight, and incubated with H2O for 10 min.
After fixing and desalting the Tube-Gels were excised from the mini gel and used for
further evaluation (see below).
An YM-3 model Microcon centrifuge filter device (Millipore) was also evaluated
using the same standard protein sample for comparison to the TSGE method. A 500 µL
protein sample was loaded onto the 3K membrane filter and centrifuged at 14,000 x g for
80 min. The procedure was repeated until all solution was loaded onto the same filter.
Then the concentrated protein sample was collected by centrifuging the same reservoir
upside down at 1000 x g.
SDS-PAGE

Small format gels (7 cm x 8 cm) with 1.5mm thickness and 5 wells were
employed for evaluation of various concentration methods. The gel consisted of a 12 %
acrylamide separating gel and a 4% stacking gel. For the TSGE method, the three layer
gels were collected by pushing the bottom of the whole gel structure through the glass
tube with a glass stir rod. The concentration layer was excised from the three-layer
“sandwich” gel and vertically inserted into a well of the small-format gel. For the TubeGel method, desalted Tube-Gel pieces were inserted into a freshly made mini gel. For
membrane filter concentration, the resultant solution was mixed with Laemmli sample
buffer and loaded onto a mini gel. The same amount of standard proteins were dissolved
in Laemmli sample buffer and directly loaded onto the adjacent lanes of the interested
samples so that the relative quantification of the standard proteins could be carried out.
Laemmli’s protocol16 was used to run SDS-PAGE. After staining with Coomassie
Brilliant Blue G-250, the gel images were captured with a Microtek ScanMaker V6UPL
Flatbed Scanner (Microtek, Inc.). The quantitative protein analysis was performed by
comparing the protein abundances between the control and the interested samples using
BioRad Quantity One software.
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Statistical Analysis

Single factor analysis of variance (ANOVA) was used for statistical analysis of
TSGE gel optimization. The ANOVA analysis tool was obtained from the website:
(http://www.physics.csbsju.edu/stats/anova_pnp_NGROUP_form.html). Paired student
T-test (http://www.physics.csbsju.edu/stats/Paired_t-test_NROW_form.html) was
employed for comparison of TSGE with the other available protein concentration
methods.
Sample Preparation for Mass Spectrometric Analysis

The obtained concentration layer from TSGE was fixed in 40% methanol, 10%
acetic acid overnight. Then the gel was washed with water and 25mM ammonia
bicarbonate, dried with acetonitrile, and incubated with trypsin solution at 4°C for 40
min. The swelled gel pellet was cut into 1mm3 pieces and covered with 100 µL of 25mM
ammonia bicarbonate. Trypsin in-gel digestion was performed at 37°C overnight, and
the resultant peptides were extracted from gel pieces by using 5% formic acid:
acetonitrile (1:1) twice to incubate the gel pieces. The peptide solution was concentrated
using vacuum centrifuge, and desalted using 350 um (I.D.) x10 cm laboratory fabricated
C18 column.
2D-LC-MS/MS Analysis

A Finnigan LCQ Deca ion trap mass spectrometer coupled with a LC Packings
Ultimate quaternary capillary LC system was used for 2D-LC-MS/MS analysis. Desalted
digests from T. gondii whole cell lysate (20 µL) were injected onto a laboratoryfabricated SCX column (350 µm I.D. x 5 cm, 10 µm particles), which was directly
connected to a laboratory fabricated fused silica capillary C18 column (350 µm (I.D.) x15
cm, 5 µm particles and 300 µm pore size). Mobile phase A was 0.1% formic acid in
HPLC grade H2O, mobile phase B was acetonitrile (ACN) with 0.1% formic acid, mobile
phase C was 300 mM ammonium acetate, and mobile phase D was 95% H2O, 5% ACN
with 0.1% formic acid. Two-dimensional LC separation was performed with 12 isocratic
salt elution by using x% C (x = 0, 1.67, 3.33, 5.00, 6.67, 10.00, 13.33, 16.67, 33.33, 50,
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75, and 100) and corresponding (100-x) % solvent D. Each salt elution was followed by
a 90 min C18 reversed phase gradient elution. The mobile phase composition was first
held at 95% solvent A for 6 min, then was linearly changed from 95% to 50% over 44
min. For the next 20 min, a linear increase of solvent B was carried out to reach the
composition of 80%. Then solvent A was changed back to 95% in 5 min and held at 95%
for the following 5 min. The mass spectrometer was operated in a data-dependent mode
with dynamic exclusion enabled. During the full MS acquisition, masses were scanned
from 400 to 2000 m/z. The most intense precursor ion was selected from the previous
full MS scan to undergo CID with parameters of an activation Q of 0.250, activation time
of 45 ms, and 35% normalized collision energy (NCE).
Protein Data Analysis

Individual mgf files obtained from the tandem mass spectra of each fraction were
manually combined. The composite mgf file was searched against Toxoplasma gondii
genome database (www.Toxodb.org) using the MASCOT daemon software. The
parameters were set as followed: trypsin was used as the cleavage enzyme with one
missed cleavage allowed. Both the peptide tolerance and the MS/MS tolerance were set
to 0.8 Da, and oxidized methionine was chosen as a variable modification. MudPIT
scoring was chosen and the ion score cut-off was set to 20. Bold red was required for
positive protein identification, which requires the protein hit to include at least one bold
red peptide match. Red indicates that the peptide is the highest scoring match to the
MS/MS spectra. Bold is used to show that the spectrum has not appeared in a higher
scoring protein.
The cellular location of each T. gondii protein identified by TSGE-MuDPIT was
predicted using the Toxoplasma database (www.toxodb.org). In addition, each
identified protein was examined for the presence of trans-membrane domains and signal
sequences using InterProScan (www.ebi.ac.uk/InterProScan). For comparison, all
theoretical proteins present in the Toxoplasma database were submitted to JVirGel v 2.0
(http://www.jvirgel.de/) for calculation of theoretical protein molecular weights and PI
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values as well as evaluating the number of trans-membrane domains and signal peptides
in those proteins.
Results
Development of the TSGE

A schematic representation of the TSGE method is shown in scheme 1. The
TSGE setup is assembled in a glass electoeluter tube blocked on one end by a frit
(Scheme 1, F). The bottom sealing layer (40% polyacrylamide) serves as a blocking
layer (Scheme 2.2.1, layer A). The middle layer of the TSGE setup is the critical
concentration layer made up of 100-150 µL of a 12% polyacrylamide gel (Scheme 2.2.1,
layer B). The protein solution is incorporated into molten agarose that is layered upon
the concentration layer and allowed to gel (Scheme 2.2.1, layer C). The volume of the
agarose layer is adjustable to the volume of the protein sample solution. The classic
Laemmli SDS-PAGE system was employed to electrophoretically drive proteins from the
agarose into the polyacrylamide layer. Proteins driven into the 100-150 µL concentration
layer are retained due to their inability to enter the sealing layer. Following
electrophoresis the TSGE gel assembly is extruded from the glass tube and the
concentration section containing trapped proteins is retained (Scheme 2.2.1). This
concentration layer is amenable to buffer exchanges as well as in-gel digestion and thus
provides an efficient and concentrated source of peptides for mass spectrometric analysis.
In order to optimize and standardize the TSGE protocol, the individual elements
were evaluated separately. This evaluation employed commercially available molecular
weight markers as these represented a broad range of molecular weights (14-98 kDa) as
our test samples.
The Design of the Agarose Loading Layer

Agarose gel (standard Low-mr, BioRad) was chosen for gel preparation because
of its characteristic large pore size and low temperature melting point. A stock agarose
solution was added to protein samples at an agarose/protein ratio of 1:10 (v/v) to avoid
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Scheme 2.2. 1: Preparation of the TSGE gel and the combination of TSGE
with LC-MS/MS. F: model 422 Electro-Eluter frit, A: the 40% polyacrylamide sealing

layer, B: The 12% polyacrylamide concentration layer, C: agarose layer with protein
solution incorporated. Proteins driven into the concentration layer are retained due to
their inability to enter the sealing layer under voltage. Following electrophoresis the
TSGE gel assembly is extruded from the glass tube and the concentration section
containing trapped proteins is retained. This concentration layer is fixed, desalted, and
then performed in-gel digestion. The resulting peptides are extracted from gel pieces and
analyzed by LC-MS/MS.
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considerable volume increases of the original protein sample. We evaluated stock
agarose solutions at concentrations of 0.1%, 0.2%, 0.3%, 0.5%, 1%, 2%, 3% and 5%.
Results indicated that the melting point and gelling temperature of agarose gel
dramatically increased with increasing concentration. At high agarose concentrations,
longer melting times were required and gels rapidly re-solidified at room temperature. In
contrast, low agarose solutions (less than 0.1%) exhibited difficulty forming gels and had
low gel strength and deformed easily. Agarose concentrations of 2 and 3% were found to
provide the best compromise between relative melting points and gelling temperatures,
thus 2% agarose was chosen for TSGE.
Bromophenol blue (BPB) was observed to migrate in advance of proteins during
TSGE and served as an indicator of protein migration. In practice, 20 µL commercial
overlay agarose (BioRad) containing 1% BPB was applied on top of the sample agarose
gel prior to electrophoresis.
Optimization of the Composition of the Sealing Layer

The gel pore size in the sealing layer should be small enough to impede protein
migration into the layer. Gel pore size is inversely proportional to percent of monomer T
and the percent of crosslinker C109, 110. Gels with 40% T can be used for peptide
separations111. We evaluated three polyacrylamide compositions for the sealing layer,
20%T-2.67%C, 30%T-2.67%C and 40%T-5%C. The TSGE gels were prepared based on
the protocol present in Table 1 except for changing amounts of T and C. Results were
monitored using SDS-PAGE (Figure 2.2.1). TSGE using 40%T-5%C in the sealing layer
had the highest average percent yields for all inspected proteins (Figure 2.2.2A). The
average percent recovery for all proteins ranged from 95.62%±1.31% to 97.50%±2.57%
for 40%T-5%C composition. An ANOVA statistical analysis of protein recoveries versus
gel composition confirmed the hypothesis that sealing gel composition was a significant
factor in protein recoveries (p<0.01, n=3). Figure 2.2.2B shows mean protein recoveries
versus gel with error bars at 95% confidence. Since protein recoveries obtained from the
40%T-5%C approached 100%, this composition was employed in further experiments.
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Figure 2.2. 1: SDS-PAGE gel image for optimization of acrylamide and Bis

composition in the sealing layer of the three-layer “sandwich” gel. BioRad SDS-PAGE
low range standards were used to evaluate performance of the system. The 100mM
glycine-HCL (pH 1.8), one of the most common elution buffers employed in
immunoprecipitation, was used to dilute the standard proteins. Proteins were
concentrated using TSGE method as described in experiment section and the results were
visualized using SDS-PAGE. Lanes: lane 1, control; lane 2, 20%T-2.67%C in sealing
layer; lane 3, 30%T-2.67% C in sealing layer; lane 4, 40%T-5%C in sealing layer.
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Figure 2.2. 2: The effect of acrylamide and Bis composition in an acrylamide sealing

layer on protein concentration. (A). % yield of different proteins concentrated by TSGE
in which different composition of sealing layer were used. Protein recoveries of four
selected proteins, BSA, ovalbumin, carbonic anhydrase and lysozyme, were calculated
using Quantity One software by comparing % adjusted volume of the tested to that of the
control sample. Error bars presented in the figure shows the standard deviations of
average protein recoveries for each selected proteins. (B). ANOVA data comparison
chart of protein % yields obtained under various acrylamide-bis compositions in the
sealing layer: a plot of the group means with 95% confidence intervals (n=3).
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Selection of pH Values for Concentration and Sealing Layers

The purpose of the three-layer design is to concentrate various proteins at the
concentration layer. Since pH of the gel can affect protein mobility during
electrophoreses 112, finding an appropriate pH was critical for optimization for both
concentration and sealing layers. Previous studies indicate that SDS-PAGE can be
conducted at a pH range of 2.5 to 11111. Taking a lead from Lammeli’s SDS-PAGE
protocol 109, we opted to evaluate pH 6.8 and 8.8 for the concentration layer and pH 6.8,
8.8 and 11 for the sealing layer resulting in four pH pairs, 6.8-6.8, 6.8-8.8, 6.8-11 and
8.8-11. TSGE concentration efficiencies in this pH study were evaluated using SDSPAGE (Figure 2.2.3.). Figure 2.2.4A shows that TSGE with pH 6.8-11 combination in
the concentration layer and the sealing layer, respectively, provided the highest average
recoveries for all tested proteins. The average percent recovery for all proteins ranged
from 98.51%±2.87% to 100.60%±2.67%. Again, an ANOVA confirmed that pH in the
concentration layer and the sealing layer is an impact factor that significantly affects
protein recovery (p<0.01, n=3). Figure 2.2.4B shows the mean protein recoveries versus
pH pairs with error bars at 95% confidence. Since high recoveries (>98%) were obtained
for all tested proteins, the pH combination 6.8-11 was chosen for further investigation.
The Effect of Sample Buffers on the TSGE Method

Large volume and extremely diluted protein samples were prepared in various
buffers, such as isotonic buffer (150mM NaCl), high salt buffer (PBS), highly acidic
buffers used for elution of antigens from antibodies (100mM glycine-HCl (pH 1.8), 0.1%
formic acid,) and a complex buffer (RIPA) that contains both high salt and several
detergents, to represent typical protein samples obtained from different experimental
designs. These buffers are not compatible with trypsin digestion and/or subsequent mass
spectrometric analysis. Neutral or weakly basic sample solutions produced better results
in TSGE than acidic sample solutions. Acidic sample solutions produced excessive heat
during electrophoresis which caused increased conductivity, increased diffusion,
decreased viscosity and even melted the agarose gel. Therefore, acidic samples were
neutralized by addition of 1M Tris prior to mixing with agarose gel. For example,
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Figure 2.2. 3: SDS-PAGE gel image for optimization of pH values employed in the

concentration layer and the sealing layer of the three-layer “sandwich” gel. Molecular
weight marker was loaded onto TSGE gel. Lanes: lane 1, control; lane 2, pH 6.8-6.8
combination in the concentration layer and the sealing layer; lane 3, pH 6.8-8.8; lane 4,
pH 6.8-11; lane 5: pH 8.8-11.
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Figure 2.2. 4: The effect of pH employed in the acrylamide concentration layer and the

acrylamide sealing layer on % yield of protein concentration. Four combinations of pH in
the two layers, pH 6.8-6.8, 6.8-8.8, 6.8-11 and 8.8-11, were used to make TSGE gel. (A).
% yield of different proteins concentrated using various pH combinations in TSGE gel. %
yield was calculated by comparing adjusted % volume of protein bands obtained from
TSGE to that of protein band from control. Error bars presented in the figure shows the
standard deviations of average protein recoveries for each selected proteins. (B).
ANOVA data comparison chart of protein recoveries obtained using various pH
combinations in TSGE gel: a plot of the group means with 95% confidence intervals
(n=3).
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100mM glycine-HCl (pH 1.8), a typical elution reagent used in immunoprecipitation
reactions was treated with 1M Tris. TSGE successfully concentrated proteins from all of
the above solutions (data not shown).
Comparison of TSGE with the Microcon YM-3 Membrane Concentration and
Tube-Gel Methods

We compared the optimized TSGE method to Microcon YM-3 with a
3000MWCO filtration and the Tube-Gel method. When a glycine (pH 1.8) buffer was
used to prepare protein samples, TSGE dramatically improved protein recoveries
compared to both the Microcon YM-3 and the Tube-Gel method (Figure 2.2.5, Figure
2.2.6A). A paired student T-test indicated a statistically significant difference when
comparing TSGE with 3K membrane and TSGE with the Tube-Gel method (p<0.05,
n=3). The average percent recovery for all proteins ranged from 96.46%±3.42% to

100.69%±3.66% for TSGE method, while the average percent recovery ranged from
45.04%±2.62% to 80.10%±4.02% and from 76.57%±3.11 to 82.49%±4.52% for 3K
membrane concentration and Tube-Gel method, respectively (Figure 2.2.6B). We also
tested the most common buffer used for biological samples, PBS. For volumes up to
3mL and protein concentration as low as 0.7 µg/mL, TSGE produced consistently higher
protein recoveries than the conventional Microcon YM-3 membrane or the Tube-Gel
method (Figure 2.2.7, Figure 2.2.8A). Recovery differences were significant (p<0.05,
n=3) when comparing TSGE (92-97% recovery) to Microcon YM-3 membrane
concentration (56-76% recovery) and the Tube-Gel method (56-76% recovery) (Figures
2.2.8B).
Application of the TSGE Method to Analysis of Toxoplasma gondii Proteome

Application of TSGE for proteomic analysis of complex biological samples was
investigated using a whole parasite lysate from Toxoplasma gondii. As a single celled
eukaryote, T. gondii contains organelles typical of most eukaryotes (nucleus,
mitochondrion, Golgi, endoplasmic reticulum) in addition to several entities that are
unique to the Phylum (Apicomplexa) including micronemes, rhoptries, conoid and
apicoplast. This balance of both common and unique entities makes T. gondii an ideal
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Figure 2.2. 5: Comparison of TSGE method with 3K membrane concentration and Tube-

Gel method. Standard proteins were diluted by 100mM glycine (pH 1.8) sample buffer.
SDS-PAGE gel images of standard proteins concentrated using different methods. lane 1,
control; lane 2, tested.
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Figure 2.2. 6: Comparison of TSGE method with 3K membrane and Tube-Gel methods.

Standard proteins were diluted by 100mM glycine (pH1.8) sample buffer. (A). Histogram
illustrates that comparison of protein recovery from different concentration methods.
Error bars presented in the figure shows the standard deviations of average protein
recoveries for each selected proteins. “*” indicates statistically significant differences
when comparing TSGE with 3Kmembrane or TSGE with the Tube-Gel method; T-test,
p<0.05, n=3. (B). Average %yields of different proteins. The highest average value for

each protein is listed in bold type.
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Figure 2.2. 7: Comparison of TSGE method with 3K membrane concentration and TubeGel method. Standard proteins were diluted by PBS buffer. SDS-PAGE gel images of
standard proteins concentrated using different methods. lane 1, control; lane 2, tested.
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Figure 2.2. 8: Comparison of TSGE method with 3K membrane and Tube-Gel methods.

Standard proteins were diluted by PBS buffer. (A). Histogram illustrates that comparison of
protein recovery from different concentration methods. Error bars presented in the figure
shows the standard deviations of average protein recoveries for each selected proteins. “*”
indicates statistically significant differences when comparing TSGE with 3Kmembrane or
TSGE with the Tube-Gel method; T-test, p<0.05, n=3. (B). Average %yields of different
proteins. The highest average value for each protein is listed in bold type.
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sample to validate TSGE. The sample solution was made by the extraction of pelleted T.
gondii in using 400 µL RIPA buffer followed by the addition of 2.3 mL of 100mM glycine-

HCl (pH 1.8) buffer. This treatment resulted in a large volume protein solution replete with
high salt and detergents at an extremely low pH. Concentration and desalting was done by
the TSGE and samples were subsequently subjected to trypsin in-gel digestion and analyzed
by 2D-LC-MS/MS. Totally, 627 peptides corresponding to 260 proteins were identified
using MASCOT with parameters set as described in experimental section (identified proteins
are listed in appendix). The availability of the Toxoplasma gondii genome database
(www.toxodb.org) facilitated protein identification. Cellular localization of the identified T.
gondii proteins was assigned using annotation at www.toxodb.org. Based on the annotation,

half of the identified proteins were assigned to specific cellular locations (Figure 2.2.9A).
All the identified proteins were also submitted to InterProScan
(www.ebi.ac.uk/InterProScan) to predict the presence of signal peptides (SP) and transmembrane domains. Secreted and transmembrane domain containing proteins are defined by
the presence of hydrophobic domains that can complicate biochemical purification and
protein identification. The distribution of proteins predicted to have N-terminal signal
sequences reveals 50 of the 259 proteins (19.3%), which is remarkably similar to the 19.7%
obtained from total protein coding genes using solely bioinformatic criteria (Figure 2.2.9B).
The distribution of putative membrane proteins based on a presence of one or more predicted
membrane spanning domains revealed a total of 51 proteins (20%) a number considerably
lower than the 42% of proteins contained trans-membrane domains based on bioinformatic
criteria predicted for the Toxoplasma genome. The high value of the in silico prediction is
almost certainly spurious as it reflects an inherent complication in defining transmembrane
domains as the amino acid composition alone is not the sole predictor of membrane insertion
for diverse organisms with a typical proportion of transmembrane proteins ranging from 1830% from Archea to humans113. Thus our experimentally defined ratio for Toxoplasma in
the 20% range is entirely consistent with typical ranges across the major Kingdoms of life.
In addition for T. gondii ROP2 family of proteins, a domain annotated as a transmembrane
domain is quite possibly a hydrophobic kinase fold required for enzymatic activity114, 115.
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Figure 2.2. 9: A. Cellular Localization of Identified T. gondii Proteins. The proteins

identified from RH lysate using TSGE localize to parasite organelles as characterized by the
Toxoplasma database (www.toxodb.org). The proteins with no listed localization were

classified as unknown even if their predicted function could be used to predict localization.
B. The percentage of secreted proteins from the total proteome. Theoretical: all theoretical
proteins present in Toxoplasma database were submitted to JVirGel v 2.0
(http://www.jvirgel.de/) for analysis the presence of signal peptides in those proteins. A total
of 1538 out of the 7793 possible proteins contain signal peptides (SP). Experimental:
Secreted and nonsecreted proteins were identified using the TGSE. The identified protein
sequences were submitted to InterProScan (www.ebi.ac.uk/InterProScan) to identify those
proteins with predicted signal peptides (SP) and no signal peptides (No SP). In total, 50 of
the 259 proteins (19%) contain signal peptides while 209 (81%) do not. C. The percentage of
membrane proteins from the total proteome. Theoretical: Total 3248 of the 7793 proteins
(42%) contain trans-membrane domain (TM). Experimental: 51 proteins (20%) contained at
least one predicted trans-membrane domain and were classified as trans-membrane proteins
(TM). 208 proteins (80%) contained no predicted trans-membrane domains and were
classified as not trans-membrane proteins (Not TM).
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The MW and PI distributions for the identified proteins were also investigated by comparing
experimental results with corresponding theoretical distributions (Figure 2.2.10.).
Distributions of the identified proteins directly coordinated the theoretical distributions in
relation to both MW (Figure 2.2.10A) and PI (Figure 2.2.10B). The observed protein MW
range was 7.6 kDa to 650 kDa, which corresponded with the theoretical T. gondii proteome.
The applicability of TSGE in the identification of proteins across a very broad range
eliminates a major limitation in protein identification.
The ability of TSGE to concentrate proteins across a broad predicted pI range (pI 3.5
to 12.5) was assessed. The majority of proteins (99.6%) in the theoretical proteome fell in
this PI range where 46% were acidic and 54% basic matching the experimental proteome
(45% acidic and 55% basic) with overlapping profiles across the pI spectrum. Notably, the
ability of TSGE to accommodate proteins at both extremes of the pI range circumvents one
of the major limitations of conventional IEF/2D gel electrophoresis. Together these data
demonstrate that the TSGE protocol provides a highly robust and adaptable methodology to
deal with difficult samples in mass spectrometric protein identification.
Discussion

Current protein desalting and concentration methods are limited, especially when
working with samples that are in uncharacteristically large volumes, contain high salt or
other contaminants, and/or are extremely diluted. Under these circumstances, significant
protein losses can occur. To address these circumstances, we developed the new protein
desalting and concentration method, the TSGE system which consists of an agarose loading
layer, a concentration layer and a sealing layer. We observed that sealing layer gel pore size
and pH in concentration and sealing layers affected TSGE performance. The TSGE with
40%T-5%C in the sealing layer and the pH 6.8-11 combination in the concentration layer
and the sealing layer, respectively, provided the highest average % recovery, which could be
explained by invoking the moving boundary theory 112. In brief, glycine is a weak acid and
can exist as a zwitterion, or glycinate anion depending on pH values. For TSGE, glycine is
present in the running buffer (pH 8.3) and all the three gel layers. Since the pH is low in
both the agarose layer (pH≈7) and the concentration layer (pH=6.8), once glycinate anions
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Figure 2.2. 10: Protein PI distribution and Protein MW distribution. A: Histogram of

theoretical T. gondii protein molecular weight distribution (blue) and experimental protein
molecular weight distribution (red) within the mass range of 3 to 300 kDa. B: Histogram of
theoretical T. gondii protein PI distribution (blue) and experimental protein PI distribution
(red).
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from the running buffer (pH=8.3) have moved into the agarose layer, a large portion of the
glycinate anions protonate to form zwitterions which slows their movement. Highly mobile
chloride ions in both the agarose and concentration layer experience high mobility and rapid
movement toward the anode. This ion movement creates a narrow zone with high field
strength at the top of the agarose gel that forces proteins to move forward. Thus, proteins
move from the top to the bottom of the agarose gel, stack into a narrow band and
subsequently move into the concentration layer. However, the pH changes from 6.8 to 11 at
the junction between the concentration and sealing layer resulting in deprotonation of the
glycine zwitterions in the sealing layer to glycinate anions, and rapid acceleration past the
proteins. Consequently, proteins are no longer in the high field strength zone and confront
the barrier created by 40% T-5% C polyacrylamide sealing layer, stop moving forward and
accumulate in the concentration layer.
To address potential applications of TSGE, we investigated protein samples with
various sample buffers and confirmed that this method is suitable for a broad range of protein
samples. Furthermore, TSGE exhibited very high protein recovery compared to Microcon
YM-3 membrane concentration and Tube-Gel methods. Application of TSGE for proteomic
analysis of complex biological samples was evaluated with a whole parasite lysate from
Toxoplasma gondii. The RIPA sample buffer used in this process not only contained high

salts, but also had Triton X-100, SDS and small molecules like sodium deoxycholate.
Numerous proteins were identified from this complex sample indicating the utility of TSGE
coupled with mass spectrometric proteomic analysis. Further bioinformatic investigation of
the identified proteins indicated that these proteins originated from all organelles of T. gondii
as well as the cytoplasm and cell surface supporting the broad applicability of the TSGE-2DLC-MS/MS methodology.
As such, the TGSE-2D-LC-MS/MS methodology showed enhanced capability for the
analysis of membrane proteins compared to IEF/2D gel electrophoresis, which is not
particularly useful for resolving insoluble proteins such as membrane proteins, as well as
proteins at the extremes of the pI spectrum. The investigation of protein MW and PI
distributions from identified T. gondii proteins also indicated that TSGE coupled with 2DLC-MS/MS method was capable of identifying any type of protein, including high molecular
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weight proteins, acidic proteins, and basic proteins (Figure 2.2.9.). Therefore, TSGE coupled
with 2D-LC-MS/MS methodology is suitable for global proteomic studies of various protein
samples and allows for high-throughput proteomics. Its superior performance with low levels
of protein, dilute protein solutions and difficult buffer conditions suggest applicability in
problematic protein identification approaches including those from limiting clinical
materials. In addition, with protein recoveries consistently above 90% and for certain
proteins approaching 100% TSGE is broadly applicable in comparative proteomic studies
where differences between protein samples due to sample preparation can be misinterpreted
as evidence of differential levels.
Conclusion

The TSGE method described here provides a relatively easy approach to
concentrating, desalting and purifying protein samples. The TSGE method can be readily
incorporated into the protein processing workflows and relies on analysis skills already
available in any laboratory routinely conducting SDS-PAGE analyses. The TSGE method
couples nicely with downstream mass spectrometry and even provides sample preparation for
MudPIT protocols. Taken together, this new TSGE method should greatly improve protein
identifications from less than optimal samples. In the next part of dissertation, the application
of the TSGE-MuDPIT methodology on the analysis of PVM of T. gondii will be presented.
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Chapter 2.3
Application of TSGE-2D-LC-MS/MS Methodology to Analysis of T. Gondii PVM
Proteome
Introduction

Apicomplexan parasites are one kind of protozoan parasites which are characterized
by the presence of a specialized organelles at their apical end116. Apicomplexan parasites
include many important pathogens of humans such as Plasmodium spp. the causative agent
of malaria, and Toxoplasma gondii, the causative agent of toxoplasmosis. Toxoplasma
gondii is one of the most successful protozoan parasites since it can infect almost any warm

blooded animal including humans. Within host cells, T. gondii resides and multiplies in the
parasitophorous vacuole (PV), which is delimited by the parasitophorous vacuole membrane
(PVM). The PVM is a critical extracellular organelle of the parasite which is derived from
the host cell plasma membrane. Formation of the PVM is achieved by the release of various
proteins from the parasite secretory organelles such as rhoptries and dense granules 117-119.
The PVM surrounding the parasite functions as a molecular sieve70. The PVM contains
nonselective pores that allow passive bidirectional permeation of small molecules116. So far
the cellular function of the PVM is still elusive. The PVM composition and PVM proteins
responsible for its activity are largely unknown.
Two breakthroughs make proteomic analysis of PVM proteins possible. One is the
development of a new methodology for purifying the PVM containing fraction. Many
secretory proteins from dense granules and rhopties of the parasite are found to be localized
at PVM, Sinai and coworkers developed a protocol for generating polyclonal antisera against
the PVM enriched fraction from infected cells. They grew T. gondii in rabbit host cells and
use selective mechanical disruption of the host cell (leaving the parasites intact) combined
with differential centrifugation and sucrose floatation gradients to purify the fractions
containing markers of the PVM. Then the PVM enriched fraction was injected into rabbits.
Since the PVM cannot be separated from host mitochondria and endoplasmic reticulum.
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Most of proteins in the enriched PVM fraction are from mitochondria and endoplasmic
reticulum, and the concentration of PVM is very low. However, once injected into rabbits,
the immune system of the rabbit will ignore “self” proteins and only recognize parasite
proteins and produce antibodies recognizing antigens in the PVM. Using the polyclonal
antisera against the PVM, A. Martin in Dr. Sinai’s group successfully developed and
performed immunoprecipitation to isolate and purify the PVM proteins. The other
breakthrough is the completion of the T. gondii genome as well as Expressed Sequence Tag
(EST) database, which makes it feasible to high throughput characterize multiple proteins
generated from immunoprecipitation using ethe merging novel technology Multidimensional
Protein Identification Technology (MuDPIT). Proteomic analysis of the protein composition
in the PVM through MuDPIT can eventually establish the foundation for characterization of
activities associated with the T. gondii PVM.
In this chapter, the novel biological sample preparation developed by A. Martin will
be briefly introduced. The resultant PVM enriched sample was further concentrated and
purified using the novel sample preparation method, Three-layer Sandwich Gel
Electrophoresis (TSGE), described in chapter 1.2. After analyzing the sample using 2D-LCMS/MS, the proteins were identified and will be discussed here.
Experimental
Biological Sample Preparation

PVM biological sample preparation, which involved cell culture, isolation of parasite,
purification and modification of Ig, and immunoprecipitation, was performed by A. Martin in
Dr. Sinai research group. The experimental procedure was briefly described as follow120.
Cell Culture and T. gondii Parasite Infection
As described in chapter 2.2, Vero cell lines were maintained in α-MEM supplemented
with 7% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, and
100 µg/mL streptomycin. The RH∆HX strain of Toxoplasma gondii was maintained in Vero
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cells by serial passage. For proteomic analysis, parasite pellets were obtained by infecting
confluent Vero monolayers with 2x107 parasites for 24 hours.
Isolation of T. gondii Parasite
The plates were washed with sterile PBS, scraped and centrifuged at 2000 rpm for 10
minutes. Parasite containing cells were selectively lysed by passage through in a 27 gauge
needle. An intact parasite pellet was obtained by low speed centrifugation. The resulting
parasite pellet was washed three times by sequential centrifugation and re-suspended in 10
mL sterile PBS and finally pelleted by a 2000 rpm 10 minute spin.
Purification and Biotinylation of Ig
Two volumes 60 mM NaC2H3O2 (pH 4.0) were added to antisera while stirring.
Dropwise, 7.5 µL of caprylic acid was added per 100 µL antisera and allowed to stir for 30
minutes. Precipitate was removed by 3 cycles of centrifugation at 5000xg for 10 minutes.
The supernatant was dialyzed overnight against 1X PBS and the pH adjusted to 7.0.
Antibody supernatant was brought to 1 mg/ml. 10 mM EzLink Sulfo-NH-LC-Biotin (Pierce)
was added to a final molar equivalent of 10:1 and incubated on ice for 2 hours and dialyzed
overnight against 1x PBS. Biotinylation of Ig was confirmed by immunoblot analysis using
streptavidin-HRP (Jackson ImmunoResearch Laboratories) (1:10,000).
PVM Protein Immunoprecipitation
3x108 RH strain of T. gondii were lysed for 30 minutes on ice in RIPA buffer (10 mM
Tris pH 8.0, 140 mM NaCl, 1% Triton X-100, 0.5% NaC29H34O4, 0.1% SDS, 0.025% NaN3,
protease inhibitor cocktail). Insoluble material was pelleted by 10,000xg centrifugation for
10 minutes. The supernatant was precleared with 100 µl 10% protein A sepharose beads for
4 hours at 4°C. The beads were removed by centrifugation at 5000xg for 10 minutes. The
lysate was incubated overnight with 5 µg biotinylated Ig chemically crosslinked to protein A
magnetic beads (Dynal) using DMP (Pierce). The beads were washed 3 times with RIPA
buffer using a magnet and once with 10 mM phosphate buffer pH 6.8. Proteins were eluted
with 100 mM glycine pH 1.8 for five minutes and brought to neutral pH with 9 µl 1 M Tris
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base. Magnetic beads conjugated to streptavidin (Dynal) were incubated with the
immunoprecipitate for 2 hours per manufacturer’s instructions to capture Ig. A magnet was
used to collect the beads and the supernatant was obtained for following proteomic analysis.
TSGE

The PVM sample obtained from Dr. Sinai’s lab was not compatible with subsequent
protomic analysis, therefore, we pre-treated the sample with TSGE method. A “Three-layer
sandwich” gel was made based on the protocol provided in chapter 2.2. Briefly, Three-layer
Sandwich gel was generated in Electro-Eluter glass tube, consisting of a polyacrylamide
sealing layer (bottom), a polyacrylamide concentration layer (middle) and an agarose loading
layer (top). Recipes for casting the sealing layer and the concentration layer gels are given in
Table 2.2.1. Each polyacrylamide gel layer was allowed to polymerize for 30 minutes. The
agarose loading layer was prepared using the following steps: 11µL of a 10% SDS solution
per milliliter protein sample was transferred to the protein sample and incubated at 60°C for
10 min. A 2% agarose gel was melted by heating in a microwave for 1min and added to the
protein sample at a ratio of 110 µL agarose per milliliter sample. After mixing, the
sample/agarose solution was quickly transferred to top of the acrylamide concentration layer
and allowed to cool at 4°C for 10 min. The elelctrophoresis was monitored by applying 10
µL of 0.5% agarose with 1% Bromphenol Blue on the gel. The running buffer preparation
for the TSGE followed Laemmli’s protocol. The gel was run at 15V for 30min, 5V overnight
and at gradually increased voltage to 150V until dye front moved to the concentration layer.
The obtained concentration layer from TSGE was fixed in 40% methanol, 10% acetic
acid overnight. Then the gel was washed with water and 25mM ammonia bicarbonate, dried
with acetonitrile, and incubated with trypsin solution at 4°C for 40 min. The swelled gel
pellet was cut into 1mm3 pieces and covered with 100 µL of 25mM ammonia bicarbonate.
Trypsin in-gel digestion was performed at 37°C overnight, and the resultant peptides were
extracted from gel pieces, concentrated using vacuum centrifuge, and desalted using 350 um
(I.D.) x10 cm laboratory fabricated C18 column.
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2D-LC-MS/MS Analysis

A Finnigan LCQ Deca mass spectrometer coupled with a LC Packings Ultimate
quaternary capillary LC system was used for 2D-LC-MS/MS analysis. Desalted digest from
T. gondii whole cell lysate (20 µL) were injected onto a laboratory-fabricated SCX column

(350 µm I.D. x 5 cm, 10 µm particles), which was directly connected to a laboratory
fabricated fused silica capillary C18 column (350 µm (I.D.) x15 cm, 5 µm particles and 300
µm pore size). Mobile phase A was 0.1% formic acid in HPLC grade H2O, mobile phase B
was acetonitrile (ACN) with 0.1% formic acid, mobile phase C was 300 mM ammonium
acetate, and mobile phase D was 95% H2O, 5% ACN with 0.1% formic acid. Twodimensional LC separation was performed with 12 isocratic salt elution by using x% C (x =
0, 1.67, 3.33, 5.00, 6.67, 10.00, 13.33, 16.67, 33.33, 50, 75, and 100) and corresponding
(100-x) % solvent D. Each salt elution was followed by a 90 min C18 reversed phase
gradient elution. The mobile phase composition was first held at 95% solvent A for 6 min,
then was linearly changed from 95% to 50% over 44 min. For the next 20 min, a linear
increase of solvent B was carried out to reach the composition of 80%. Then the solvent A
was changed back to 95% in 5 min and held at 95% for the following 5 min. The mass
spectrometer was operated in a data-dependent mode with dynamic exclusion enabled.
During the full MS acquisition, masses were scanned from 400 to 2000 m/z. The most
intense precursor ion was selected from the previous full MS scan to undergo CID with
parameters of an activation Q of 0.250, activation time of 45 ms, and 35% normalized
collision energy (NCE).
Protein Data Analysis

Individual mgf files obtained from the tandem mass spectra of each fraction were
manually combined. The composite mgf file was searched against both Toxoplasma gondii
genome database (www.Toxodb.org) and NCBInr database using the MASCOT daemon
software. The parameters were set as followed: trypsin was used as the cleavage enzyme
with one missed cleavage allowed. Both the peptide tolerance and the MS/MS tolerance
were set to 0.8 Da, and oxidized methionine was chosen as a variable modification. For
NCBInr database searching, other alveolata was chosen as taxonomy.
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Result and Discussion

To employ mass spectrometric analysis characterizing the proteome of PVM, it is
essential to develop a protocol for highly purified PVM sample preparation so that sufficient
quantities can be obtained for MS analysis. Sinai and coworkers described a methodology to
enrich for the PVM using the selective mechanical disruption of the host cell combined with
differential centrifugation and sucrose floatation gradients (scheme 2.3.1.). However, results
showed a co-fractionation of the PVM fraction with host organelles including mitochondria
and ER. Compared to that of the host mitochondria and ER, the amount of PVM proteins is
exceptionally low, which seriously affects the characterization of PVM proteins using
proteomic methodology. The novel immunoprecipitation method based on the generation of
PVM antibodies by injecting PVM containing fractions from cultured rabbit fibroblasts back
to rabbits was shown in scheme 2.3.1. Using this method, they obtained two resultant
polyclonal antisera (PVM45 and PVM46). They found both both PVM45 and PVM46 are
capable of immunoprecipitating proteins unique to T. gondii infected cells and simutaniously
exhibit minimal reactivity in uninfected cells based on the western blot results. A. Martin et
al also evaluated the PVM antisera using immunofluoresence assay and found the generated
antisera contain enriched PVM antibodies due to colocalization with three well-known PVM
proteins in the PVM.
Elimination of Serum Proteins and Ig from Immunoprecipitations

The resultant polyclonal antisera (PVM45 and PVM46) contain rabbit serum proteins,
which seriously affect the following proteomic analysis. Therefore, serum proteins must be
removed prior to application of immunoprecipitation. A. Martin et al 120developed a novel Ig
purification method. They used capryilic acid precipitation protocol to remove serum
proteins from immunoglobins. Then the antisera are ready to be crosslinked to magnetic bead
for immunoprecipitation. However, in order to maximize elution of the low concentration
proteins of interest, the harsh elution condition (200 mM glycine pH 1.8) was used which
caused a small percentage of Ig being leached from the beads. This amount was significant
when compared to our target protein concentration. Therefore, as shown in Scheme 2.3.1B,
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A

Infected Rab 9 cells (6 dishes/ 24 hours)
Washed with PBS

B
Caprylic Acid Purify and Biotinylate Ig

Collected by scraping in 10mL PBS

Lyse RH in RIPA buffer

Centrifuge
1000 x g, 10’

Preclear lysate with protein A beads

Supernatant
(Discard)

Pellet

Resuspend in 3 mL CDB

Incubate lysate with protein A beads
crosslinked to 5 µg biotinylated PVM
antibody/ 3x108 RH

Passage 6X in ball bearing
homogenizer 0.0007 inch
clearance

Pull out magnetic beads and wash

Centrifuge
1000 x g, 10’
Pellet
(parasites and
cell debris)

Supernatant
(organelle
fraction)

Elute in 100 mM glycine pH 1.8
Capture eluted Ig with streptavidin beads

Centrifuge 100,000
x g, 1 hr.
Pellet
(membrane
fraction)

Supernatant
(Discard)
(soluble fraction)

Sucrose Floatation
Gradient
(60- 25%)

Scheme 2.3. 1: purification and enrichment of PVM proteins. (A) generation of PVM

fraction for preparing polyclonal antisera against the PVM. (B) immunoprecipitation.
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Martin et al121 biotinylated the purified Igs prior to crosslinking Igs to protein A beads. The
biotinylated Igs leached from the beads during immunoprecipitation was selectively removed
from the eluate by using streptavidin capture prior to mass spectrometry using streptavidin
bound to magnetic beads.
Identified Secretory Proteins

Once the PVM sample was obtained, I applied the TSGE-2D-LC-MS/MS
methodology described in chapter 2.2 to PVM proteome analysis. A total of 59 proteins were
identified. Table 2.3.1 shows all 17 identified proteins secreted by secretory organelles
rhoptry and Dense Granule. When comparing protein distribution of the identified proteins
from T. gondii whole cell lysate (chapter 1.2) with those from PVM sample. A fraction of
29% of proteins identified from PVM sample belong to microneme, rhoptry, dense granule
organelle, where only 4% proteins belong to those organelles in whole cell lysate, which
proved that the novel PVM purification method based on immunoprecipitation successfully
enriched secretory proteins. The highly confident identification of those proteins from
another aspect proved the success of PVM purification. The highest Mowse score obtained in
table 1 is 480 for protein GRA3, which implies 10-48 probability that this match between the
experimental data and the database sequence is a random event.
In Table 2.3.1, nine out of 17 proteins are rhoptry proteins. Rhoptries are unique
secretory organelles found exclusively in the Apicomplexia of T. gondii. Rhoptry proteins
are discharged during host cell invasion79. Studies reveal that rhoptry proteins are critical in
the establishment of the machinery for both parasite invasion and the formation of nascent
parasitophorous vacuole. To date, all rhoptry proteins either associate with the PVM or are
transported across the PVM into the host cell cytoplasm. Among these rhoptry proteins, the
ROP2 family has received more attention due to its importance for parasite invasion. We
identified 6 proteins belonging to ROP2 family, which include, ROP2A ROP2B, ROP2,
ROP5, ROP18 and ROP4122. It has been shown that all these identified ROP2 family
members associate with the PVM. Protein ROP2 is secreted to the PVM during infection. It
is located in the PVM with its N-terminus exposed to the host cell cytoplasm, where it
mediates an association between the PV and host cell mitochondria123. Protein ROP2A and
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ROP2B are paralogs of ROP2, which have similar function as ROP2. ROP5 exhibits unique
features among the ROP2 family proteins. Compared to ROP2 and 4, ROP5 is not processed
during biosynthesis, and although it is targeted to the PVM during invasion, its topology in
the PVM shows ROP5 exposes its C-terminus toward the host cell cytoplasm124, which is
inverted compared with ROP2. ROP4 is secreted from the parasite during host cell invasion
and is related to the PVM125. Like other ROP2 family proteins, ROP18 is also secreted to the
PVM126. It is described as genuine kinase. The mature recombinant ROP18 can selectively
phosphorylate an unknown parasite protein, demonstrating its kinase activity115. Beside
ROP2 family proteins, ROP1 was also identified using TSGE- MuDPIT technology.
Although the function of ROP1 still remains unknown, it is believed to be an active
component of the penetration-enhancing factor, which can increase the efficiency of host cell
invasion127, 128. However it is not essential for invasion129. ROP1 has been used as a model
for studying rhoptry protein trafficking and processing130.
We also identified a recently verified rhoptry protein, toxofilin, in the PVM
fraction131. Toxofilin is found localized within the luminal domain of rhoptries. However, its
functional roles have not been thoroughly studied. Some research indicated that toxofilin
may bind to actin and protein phosphatase 2C and play an important role in parasite gliding
motility and host cell invasion132, 133. The co-characterization of actin in our experiment can
be explained by this theory. The identification of toxofilin in the PVM sample might be due
to its secretion into PV where it interacts with actin and/or a protein phosphatase 2C.
Five dense-granule proteins were also identified. They are GRA1, GRA2, GRA3,
GRA5 and GRA8. All these proteins are associated with the PVM134. The dense granule
proteins are secreted into the PV and the PVM after the parasite penetrates into host cell. The
secretion continues during the entire intracellular residence of the parasite. Within a few
minutes after penetration, parasites modify the newly formed PV and the PVM with parasite
proteins. A tubulovesicular membranous network (TMN) also develops within the PV,
which is a pore structure that allows small charged molecules with MW less than 1,200 Da to
pass through between the PV and the host cell cytoplasm,. It was proved that GRA3 and
GRA5 are localized on the PVM135, 136, while GRA1 and GRA2 associate with the
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Table 2.3. 1: Proteins Secreted by Rhoptry and Dense Granule

protein
#
1
2
3

protein name(Toxdb/NCBInr)
rhoptry antigen, putative/rhoptry
protein 5

database

protein 18

gene
name

mass

Mowse
Score

queries
matched

NCBInr

Toxodb

x

x

551.m00238/gi|72536429

ROP5

60933

169

5

x

33.m01398

ROP2A

66706

63

1

x

20.m03896/gi|84618297

ROP18

62626

57

1

x

83.m02145

ROP4

103803

53

3

rhoptry antigen, putative
rhoptry protein, putative/rhoptry

ID #(Toxdb/NCBInr)

x

81

4

rhoptry antigen, putative

5

/rhoptry protein

x

/gi|897823

ROP1

42645

162

11

6
7

/54-kda antigen or ROP2

x

/gi|235333

ROP2

61167

66

3

63.m00146

ROP2B

42334

63

1

8

Rhoptry protein or rhoptry protein 4
dense granule protein 5
precursor,putative
/23K calcium-binding major antigen
precursor
28 kDa antigen

/gi|6689341

ROP4

63937

42

5

76.m00004

GRA5

12831

62

4

20137

38

1

9
10
11
12
13
14
15

54-kDa antigen, partial

P35 surface antigen/dense granule
protein
dense granule protein 3/dense
granule protein
major surface antigen p30
/Dense granule protein 1 precursor
(Major antigen p24)

x
x
x

x

x

/gi 102305

x

x

42.m00015/gi|161913

GRA2

19792

49

3

x

x

52.m00002/gi|5901701

GRA8

28610

105

3

x

x

42.m00013/gi|22652337

GRA3

23861

480

17

x

x

44.m00009/gi|10725

SAG1

34709

101

10

/gi|129322

GRA 1

20137

102

4

x

81

16

/surface antigen

x

17

toxofilin

x

/gi 13447088
x

33.m02185/gi|27763993

82

82

SAG3

41747

42

1

75026

36

1

tubulovesicular membranous network (TMN)137. GRA5 is inserted into the PVM as a
transmembrane protein with its N-terminal domain extending into the cytoplasm and its C
terminus in the vacuole lumen138. Two surface proteins, SAG1 and SAG3, were also
identified. They are highly immugenic surface proteins and contaminant in the preparation.
They have been shown to act as attachment factors, mediating the contact between the
parasite and host cell during host cell invasion139.
The facts of all identified secretory proteins directly or indirectly associating with the
PVM further indicates the novel methodology of combination immunoprecipitation with
TSGE-MuDPIT effectively enriched and characterized the proteins from the PVM.
Other Identified Proteins

Beside secretory proteins, 42 other proteins were also identified using the novel
method. Those proteins are listed in Table 2.3.2. Surprisingly, we identified large number of
translational machinery proteins and DNA related proteins. A total of 11 out of 59 proteins
were translational machinery proteins (19%), including eight ribosomal proteins and three
elongation factor proteins. Also, five DNA related proteins (8%) were characterized. Even
though it is not clear yet how ribosomal proteins gets transported on the surface, it has been
reported that some ribosomal proteins like P0 are presented on the surface of T. gondii140.
The function of P0 is mediated through a P12.P0.P22 complex and P0 also interacts with the
elongation factor eEF2141, 142. Therefore, identification of large number of ribosomal and
elongation factor proteins may be due to the cell surface localization of those proteins.
Further biological investigation is needed to confirm these results. The possibility of nucleus
contamination during subcellular fractionation and the subsequent immunoprecipitation can
not be excluded, since the high percentage of translational machinery proteins and DNA
related proteins were identified. The whole parasite cell lysate was centrifuged by 10,000xg
for 10 minutes, and the remaining supernatant was directly subjected to immunoprecipitation,
the supernatant contains various subcellular components such as nuclei, mitochondria,
lysosomes and ribosome sediments. Ribosomal proteins from ribosome sediments or nuclei
are likely to be extracted from sample by nonspecific interaction with magnetic beads during
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the immunoprecipitation. Other proteomic analysis for the Toxoplasma Conoid reveals the
same sorts of contaminants.
Five chaperones were also identified, which are two heat shock 90 homologs, two
putative heat shock 70 homologs and protein disulfide isomerase. All these chaperone
proteins were also identified in the proteomic study of the parasitophorous vacuole of
Plasmodium falciparum, which is also an intracellular parasite of the phylum Apicomplexa

like T. gondii143. HSPs in T.gondii share significant homologies with their host counterparts,
but there is very limited information about their functional roles for the parasite144. The
chaperones may mediate protein translocation into and across the PVM. Protein disulfide
isomerases might play an essential role on unfolding proteins in the vacuole by breaking
disulfide bridges so that they can translocate across the PVM 145. The novel
immunoprecipitation method used in our experiment not only can enrich protein located in
the PVM, but also extract any proteins that have interaction with the PVM proteins. So
proteins those locate in PV or are secreted into the host cytoplasm at any stages of host-cell
invasion and have protein-protein interactions with the PVM proteins can also be
characterized using the subsequent TSGE-2D-LC-MS/MS. The identification of the
chaperones implied that these proteins may either locate at the PVM at certain stage of the
invasion or have intimate interaction with the PVM proteins. In order to elucidate structural
and functional roles of the chaperones, further biochemical research is required.
One interesting finding of our study is identification of the cyst matrix protein, a 65
kDa antigen that is expressed in the tissue and the cyst wall. Tissue cysts are specialized
parasitophorous vacuoles containing bradyzoites, the slowly replicating form of the parasite.
The cyst wall of this structure is produced by modification of the parasitophorous vacuole by
the parasite81. The PVM is the innermost cyst wall layer146. The identification of the the cyst
matrix protein indicates the recognition of cyst wall components is surprising, given that the
stain of Toxoplasma used (RH) does not form systs. So far neither the characterization of this
protein and nor functional roles of this protein has been studied or reported. Actin and a
membrane anchor protein for myosin XIV precursor were also identified from the enriched
PVM sample in our experiments, which is consistent with other biochemical studies. It has
been shown that T. gondii invade host cells in an actin-myosin84

Table 2.3. 2: Other Proteins Identified from PVM Samples
protein
#

protein name(Toxdb/NCBInr)

database
NCBInr

Toxodb

ID #(Toxdb/NCBInr)

mass

Mowse
Score

queries
matched

protein description

85

1

60s ribosomal protein L36, putative

x

49.m03096

11401

89

1

Translational Machinery

2

60s ribosomal protein L19, putative

x

80.m02220

22146

64

1

Translational Machinery

3

60S ribosomal protein L18a, putative

x

55.m05004

21317

56

1

Translational Machinery

4

60s ribosomal protein l6, putative

x

583.m05552

21506

31

2

Translational Machinery

5

40S ribosomal protein S11, putative

x

42.m00125

18665

37

1

Translational Machinery

6

ribosomal protein L32, putative

x

57.m00005

15607

38

1

Translational Machinery

7
8

60s ribosomal protein L36, putative

x

49.m03096

11401

45

3

Translational Machinery

60S acidic ribosomal protein P2, putative

x

583.m00610

11761

45

1

Translational Machinery

9

elongation factor 1-alpha, putative

x

x

76.m00016/gi|10140

48974

333

9

Translational Machinery

10

elongation factor 2, putative

x

x

20.m03912/gi|3122059

106504

44

1

Translational Machinery

11

elongation factor TS, putative

x

547.m00087

60260

31

1

Translational Machinery

12

histone H2A/histone h2A

x

x

145.m00002/gi|68060347

15910

158

8

DNA related proteins

13

histone H4, putative/histone 4

x

x

49.m03134/gi|19880139

11432

57

2

DNA related proteins

14

histone H4

x

/gi|223273

11190

85

3

DNA related proteins

15

seryl-tRNA synthetase, putative

x

50.m00020

54082

55

1

DNA related proteins

16

DNA replication licensing factor, putative

x

49.m00049

88157

92

7

DNA related proteins

17

protein disulfide isomerase, putative

x

x

27.m00003/gi|14494995

52769

62

1

Heat Shock Proteins

18

heat shock protein 90

x

x

80.m00001/gi|33669480

81882

115

2

Heat Shock Proteins

19

heat shock protein 90, putative

x

x

49.m00060/gi|66735118

96763

37

1

Heat Shock Proteins

20

heat shock protein 70, putative

x

x

73208

86

2

Heat Shock Proteins

21

heat shock protein 70, putative

x

x

583.m00009/gi|3098140
59.m00003/gi|3323502

72834

68

2

Heat Shock Proteins

85

cyst matrix protein, putative/65-kilodalton
22

antigen that is expressed in the tissue cyst

x

x

59.m00006/gi|520474

49150

510

16

Cyst Proteins

x

x

25.m00007/gi|89214066

41881

63

2

Structural Proteins

38.m01061/gi 46948064

46577

40

2

Structural Proteins

x
x

44.m00037
583.m00021

36767
22536

59
265

3
12

Structural Proteins
Enzymes

x

641.m01538

42598

39

1

Enzymes

x

162.m00001

65380

33

1

Enzymes

matrix and the cyst wall

25
26

actin
acid phophatase, putative/membrane
anchor for myosin XIV precursor
serine-threonine phosphatase 2C
superoxide dismutase

27

ubiquitin-conjugating enzyme E2, putative

23
24

28

x
x
x

calcium-dependent protein kinase, putative /
calmodulin-domain protein kinase, putative

86

29

lactate dehydrogenase

x

x

44.m00006/gi|1695772

35525

62

4

Enzymes

30

fructose-1,6-bisphosphate aldolase

x

x

46.m00002/gi|25989716

46930

93

4

Enzymes

31
32

enolase, putative

x

x

59.m03410/gi|12619316

52080

77

1

Enzymes

x

57.m01692

324180

471

23

Enzymes

x

x

65.m00001/gi|84176

69112

98

3

Enzymes

x

x

80.m00003/gi|13377044

36605

49

3

Enzymes

x

50.m03408

19160

75

1

Enzymes

SRS domain-containing, N-acetylglucosaminephosphate mutase, putative

33
34
35

nucleoside-triphosphatase
I/adenosinetriphosphatase (EC 3.6.1.3)
glyceraldehyde-3-phosphate
dehydrogenase
translationally-controlled tumor protein,
putative
14-3-3 protein homolog-related
thioredoxin, putative

x

42.m03594

189418

39

2

Enzymes

37

x

50.m00069

46946

47

1

Enzymes

38

hypothetical protein

x

44.m02649

172258

39

3

hypothetical proteins

39

hypothetical protein

80.m02161

47892

91

2

hypothetical proteins

40

hypothetical protein

x
x

20.m03773

187499

36

2

hypothetical proteins

36

86

41

hypothetical protein

42

/hypothetical protein PC000659.03.0

x
x

87

87

46.m02915

72948

35

2

hypothetical proteins

/gi|70944159

9490

66

9

hypothetical proteins

dependent way147. It has been proved that actin and myosin are localized at the apical end
and in the space between the plasma membrane and the inner membrane complex (IMC),
which lies beneath the cell membrane of T. gondii. Actin filament was observed at the
anterior end of the parasite in association with the conoid when treating with filamentstabilizing drug, Jasplakinolide148. Study also showed a class XIV myosin is critical for the
gliding motility of the parasite. Since actin and myosin XIV is intimately associated with the
host-cell invasion, it is likely that actin and myosin XIV is also localized in the PVM or have
interaction with the PVM proteins. Besides these identified proteins, we also observed a large
number of enzymes (twelve) including kinases, phosphatases, and proteases. These proteins
are likely to have specialized functions in the parasitophorous vacuole, or on the PVM.
Molestina and Sinai149 have shown recently that an unidentified parasite kinase is responsible
for the phosphorylation of host IKBα localized at the PVM in infected cells. The most
important funding is the identification of hypothetical proteins that would not have been
found otherwise. Total five hypothetical proteins were identified in our study.
All identified proteins were searched against toxodb.org, a total of 11 proteins contain
trans-membrane domains (listed in Table 2.3.3) and are considered as membrane proteins.
These proteins are very important for study of the composition of the PVM. Seven proteins
(ROP2A, ROP2, toxofin, GRA1, GRA3, GRA5 and SAG3) out of eleven are secreted
proteins from dense granule and rhoptry. Proteins, membrane anchor for myosin XIV
precursor and cyst matrix protein, which already discussed above, also contain transmembrane domain. The remaining two identified membrane proteins are hypothetical
proteins, which have not been reported before. The localization of many identified proteins
in our experiment needs to be further confirmed by immunoflueresence assay (IFA). In
addition, the functions of these proteins needs to be studied by generating mutant parasites
that are lacking of the relevant gene, by identifing the proteins with which they interact, and
by characterizing their substrates if they are found to be enzymes. The successful
construction of the PVM sub-proteome in our study provides many important targets for such
analyses and establishes the foundation of the thorough study of the important organelle of T.
gondii, the PVM.
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Conclusion

The Parasitophorous vacuole membrane (PVM) is an extracellular organelle of T.
gondii, which is critical for the parasite’s survival. In this chapter, we presented a novel

methodology which combined immunoprecipitation with TSGE-2D-LC-MS/MS. By using
this methodology, we successfully profiled T. gondii PVM proteome. 59 proteins were
identified from the PVM enriched sample. Result showed that 17 (29%) identified proteins
were from secretory organelles Rhoptry and Dense Granule, where only 4% proteins belong
to those organelles in whole parasite cell lysate. Furthermore, many proteins identified in our
study were previously reported to be localized in the PVM or intemite related to the PVM.
Therefore, the novel PVM purification method based on immunoprecipitation successfully
enriched secretory proteins. The combination of immunoprecipitation with TSGE-2D-LCMS/MS can successfully analyze challenging organelle like the PVM.
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Table 2.3. 3: Identified membrane proteins

protein name(Toxdb/NCBInr)
/54-kda antigen or ROP2
dense granule protein 5 precursor,putative
(GRA5)
dense granule protein 3/dense granule protein
(GRA3)
rhoptry antigen, putative (ROP2A)
/surface antigen( SAG3 protein)
/Dense granule protein 1 precursor (Protein
GRA 1) (Major antigen p24)

database
NCBInr

Toxodb

x

ID #(Toxdb/NCBInr)

mass

Mowse
Score

protein description

transmembrane
domain

/gi|235333

61167

66

PVM

1

90

x

x

76.m00004

12831

62

PVM

2

x

x

42.m00013/gi|22652337

23861

480

PVM

2

x

33.m01398

66706

63

PVM

1

x

/gi 13447088

41747

42

PVM

1

x

/gi|129322

20137

102

PVM

1

80.m02161

47892

91

hypothetical protein

1

38.m01061/gi 46948064

46577

40

Structural Proteins

2

x

59.m00006/gi|520474

49150

510

Cyst Proteins

1

x

46.m02915
33.m02185
/gi|27763993

72948

35

hypothetical protein

1

75026

36

PVM

1

hypothetical protein
acid phophatase, putative/membrane anchor
for myosin XIV precursor
cyst matrix protein, putative/65-kilodalton

x

antigen that is expressed in the tissue cyst

x

x

matrix and the cyst wall
hypothetical protein
toxofilin

x

x
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Chapter 2.4
Conclusion

As an interface between the parasite and host cell, parasitophorous vacuole membrane
(PVM) plays critical roles on various respects of the parasite’s life. It is understudied due to
its unique structural features. In this part of the dissertation, we developed a novel proteomic
methodology for qualitative analysis of the sub-proteome, T. gondii PVM. A new method,
the “Three-layer Sandwich Gel Electrophoresis” (TSGE), was first developed based on the
need for cleanup of the challenging PVM sample from biological preparation for subsequent
bottom-up proteomic analysis. The TSGE is used for concentrating and cleaning up protein
samples which are in uncharacteristically large volumes, contain high salt or other
contaminants, and/or extremely dilute. Several parameters for three-layer gel formation were
explored and their values were optimized to obtain the most effective methodology. The
optimized TSGE method was compared with other available protein concentration and cleanup methods. Results showed the TSGE methods can not only efficiently removed solvents
and contaminants but also produced had the highest protein recoveries compared to other
methods. Furthermore, the TSGE method in combination with 2D-LC-MS/MS was applied
to analyze T. gondii whole cell lysate. The results proved its reliability and usefulness of
analyzing complex protein samples.
The developed TSGE-2D-LC-MS/MS methodology then was applied in the analysis
of enriched PVM protein samples which was achieved by using a novel PVM enriching
method based on immunoprecipitation developed by Sinai and coworkers. The construction
of the PVM proteome indicated the immunoprecipitation methodology successfully enriched
the proteins in the PVM and immunoprecipitation coupled with TSGE-2D-LC-MS/MS can
be applied to analysis of challenging organelles.
In this part, we focused on proteomic method development on qualitative analysis of
complex biological samples. In next part, we are going to devote to method development on
quantitative proteomics.
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CHAPTER THREE

DEVELOPMENT OF NOVEL ISOCYANATE PEPTIDE N-TERMINAL LABELING
REAGENT FOR QUANTITATIVE PROTEOMIC APPLICATION USING LC-ESIMS/MS
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Chapter 3.1
Introduction

A major goal of proteomics is to qualitatively and quantitatively analyze all the
proteins expressed in a biological system like an organism, a tissue, an organelle, or a body
fluid, under a specific condition150. Various global quantitative approaches, which have the
ability to accurately measure differential protein expression and directly detect global
changes in health and disease, have been developed for analyzing complex biosystems.
These approaches are being employed in a varity of biological studies such as the discovery
of biomarkers of disease, the detection of new therapeutic targets and the studies of basic
biological processes and mechanisms of cell function and signaling151, 152. For this purpose,
the protein patterns of two protein samples after perturbations like drug treatment and
metabolic stress are compared. Most of these quantitative methods are based on two
strategies employed in bottom-up proteomics: Two-dimensional Gel Electrophoresis (2DSDS-PAGE) coupled with MS and 2D chromatography coupled with MS. Efficient
quatitative proteomic methods should have automated, robust and highly sensitive feature to
meet the requirement of high through-put protein analysis. Innovations in both gel-based and
gel-free strategies make it possible to expand quantitative proteomics to new areas of
biological research.
This part of dissertation focuses on the systematic study of mass spectrometric
properties of N-terminal labeled peptides with isocyanates using LC-ESI-MS/MS and the
development of the appropriate isocyanate labeling reagent for quantitative proteomics
application.
Quantitative Proteomics Background

Traditional quatitative proteomics is conducted using two dimensional gel
electrophorisis, which was described in chapter 1.1. However, since the quantitative analysis
results directly rely on the performance of both 2D gel and staining techniques, several issues
have to be considered when using 2D-SDS-PAGE as separation and detection means for
quantitative protein analysis. The first issue is the relatively low reproducibility of 2D-SDS93

PAGE analysis due to the difficulty of making the exact same two gels. Another problem is
that 2D-SDS-PAGE has limited capability in the analysis of membrane proteins. Many large
and hydrophobic proteins cannot be resolved and separated using 2D-SDS-PAGE. Also 2DSDS-PAGE has relatively low sensitivity and a small dynamic range, which causes low
abundant proteins which below limitation of detection of selected staining technique can not
be detected. More significantly, this method is sequential, labor intensive and difficult to
automate and can’t be on-line coupled to mass spectrometry153. All these issues limit the
application of 2D-SDS-PAGE on quantitative proteomics.
Stable Isotope Labeling

Instead of using gel involved technology, gel-free methods such as LC-MS- based
stable isotope labeling strategy have become popular for the quantitative analysis of proteins
in complex biological samples recently154, 155. Based on the different strategy, stable isotope
labeling is classified as enzymatic labeling156, AQUA157 and chemical labeling.
Enzymatic labeling refers to protein digestion with a particular enzyme in the
presence of either H216O or H218O, which is used for relative quantification. Under this
process, the enzymatically digested peptides are correspondingly labeled with 16O and 18O at
their C-termini through the enzyme catalyzed incorporation of oxygen. Then both samples
are combined and analyzed by LC-MS. The pairs of 18O-labeled and unlabeled peptides are
detected due to the same retention time and a 4 Da mass difference. The relative quantitation
is determined by the ratio of peptide pairs. For the identification of proteins, the fragment ion
spectra are automatically collected in the MS/MS mode and database searches are performed
using one of the computer-searching algorithms. While enzymatic labeling with H218O is a
straightforward method for introducing stable isotopes into a peptide sample, however, since
the resulting peptide pairs have only a 4 Da mass difference, it is difficult to distinguish
between labeled and unlabeled peptide pairs for multiply charged species when using lowresolution mass spectrometers.
AQUA as an absolute quantification strategy was developed recently. In this strategy,
special peptides are designed and synthesized with incorporated stable isotopes as ideal
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internal standards to mimic native peptides produced from protein digestion. After
proteolysis of protein of interest, the isotope labeled AQUA peptide is introduced, and
sample analyzed using LC-MS. Even though AQUA can be used for absolute quantification,
the preparation of the isotope labeled AQUA peptide is expensive and time-consuming.
Furthermore, the AQUA peptide is not universal, a suitable peptide candidate has to be
investigated and chosen for each different protein of interest.
The most widely employed LC-MS-based stable isotope labeling strategy is chemical
labeling, which involves labeling the control and the test sample with distinct labeling
reagents via chemical reaction. The labeling process can be performed either before or after
enzymatic digestion depending on labeling reagents and targeted functional group in the
protein. Then the two enzymatically digested samples are mixed and subjected to LCMS/MS in a data-dependant mode. In this manner, pairs of the isotopic labeled peptides are
differing only in mass from their counterparts, therefore are chemically identical and act as
mutual internal standards for accurate quantification158. Theoretically, an isotopically labeled
pair of peptides has identical physical chemical properties, thus they should behave the same
during chromatographic separation and ionization procedure. In another words, all pairs of
isotopic labeled peptides should be co-eluted from the chromatographic column and have
same ionization efficiency during ESI process. Therefore, the relative quantity of individual
peptide can be determined by calculation of the isotope ratios obtained from full mass scan.
At the same time, peptide sequence information can be obtained by the subsequent tandem
spectrum. However, when deuterium isotope is used in heavy labeling reagents, an isotopic
effect will take place during chromatographic separation159, which means modified peptides
with differential isotopic labeling can be partially or even completely resolved during
reversed-phase chromatography (RPC). This causes the isotope ratio to vary during the
course of elution from RPC columns. Thus quantification can only be achieved by comparing
their chromatographic peak areas using MS data. This means the relative quantity of the
peptide of interest only can be determined after the corresponding analyte peak completely
eluted from the LC-MS system160. The degree of chromatographic isotope effects depends on
several factors including (1) the number of deuterium atoms (2) the structure of the labeling
reagent, (3) peptides sequence and (4) peptide size 159. Currently, 13C is used in most isotopic
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labeling reagents to eliminate the isotopic effect161. Compared to traditional two-dimensional
gel electrophoresis methods, the major advantage of stable isotope-coding strategies is that
identification and quantification of proteins can be obtained simultaneously using MS and
MS/MS analysis. In addition, since these strategies can directly be coupled to LC-MS, it has
the potential for automated large-scale quantification analysis.
Among chemical labeling strategies, two different stable isotope labeling schemes
have been applied to quantitative analysis of proteomes. One scheme is targeted labeling162,
which means labeling specific amino acid residues in proteins. The most famous example is
Isotope Coded Affinity Tag (ICAT) labeling coupled with tandem mass-spectrometry
(MS/MS), which has been relatively widely applied to identification and quantitative analysis
differentially expressed proteins 11, 154, 163. In this method, Cys-containing proteins in two
samples are labeled separately with isotopically labeled light and heavy ICAT reagents which
have specificity toward thiol groups (cysteines). The labeled protein mixtures are combined
and proteolyzed to peptides. Then the ICAT-labeled cys-containing peptides are isolated
using affinity chromatography and then analyzed by LC-MS/MS. Since all non-cys
containing peptides are removed prior to MS analysis, it significantly reduces the complexity
of the sample, thereby facilitating the detection of less abundant peptides. Even though ICAT
is a promising approach, it also has some limitations. For example, the ICAT method is not
suitable to the analysis of non-Cys containing proteins, which probably constitute about 14%
of all proteins164. Also, this method can’t be used to analyze protein modifications and posttranslational modifications if the peptides containing modifications do not have cysteine
residues. In addition, the recovery from the avidin column is rather poor because of
irreversible binding, which may cause reduction of the number of cys-containing peptides
identified by the ICAT method165.
Another scheme, which is called global coding, labels N-terminus or C-terminus of
peptides instead of labeling specific amino acid in protein. So it allows any peptide, from any
place in a protein, to be used for quantitative analysis. As shown in Figure 3.1.1, in the
Global Coding Strategy, first two protein mixtures representing two different cell states are
proteolyzed to generate peptides. Then the two samples are labeled with light or heavy
labeling reagents respectively. Finally, the two samples are combined and analyzed by LC96

ESI-MS/MS. Then they are ionized during ESI process and introduced to the mass
spectrometer for MS and MS/MS analysis. The relative quantity of the pair of peptides is
determined by the ratio of extracted chromatographic peak areas in MS mode. Proteins are
identified by sequence information obtained from MS/MS spectra. The advantage of this
strategy is that it allows any peptide, from any place in a protein, to be used for quantitative
analysis. In this part of dissertation, we introduce a novel methodology for selecting
appropriate labeling reagent for global coding strategy based quantitative proteomics.
Peptide Fragmentation Mechanism

Peptides generate a series of fragment ions under low-energy CID. The most widely
accepted theory to describe how protonated peptides dissociate under low-energy CID is the
‘mobile proton model’166, 167. In brief, peptides can be protonated at various proteonation
sites such as N-terminal, peptide bond backbone and side chain groups (arginine, lysine, and
histidine), leading to various isomers. Based on the energetics of the protonated isomers, they
are classified as two classes. The characteristic of class one is that large energy is needed to
mobilize the proton to energetically less favored sites, for example, peptide containing
arginine. For the second group, many of the protonation sites are accessible in a narrow
energy range. Investigation of a large number of peptides showed that backbone dissociation
of protonated peptides under low-energy CID is a charge-directed process. In the gas phase,
protons from the initial protonation sites migrate to amide nitrogen along the peptide
backbone and trigger the cleavage of amide bonds in peptides to generate b ions and y ions.
The energy required for proton ‘mobilization’ from protonation sites depends on the amino
acid composition. For instance, proton on arginine need more energy to migrate compared to
the proton on lysine. Proton on both arginine and lysine need more energy to move compared
to that on N-terminal and non-basic peptide. Arginine is easier to protonate than lysine and
the N-terminal due to its high basicity. Since the probability of protonation depends on the
basicity of the protonation sites during electrospray ionization, large populations of singlycharged peptides are protonated on the C-terminal basic residues, which need high energy to
dissociate. Large population of doubly-charged peptides is protonated on both N-terminal
and C-terminal basic residues, which need less energy to dissociate compared to former.
Therefore, doubly-charged precursors need less energy to fragment and fragment in the way
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trypsin digestion

trypsin digestion
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Figure 3.1. 1: A schematic of global coding scheme. First two protein mixtures

representing two different cell states are trypsin digested to generate peptides. Then the two
samples are labeled with light or heavy labeling reagents respectivly. Finally, the two
samples are combined and analyzed by LC-ESI-MS/MS. The relative quantity of the pair of
peptides is determined by the ratio of extracted chromatographic peak areas in MS mode.
Proteins are identified by sequence information obtained from MS/MS spectra.
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such that most of the peptide bonds break with comparable frequency, such that one is more
likely to derive a complete sequence. Furthermore, since most fragment ions generated from
doubly charged precursor ion are singly charged, the generated spectra become the easiest to
interpret. In a nutshell, doubly charged peptides produce more product ions than singly
charged forms of the same peptide.
Study Rational

Protein identification using MS/MS database search is based on matching acquired
tandem spectrum to theoretical fragments from database. So peptide fragmentation is directly
related to protein identification. The more sequence useful fragments obtained, the more
probability the protein is identified during database search. Since doubly-charged precursors
also fragment such that most of the peptide bonds break with comparable frequency, such
that one is more likely to derive a complete sequence, obtaining high intensive doubly
charged ions during ESI process for further fragmentation is very important for protein
analysis.
When subjecting the modified peptides into mass spectrometer, which operated in a
data-dependent mode, the peptides are full scanned. Then the mass spectrometer
automatically chooses the most intensive peak from the previous full mass scan for further
CID fragmentation. If the N-terminal modification causes generating relatively more singly
charged ions compared to doubly-charged ions, mass spectrometer may automatically choose
singly-charged ion for further fragmentation, thus affecting protein identification. Therefore,
beside the factors such as the completeness and the specificity of the labeling reaction, the
influence of the modification on forming doubly charged ions during the electrospray
ionization process need to be investigated when choosing N-terminal labeling reagent for
quantitative proteomics. More importantly, because fragmentation of modified peptides is
directly related to identification of proteins, the effect of the modification on the
fragmentation during low-energy CID must also be evaluated.
Mason et al168 used phenyl isocyanate (PIC) as an N-terminal labeling reagent to
study relative quantification of several styrene oxide adducts of human hemoglobin.
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Isocyanate can react with N-terminal amino groups of peptide to form urea bonds. The
reaction is shown in Figure 3.1.2. However, when we investigated the mass spectrometric
properties of PIC modified peptides, we found several issues that may affect protein
identifications. First, PIC N-terminal modification seriously affects the formation of doubly
charged ion during ESI process. Figure 3.1.3 shows a full scan MS spectrum for peptide with
m/z 1042, +1, singly charged ion dominates the spectrum, while the doubly charged ion is
not detected. In data-dependant mode, the singly charged ion m/z 1042, +1 is selected for
further fragmentation. Figure 3.1.4 shows the subsequent ms/ms spectrum at m/z 1042, +1.
The two most intensive peaks m/z 922, +1 and m/z 948, +1 are formed by cleavages of two
urea C-N single bonds. When the parent ion cleaves at position 1 (labeled in Figure 3.1.4), it
produces the native form of product ion (m/z 922, +1) and at the same time loses a neutral
PIC molecule. While the parent ion cleaves at position 2, it forms the isocyanate peptide
form product ion (m/z 948, +1) and at the same time loses a neutral aniline molecule. A
series of b ions and y ions are also formed. However, compared to the two dominant product
ions, these b and y ions are in relatively low intensity. So the N-terminal labeling with PIC
apparently affects the fragmentation of the modified peptide. Based on these observations,
phenyl isocyanate is not likely an ideal N-terminal labeling reagent for quantitative
proteomics. Therefore, one of our study goals is to find an isocyanate reagent that is more
appropriate for quantitative proteomics application than phenyl isocyanate.
Study Hypothesis

Our hypothesis is alteration of isocyanate structure will change fragmentation pattern
and ESI property of isocyanate modified peptides. Novel isocyanate reagent, which can be
applied to quatitative proteomics, will be discovered by systematically studying mass
spectrometric properties of isocyanate modified peptides.
Study Goals

We aim to systematically investigate the ESI property and the collision-induced
dissociation of peptides labeled with a variety of aromatic isocyanates. Based on the results
obtained from this investigation, we design a new isocyanate reagent and evaluate the new
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agent labeled peptides. Eventually, we seek to find an appropriate isocyanate reagent for
future quantitative proteomics applications.
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Figure 3.1. 3: Full MS scan of phenyl isocyanate (PIC) N-terminal labeled peptide with
sequence AEFVEVTK (m/z1042, +1). Only singly charged peak was observed. Doubly

charged peak was not detected.
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Figure 3.1. 4: Tandem MS spectrum of peptide PIC-EFVEVTK with m/z 1042, +1. The
two most intensive peaks m/z 922, +1 and m/z 948, +1 are formed by cleavages of two urea
C-N single bonds. When the parent ion cleaves at position 1 (labeled in Figure 3.1.4), it
produces the native form of product ion (m/z 922, +1) and at the same time loses a neutral
PIC molecule. While the parent ion cleaves at position 2, it forms the isocyanate peptide
form product ion (m/z 948, +1) and at the same time loses a neutral aniline molecule. A
series of b ions and y ions are also formed.
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Chapter 3.2
Fragmentation of N-terminal Labeled Tryptic Peptides with Various Isocyanates by
using low-energy collision-induced dissociation CID
Introduction

Various labeling reagents targeting specific amino acid residues in proteins or
peptides have been explored169-171. For example, the ICAT reagent specifically targets
cysteines169 and NBS labeling reagent specifically reacts with tryptophan residues172.
Labeling methods can involve enrichment of labeled peptides using affinity chromatography,
which significantly reduces the complexity of the sample, thereby facilitating the detection of
less abundant peptides. However, these methods are not suitable for analyzing proteins not
containing targeted amino acid residues. Also, these methods have difficulty in the analysis
of protein post-translational modifications if the peptides containing modifications do not
have targeted amino acids165.
Instead of targeting specific amino acid residues, an alternative labeling reagent,
which reacts with N-terminal amino group of peptides, had also been studied159. The
advantage of this kind of reagent is that it allows any peptide, from any location in a protein,
to be used for analysis. A number of reagents for N-terminal modifications have been
studied for quantitative analysis, such as phenyl isocyanate168, 4-sulfophenyl isothiocyanate
(SPITC)173 and S-methylthioacetimidate174. Some N-terminal labeling reagents with fixedcharge are also employed to explore peptide fragmentation pathways (PFPs)175. For
example, tris (2,4,6-trimethoxyphenyl) phosphonium has been used as blocking reagent for
obstructing the protonation site on N-terminus to investigate low-energy charge-remote PFPs
in Asp-containing peptides176. Another application of the N-terminal labeling reagents is de
novo sequencing of peptides. Noga et al.177 applied a 1:1 mixture of acetic anhydride and

deuterated acetic anhydride to the peptide N-terminus and found it allows single and
unambiguous identification of ions fitting in either y ion or b ion series, significantly
simplifying peptide sequencing. Munchbach et al.178 investigated the effect of N-terminal
labeling of peptides with 1-(nicotinoyloxy) succinimide (Nic-NHS) esters and discovered
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that the modification by highly basic nicotinyl group greatly increases the relative yield of
the b-ions compared to the native peptide, therefore the modification facilitates de novo
sequencing of full-length peptides.
In this part, we focused on systematic studies of the fragmentation behavior of
isocyanate modified peptides. N-terminal modification of peptides with isocyanate, a highly
reactive functional group, caught our attention for potential application with quantitative
proteomics. Isocyanates can react with various hydrogen donors such as amino179,
sulfhydryl180, carboxyl179, and hydroxyl181 groups depending on the pH of solution. Under
neutral and basic condition, isocyanates can selectively react with amino and sulfhydryl
groups. Because of these unique chemical properties, it is possible to obtain quantitative
reactions by optimizing reaction conditions. Thus isocyanates were evaluated as promising
reagents for use in quantitative proteomics. Mason et al.168 has proved the potential
application value of isocyanates, they used phenyl isocyanate as a labeling reagent to modify
N-terminal amino group of all peptides in proteolytic digests to study relative quantification
of several styrene oxide adducts of human hemoglobin and reported 10000-fold linear
dynamic range of quantification. However, there have been no systematic studies of the
fragmentation behavior of various isocyanate modified peptides. The primary objective of
our study is to investigate the low-energy collisionally induced dissociation of peptides
labeled with a variety of isocyanates. An understanding of fragmentation mechanisms will
facilitate selection of appropriate isocyanate reagents to enhance quantitative proteomics
applications.
Experimental
Materials

Pyridine-3-isocyanate was obtained from Oakwood Products, Inc. (West Columbia,
SC). Phenyl isocyanate, phenethyl isocyanate and ammonium bicarbonate were acquired
from Sigma-Aldrich Co. (St. Louis, MO). Proteins including serum albumin (bovine),
cytochrome c (horse), myoglobin, actin (bovine) and carbonic anhydrase were obtained from
Sigma. Sequencing grade modified trypsin was supplied from Promega (Madison, WI).
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HPLC grade acetonitrile (ACN), HPLC grade water and formic acid were obtained from
Fisher Scientific International Inc (Chicago, IL).
N-terminal Labeling of Tryptic Peptides

Proteins were digested with trypsin at a trypsin/protein ratio of 1:20(w/w) at 37°C
overnight. Separate N-terminal modification reactions were performed by mixing tryptic
digests with 100 mM of the various isocyanates in ACN at a peptide/isocyanate molar ratio
of 1:150 and incubating at 37°C for 1hour. Reactions were terminated by adding 1µL of
88% formic acid.
LC-ESI-MS/MS Peptide Sequence

A Finnigan LCQ ion trap mass spectrometer coupled with a Hewlett Packard HPLC
system (1100 series) was used for LC-ESI-MS/MS analysis. Unmodified tryptic peptides or
N-terminal modified tryptic peptides obtained from protein mixture were injected into a 350
um (I.D.) x15 cm laboratory fabricated fused silica capillary C18 column for
chromatographic separation and analyzed by Finnigan LCQ. The column was first
equilibrated with 95% solvent A (0.1% formic acid in HPLC grade H2O) and 5% solvent B
(0.1% formic acid in ACN) at a flow rate of 4µL/min. After injection, the mobile phase
composition was held at 95% solvent A, for 5 min, then was linearly changed from 95% to
90% over 10 min. For the next 90 min, a linear increase of solvent B was carried out to reach
the composition of 55%. Then solvent B was rapidly increased to 90% in 10 min and
maintained at that concentration for additional 10 min. In the following 10 min, the solvent
A was changed back to 95% and held at 95% during the last 5 min.
The mass spectrometer was operated in a data-dependent mode in which a full scan
mass spectrum was followed by a tandem mass spectrum. During the full MS acquisition,
masses were scanned from 400 to 2000 m/z. The most intense precursor ion was selected
from the previous full MS scan to undergo CID with parameters of an activation Q of 0.250,
activation time of 30 ms, and 35% normalized collision energy (NCE). Once sampled, the
precursor mass was placed in an exclusion list and no CID was performed on this mass for
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the following 0.5 min. Both full scan and tandem MS spectra were collected by averaging
five microscans.
Unmodified tryptic peptide sequences were identified by using MASCOT server,
which searched tandem mass spectra of unmodified peptides against the NCBInr protein
sequence database.
Results and Discussion

Our study was based on the assumption that alterations in the isocyanate structure
will change the fragmentation pattern of isocyanate modified peptides. Systematic study of
fragmentation of various isocyanates modified peptides will help explain the effect of
isocyanate structure on CID fragmentation of modified peptides and will eventually lead to
an appropriate isocyanate reagent for quantitative proteomics applications. The study was
carried out by choosing three isocyanates that have distinct structural characteristics. Phenyl
isocyanate (PIC) was previously reported for quantitative proteomics by Mason et al.168.
They used PIC as an N-terminal labeling reagent to study relative quantification of several
styrene oxide adducts. Note that one distinct structural characteristic of PIC is the
conjugation of an aromatic ring and isocyanate moiety, which may influence aspects of
fragmentation. In order to determine effects of conjugation, phenethyl isocyanate (PEIC)
was also selected for study. PEIC has an ethylene group between phenyl and isocyanate
moiety in its structure, which serves as a spacer to break any conjugation between the two
groups. Finally, pyridine-3-isocyanate (PyIC) was selected since it has a similar structure to
PIC in terms of electronic conjugation. But unlike PIC and PEIC which are neutral species,
PyIC is a basic isocyanate, which will enable us to determine the effect of basic groups on
fragmentation behavior.
Charge State Distribution Shifts

During preliminary data collection of full scan mass spectra of PIC N-terminal
modified peptides, we observed that for small peptides such as peptide AEFVEVTK, only
singly charged ions appeared in full scan mass spectra. For many peptides, doubly charged
ions were observed in very low abundance or were not detected at all. As a result, the data
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dependent algorithm automatically selected singly charged ions as precursor ions for CID
fragmentation, and no tandem spectra for doubly charged ions from those peptides were
obtained. Based on the above observations, we conducted a thorough investigation of the
electrospray ionization characteristics of the N-terminal modified peptides. In this
experiment, the charge state distribution of unmodified tryptic peptides and modified
peptides with the model isocyanates were compared. The charge state distribution of each
peptide was evaluated based on average charge state (ACS), which was calculated as follows:
N

ACS

=

∑

i =1

qi ∗ Ii

Eqn.3.2.1

N

∑

i =1

Ii

Where qi represents the ith charge state present in the mass range from 400 to 2000, Ii is the
corresponding relative intensity and N is the number of observed charge states in the mass
spectrum. Fourteen tryptic peptides from standard proteins including BSA, cytochrome c.,
myoglobin, actin and carbonic anhydrase were selected for this study and their sequences
were listed in Table 3.2.1. Based on the consideration of the maximum observed charge state
of peptides obtained by ESI intimately correlated to the number of basic sites of peptide,
peptides were classified as having two basic sites, one basic side chain and the N-terminal
amino group, and peptides with three basic sites, caused by either one miss cleavage during
trypsin digestion or histidine present in the peptides. Each peptide was N-terminal labeled
with PIC, PEIC and PyIC, respectively. Full scan mass spectra of both unmodified and
various modified peptides were obtained using LC-MS analysis. Considering that various
factors, such as elecrtrospray instrumental parameters182-184, solution pH values185, 186, and
solvent composition187, have influences on the observed charged state distribution of analyte,
all experiments were carried out with the same instrumental parameters and at the same pH.
A possible issue that may affect some of the experimental results is solvent composition at
the point of elution. For most of the peptides, a slight change in hydrophobicity after PyIC
modification resulted in the observed coelution of PyIC modified and unmodified peptides
(listed in Table 3.2.1) by HPLC, therefore these pairs of peptides were ionized under
identical electrospray conditions. Conversely, modification of peptides with PIC or PEIC
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significantly increased hydrophobicity of the peptides, thus PIC and PEIC modified peptides
were observed to elute at higher concentrations of acetonitrile compared to corresponding
unmodified peptides, which further leads to the increase of the observed ACSs for PIC and
PEIC modified peptides187.
Figure 3.2.1 shows a comparison of average charge states of unmodified and
corresponding modified peptides with PyIC, PIC, and PEIC. Not surprisingly, we found that
N-terminal modifications with different isocyanates dramatically affected the charge state
distribution of peptides when peptides with two basic sites were examined (Figure 3.2.1A).
For N-terminal PyIC modification, peptide protonation was greatly enhanced compared to
unmodified peptides. Doubly charged modified peptides were observed to dominate the full
scan MS spectra in almost every case. Figure 3.2.1A shows that all PyIC modified peptides
had ACS values of greater than 1.5; while most of ACSs from corresponding unmodified
counterparts were less than 1.5. In contrast, N-terminal PIC and PEIC modifications of the
peptides significantly decreased average charge state values compared to unmodified
counterparts. ACS values for all PIC and PEIC modified peptides were close to 1. As shown
in Figure 3.2.1A, four peptides, VATVSLPR, YLYEIAR, VLDALDSIK and
VGDANPALQK, with native peptide m/z 842, 927, 973 and 1012 respectively displayed
significant decreases of protonation compared to corresponding unmodified peptides. Singly
charged ions were mainly produced in the full scan mass spectra of these peptides. For the
case of peptides MIFAGIK (m/z 779, +1) and LVTDLTK (m/z 789, +1), similar average
charge state (ACS) values were obtained for unmodified, PIC and PEIC modified peptides.
The reason for this observation is that doubly charged unmodified peptides were below lowmass cutoff in full MS scan, consequently, the calculation of average charge states for
unmodified peptides was only based on singly charged ions and produced ACS values of 1.
It appears that modifications assisted by shifting masses of doubly charged ions to higher
values and made it possible to detect doubly charged peptides with low m/z.
For peptides with three basic sites (Figure 3.2.1B), doubly charged ions were
observed to dominant in MS spectra and triply charged ions had relatively low contribution
to charge state distribution. Furthermore, it was found that N-terminal modification typically
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Figure 3.2. 1: Comparison of average charge states of unmodified tryptic peptides and
modified peptides with PyIC, PIC and PEIC, respectively. The mass spectra for each

unmodified and modified peptides were obtained by averaging five microscans during the
full MS scan experiments.
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Table 3.2. 1: Sequences of selected peptides used for charge state distribution investigation
Peptides with two basic sites
Unmodified
sequence
m/z, +1

Peptides with three basic sites
Unmodified
sequence
m/z, +2

779

MIFAGIK

454

MIFAGIKK

789

LVTDLTK

584

TGPNLHGLFGR

842

VATVSLPR

602

VLDALDSIKTK

922

AEFVEVTK

681

ALELFRNDIAAK

927

YLYEIAR

690

HGTVVLTALGGILK

973

VLDALDSIK

803

VEADIAGHGQEVLIR

1012

VGDANPALQK

847

AEFVEVTKLVTDLTK
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affected triply charged ions of the modified peptides in full mass spectra. Therefore,
modifications with different isocyanates had relatively less effect on the charge state
distribution of the modified peptides compared to peptides with two basic sides. N-terminal
modification with PIC and PEIC was observed to slightly decrease average charge state
values. For small peptides like peptide MIFAGIKK (m/z 454, +2) shown in Figure 3.2.1B,
triply charged ions of both unmodified and modified were below the detection mass range.
Average charge states were calculated only based on singly and doubly charged ions. As a
result, no significant difference between unmodified and various modified peptides was
observed. For other peptides such as peptide TGPNLHGLFGR (m/z 584, +2), the triply
charged ion of unmodified peptide was not observed in mass spectrum due to its low mass.
Not surprisingly, the average charge state value of unmodified peptide was the lowest
compared to all corresponding modified peptides.
In short, PyIC maintained and in some cases even increased the protonation of
modified peptides compared to unmodified peptides. Doubly charged ions dominated in full
scan spectra. In contrast, PEIC and PIC shifted the peptide charge state distributions to lower
values. A possible explanation is that during the ESI process, peptides can be protonated at
various sites including N-terminal amino group, side chain groups and amides188. Of all
those protonation sites, basic side chains, such as arginine, lysine, and histidine, and the Nterminal amino group are more easily protonated. Modification of peptides N-terminus by
neutral reagents like PIC or PEIC removed one protonation site of the peptides and directly
led to a significant decrease of maximum charged state values. The replacement of PIC with
PyIC increased the basicity of the N-terminus of modified peptide, which compensated for
the lost of one basic site caused by turning N-terminal amino group into a urea bond. In
addition, the charge delocalization on the pyridine aromatic ring stabilized the protonated Nterminus to some extent, therefore increased the protonation of PyIC labeled peptides
compared to unmodified peptides especially for peptides with two basic sites. The charge
state for PIC or PEIC modified peptides primarily depended on the sequence of the peptides.
Singly charged ion had the highest intensity in full scan MS spectrum for peptides with two
basic sites, while doubly charged ion dominated for peptides with three basic sites. When
comparing PEIC with PIC modified peptides, similar charge state distributions for all cases
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were found, which was consistent with the discussion motioned above. Since multiply
charged peptides fragment in more facile manor and give higher yields of product ions than
singly charged forms of the same peptides189, and given that N-terminal modified peptides
fragment in a similar way as unmodified pepetides, then theoretically, PyIC should be a
better N-terminal modification reagent than PEIC and PIC.
Fragmentation Characteristics of N-terminal Labeled Tryptic Peptides with Various
Isocyanates using LC-ESI-MS/MS

As discussed in Chapter 3.1, isocyanates react with the N-terminal amino group of a
peptide to form a urea derivative. To investigate the low-energy collision-induced
dissociation characteristics of the modified peptides, all tryptic peptides from standard
proteins were N-terminal modified with PIC, PEIC and PyIC, respectively. A total of 72
tandem mass spectra from singly charged peptides and 81 tandem spectra from doubly
charged peptides were collected and compared. We found that one striking characteristic of
the fragmentation of N-terminal isocyanate modified peptide was the dominance of two
product ions in the tandem spectrum. A scheme of fragmentation of N-terminal isocyanate
modified peptides is shown in Figure 3.2.2B. One of the two main product ions resulted
from the cleavage at site 1 (labeled in Figure 3.2.2B) and the loss of the intact isocyanate
returning the native form of the peptide [M+H]+ or [M+2H]2+ (Figure 3.2.2B). The other
major product ion resulted from the cleavage at site 2 (labeled in Figure 3.2.2B) and the loss
of the aryl portion of the isocyanate returning a peptide isocyanate [M+26+H]+ or
[M+26+2H]2+, depending on the charge of the precursor ion. When singly charged modified
peptides were subjected to CID, two singly charged product ions were observed that
dominated the spectrum. In the same manner, peaks corresponding to doubly charged form of
both product ions were most intense in MS/MS spectra from doubly charged modified
peptides. Given that both dominant product ions resulted from cleavage of the urea bond in
the labeled peptide, the urea bonds are thought to be more fragile than the peptide amide
bonds such that only low abundance b and y ions were observed. In order to inspect the
characteristics of the fragmentation of modified peptide with various isocyanates in more
detail, two concepts, Net Fragmentation Efficiency (NFE) and the ratio of two major
products ion intensities (RN/I), were defined as
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Figure 3.2. 2: (A) Structures of isocyanates employed in the study. (B). Scheme of

fragmentation characteristic of N-terminal modified peptide by various isocyanates.
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Where ΣII represented the total fragment ion intensity, IM* was native peptide ion intensity
and IM** was isocyanate-form ion intensity. Figure 3.2.2 shows the scheme of fragmentation
Characteristic of N-terminal modified peptide by isocyanates as well as the structures of M*
and M**. Since the formation of native and isocyanate-form fragments directly suppressed
the production of other sequencing useful fragments, NFE was used to measure the ion yield
of fragments that were useful for obtaining sequence information of peptide. The higher the
value of NFE obtained, the more number or the higher relative intensities of useful fragments
for peptide sequencing was acquired in tandem spectra. The other concept, RN/I, was
designed to monitor the cleavage preference between site 1 and site 2 (labeled in Figure
3.2.2B), as N-terminal modified peptide with various isocyanates was subjected to CID
fragmentation. For instance, when a higher RN/I was obtained, the native peptide form of
product ion dominated the tandem spectra, which implied that the modified peptide was more
prone to cleaved at site 1 as labeled in Figure 3.2.2B.
As can be seen from the previous experiment, singly charged ions were
predominantly produced in mass spectra during ESI of peptides with two basic sites modified
by PIC or PEIC, while doubly charged ions dominated the full scan mass spectra when
peptides with three basic sites were electrospray ionized. Understanding the fragmentation
of both types of peptides by low-energy CID is critical for the quantification application in
proteomics. A total of 38 peptides were chosen for this study and they were classified into 2
categories: peptides with two basic sites and peptides with three basic sites as described in
‘charge state distribution’ experiments. All 38 peptides were used to react with all three
isocyanates, respectively. Twenty peptides with two basic sites out of 38 peptides were
chosen for investigation of fragmentation of singly charged precursor ions. Tandem
spectrum of each singly charged peptide was acquired for comparison between unmodified,
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PIC, PEIC and PyIC modified peptides additionally, the remaining eighteen peptides with
three basic sites were selected to investigate fragmentation of doubly charged peptides
modified by PIC, PEIC and PyIC, correspondingly. The sequences of those peptides were
listed in table 3.2.2. NFE values and RN/I data of all modified peptides were calculated, and
the consequent results were displayed in Figure 3.2.3. In order to easily present RN/I data,
mass to charge ratios of the unmodified peptides were shown on the abscissa and the natural
logarithm of RN/I values were given on the ordinate in Figure 3.2.3B. Since RN/I was defined
as the ratio of native peptide ion intensity to isocyanate-form ion intensity, Ln(RN/I) indicated
the probability of the cleavages on site 1 and site 2 labeled in Figure 3.2.2B. Value zero of
Ln(RN/I) showed that the modified peptide statistically cleaved at both site 1 and site 2.
Positive value represented that cleavage was more prone to occur at site 1, while negative
value displayed the preference of cleavage at site 2.
The Impact of the Structure of Isocyanates on Fragmentation of N-terminal Modified
Peptides

A significant effect of the isocyanate structure on the fragmentation pattern of
modified peptides is shown in Figure 3.2.3. Among the three isocyanate modified peptides,
PIC modified peptides were observed to have relatively high net fragmentation efficiencies:
74 percent of PIC modified peptides obtained the highest NFE values in contrast with
corresponding PEIC and PyIC modified peptides. Thus PIC modified peptides produced
more sequence fragments and were more appropriate for quantitative proteomics than PyIC
and PEIC. In Figure 3.2.3B, the Ln(RN/I) values achieved from PIC modified peptides
constantly lie in the middle compared to the corresponding values obtained from the other
two isocyanate modified peptides. This indicated that the two C-N bonds in urea of PIC
modified peptides seemed to have relatively similar bond strengths and could be cleaved at
both sites to form both native peptide and isocyanate-form fragments.
A structural characteristic unique to PEIC is insertion of the aliphatic spacer between
the aromatic ring and isocyanate moiety, which breaks the conjugation between the two
groups. The effect of PEIC structure on the fragmentation of modified peptides is also
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Table 3.2. 2: The sequences of peptides used for the study of fragmentation of modified

peptides.
Unmodified
m/z, +1

Peptide sequence

644

GILTLK

660
678
779
789
842
922
927
973
980
909
1003
1012
1019
1045
1130
1147
1429
1471
1495

TPVSEK

Unmodified
m/z, +2
437
454
584
602
636
653
676
681
690
720
752
791
803
813
820
847
978
1100

YIPGTK
MIFAGIK
LVTDLTK
VATVSLPR
AEFVEVTK
YLYEIAR
VLDALDSIK
DGPLTGTYR
DLTDYLMK
QSPVNIDTK
VGDANPALQK
DFPIANGER
GTDVQAWIR
GYSFVTTAER
EPISVSSQQMLK
FESNFNTQATNR
TGQAPGFTYTDANK
EETLMEYLENPK
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Peptide sequence
HGLDNYR
MIFAGIKK
TGPNLHGLFGR
VLDALDSIKTK
LFTGHPETLEK
HLVDEPQNLIK
TEREDLIAYLK
ALELFRNDIAAK
HGTVVLTALGGILK
RHPEYAVSVLLR
HPGNFGADAQGAMTK
YAAELHLVHWNTK
VEADIAGHGQEVLIR
EETLMEYLENPKK
KVPQVSTPTLVEVSR
AEFVEVTKLVTDLTK
VAPEEHPTLLTEAPLNPK
AVVQDPALKPLALVYGEATSR

shown in Figure 3.2.3. Compared to PIC modified peptides, 90% of PEIC modified peptides
had lower NFE values regardless of charge of the precursor ion. However, when compared
to PyIC modified peptides, the result for singly charged peptides was different from that for
doubly charged. For singly charged peptides, PyIC modified peptides were inclined to
generate more sequence fragments than corresponding PEIC modified peptides. Conversely,
in doubly charged cases, PEIC modified peptides were more likely to have higher NFE
values than PyIC. Figure 3.2.3B revealed that PEIC modified peptides had the lowest
Ln(RN/I) among the three isocyanates, which implied PEIC modified peptides were prone to
generate isocyanate-form peptide fragments by cleaving at site 2 (labeled in Figure 3.2.2).
PyIC, which has similar structure as PIC except introduction of nitrogen on aromatic
ring, was expected to have a similar effect on the fragmentation pattern of modified peptides
as PIC. And since PyIC modified peptides can easily form multiply charged ions during ESI,
multiply charged PyIC modified peptides were expected to have even better fragmentation
than PIC and PEIC. Surprisingly, the net fragmentation efficiencies of PyIC modified
peptides were low comparied to PIC and PEIC modified peptides, which meant that fewer
sequence fragments were obtained when PyIC modified peptides were subjected to CID
fragmentation. In all cases, the most intensive peak in tandem spectra was observed to be the
native peptide product ion, leading to the highest Ln(RN/I) values obtained in comparison to
the corresponding PIC and PEIC modified peptides (Figure 3.2.3B). As mentioned before,
the native peptide product ion was formed by cleaving at site 1 on the urea bond. Therefore,
PyIC modified peptides were prone to cleave at site 1 instead of site 2 (Figure 3.2.2B).
A possible explanation for this fragmentation behavior of various isocyanate modified
peptides is that for PIC modified peptides, conjugation of the aromatic ring with urea bonds
may stabilize both of the two urea bonds, which led to relatively high NFEs compared to
PEIC and PyIC modified peptides. For PyIC modified peptides, due to the basicity of
pyridine ring, the infused nitrogen could be protonated during the ESI process. The
population of protonated and unprotonated pyridine on N-terminus of the modified peptides
depends on the gas-phase basicities of the different protonation sites of the peptides.
However, even for PyIC modified peptides with unprotonated N-terminus, due to the strong
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π electron-withdrawing effect of the infused nitrogen in pyridine190 and the conjugation of
pyridine ring with urea bonds, pyridine weakened both urea bonds, especially urea bond on
site 1. Furthermore, the electron-withdrawing effect of the pyridine group increased when the
pyridine nitrogen was protonated during the ESI process, causing more pronounced
weakening of the two urea bonds. Therefore, PyIC modified peptides had relatively low
NFEs compared to PIC and PEIC modified peptides during CID and the dominance of the
native peptide fragment in spectrum. While considering the feature of PEIC structure, the
lack of conjugation between aromatic ring and two urea bonds caused the two urea bonds
more unstable compared to PIC. Consequently, PEIC modified peptides had relatively low
NFEs compared to PIC and had the preference of producing isocyanate-form fragments to
native peptide fragment.
The Influence of Peptide Sequence on Fragmentation of N-terminal Isocyanate
Modified Peptides

In addition to the isocyanate structure, Figure 3.2.3 clearly shows the amino acid
composition of peptide was intimately related to both net fragmentation efficiency and the
preference of cleavage site of urea bonds. In Figure 3.2.3A, it was observed that fragments
derived from the cleavage of peptide bonds were suppressed to some extent regardless of
isocyanate modified peptide charge state. Among 114 NFE values presented in Figure 3.2.3,
the highest NFE was 88% and the lowest was only 5% which yielded an average NFE value
of 40.83%. The low NFE values indicated that isocyanate modified peptides produced
relatively few useful fragments compared with unmodified peptides. As a result, labeling
peptides with isocyanates can limit identification of peptides and corresponding proteins. The
basicity of basic sites that peptides contained in their sequences seemed to play an important
role on NFE values. Eleven investigated peptides have arginine and but no lysine, and
relatively low NFEs were obtained from those peptides (Table 3.2.2). Among all arginine
containing isocyanate modified peptides, 72% had NFEs lower than the average NFE value.
Conversely, Lys-containing modified peptides were more likely to obtain high NFE values
compared to Arg-containing peptides, where 56% of lysine containing modified peptides had
NFE values higher than the average. This observation could be explained in terms of the
“mobile proton” model166, 167. In brief, a proton migrates from the original
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Figure 3.2. 3: Net fragmentation efficiency values (A) and Ln(RN/I) (B) of singly charged

(shown in the left) and doubly charged (shown in the right of the figure) modified peptides
by PyIC, PIC and PEIC. The tandem mass spectra for each modified peptides were obtained
by averaging five microscans during the MS/MS experiments.
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protonated site to the amide nitrogen, triggering the cleavage of amide bonds and generating
a series of bn and yn ions. The energy needed for proton migration relied on the amino acid
composition of the peptide. For instance, arginine-containing peptides need the highest
energy to migrate a proton; peptides without basic amino acid require the least; and lysinecontaining peptides sit about in the middle. Based on the “mobile proton” model, we can
rationalize that the urea bonds of isocyanate modified peptides are so weak that cleavage of
the urea bond could be achieved via charge-remote fragmentation at much lower energy than
that is required for charge-directed fragmentation by migrating a proton from lysine or
arginine. Consequently, two product ions (native form and peptide isocyanate) dominate the
MS/MS spectrum. Relatively high NFE values were observed in lysine-containing peptides,
because less energy is needed than arginine-containing peptides.
Similar to net fragmentation efficiency, the peptide sequence also significantly
influenced the preference of cleavage of the two urea bonds and the relative intensities of
resultant native form and peptide isocyanate product ions. In Figure 3.2.3B, Ln(RN/I) values
for peptides modified by PyIC, PIC and PEIC were observed to vary from 6.31 to 0.06, from
1.98 to -1.45 and from 0.62 to -3.25, respectively. A five-hundred-fold difference was
observed between the maximal and the minimal RN/I value in PyIC modified peptides, which
indicated the strong effect of peptide sequences on bond strength of the two urea bonds.
Potential Application on De Novo Peptide Sequencing

Since fragmentation patterns of singly charged precursor ions and those of doubly
charged precursor ions are quiet different, the effect of charge on fragmentation of those
precursor ions will be discussed individually.
Figure 3.2.4 gave four examples of the comparison of tandem spectra obtained from
singly charged precursor ions of unmodified peptide (a) and modified peptide by PIC (b),
PyIC (c) and PEIC (d). All singly charged precursor ions of the peptides of interest were
selected to perform CID fragmentation. It was observed that in addition to the two
characteristic product ions (native peptide ion and isocyanate-form ion), the cleavage patterns
of unmodified peptides were strikingly different from those of isocyanates modified peptides.
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The isocyanate modified peptides were observed to produce a limited number of fragment
ions by low-energy CID compared to unmodified peptides. In some cases, the b-ion series
can be easily identified and provide complete sequence coverage of the peptides. For
example, a peptide EDLIAYLK was modified with all isocyanates. The tandem spectrum of
the unmodified peptide is shown in Figure 3.2.4A (a). It was observed that b ions were
absent or of low abundance which was in good agreement with the characteristic
fragmentation of peptides with an N-terminal glutamic acid189. However, Figure 3.2.4A (b to
d) showed that the modified peptides with various isocyanates were able to form both yn and
bn ions. In addition, the relative intensities of entire generated b-ion series were significantly
enhanced in all spectra of modified peptide compared to unmodified peptides. The complete
sequence of this peptide can be easily and rapidly extracted using the modification of
isocyanates. Interestingly, it was found in Figure 3.2.4D that tandem spectra of different
isocyanates modified peptide (AEFVEVTK) exhibited tremendous differences.
Fragmentation of PIC modified peptide was shown in Figure 3.2.4D (b), where b-ion series
were observed dominating the MS/MS spectrum. Due to the limited mass range of the ion
trap, b1 and b2 ions were absent in the spectrum. In contrast, both y and b ion series were to a
certain extent suppressed for PEIC and PyIC modified peptides (Figure 3.2.4D (c), (d)).
Consequently, we believed that PIC is a better N-terminal labeling reagent for application in

de novo peptide sequencing than PyIC and PEIC. One problem we discovered was that some
modified peptides produced very low intensities of either yn or bn ion series no matter which
isocyanates were used. For example, Figure 4C shows tandem spectra of peptide
DLTDYLMK, entire b-ion and y-ion series were in very low intensities.
Figure 3.2.5 showed six examples of comparing tandem spectra obtained from doubly
charged precursor ions of unmodified peptide (a) and modified peptide by PIC (b), PyIC (c)
and PEIC (d). The most distinguishing feature is the detection of b1 ions in almost every case
when N-terminal PIC and PEIC modified peptides were subjected to CID. Those b1 ions
were labeled with bold characters in Figure 3.2.5. The limited MS/MS mass range of the ion
trap usually precluded the collection of an entire fragment series, especially low mass
fragments. Adding the isocyanate on the N-terminal shifts the entire b-ion series to higher
mass range, making the detection of low mass fragments feasible. The combined use of
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unmodified and N-terminal PIC or PEIC modified peptide should prove useful in de novo
sequencing of peptides. The other feature observed from Figure 3.2.5 was that PyIC
modified peptides produced less fragments with very low relative intensities compared to
PIC and PEIC modified peptides. Furthermore, PyIC modified peptides were more likely to
produce b-T ions (b ions which lost the N-terminal isocyanate derivative tag) compared to
PIC and PEIC modified peptides. That may be because the urea bonds in PyIC modified
peptides are unstable during CID. Fragments assigned to b-T ions were observed in 4
peptides in Figure 3.2.5. Similar to singly charge modified peptides, another important factor
that also affected the fragmentation pattern of modified peptides was the basic site in
peptides. For example, Figure 3.2.5 shows three peptides (Figure 3.2.5A, C, D), which had
either two lysines or one lysine and one histidine in their sequences, and peptide
TGPNLHGLFGR (Figure 3.2.5B), which had one arginine and one histidine in its sequence.
It could be seen from these tandem spectra that modified peptide with arginine in the
sequence had less fragments compared to peptides with lysine in the sequences. Figure
3.2.5E and Figure 3.2.5F showed tandem spectra of doubly charged modified peptides with
one basic amino acid in the sequences. These peptides could easily acquire one positive
charge via protonation of the basic residue. However, the second charge for doubly charged
modified peptides had to be obtained by protonating a non-basic site of the peptide because
of the block of N-terminal amino group. It can be easily seen from Figure 3.2.5E and Figure
3.2.5F that when modified by PIC or PEIC, these peptides produced spectacularly low
relative-intensities of native peptide and isocyanate-form fragments. In Figure 3.2.5E (b) and
(d), the two fragments did not even appear in the spectrum. Meanwhile, fragments derived
from the cleavages of amide bonds dominated the spectra. The unusually high net
fragmentation efficiency results from the highly active proton obtained during protonation of
peptide. Less energy was required to mobilize the active proton along the backbone of the
peptide and perform charge-directed fragmentation than that is required to activate the
cleavage of the urea bonds in modified peptides. Moreover, PIC and PEIC modification also
produced new b ions or y ions that were not apparent in unmodified peptide tandem spectra
(labeled with bold characters), which may facilitate de novo peptide sequencing.
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The Effect of N-terminal Modification on Peptide Identification

The above discussion indicated that PIC modified peptides produced the best
fragmentation, while PyIC modified peptides formed the fewest fragments useful for peptide
sequencing during CID. Based on these results, PIC and PyIC were chosen to study the
effect of N-terminal modification on peptide identification. Myoglobin tryptic peptides were
N-terminal labeled with PIC and PyIC as described in the experimental section. Both
unmodified and various isocyanate modified peptides were mixed at a ratio of 1 and
subjected to CID.
The resulting MS/MS data were used to search against NCBInr database using the
Mascot algorithm, in which PIC and PyIC N-terminal modification was added to the
modification list by putting masses of those reagents into the Unimod database. Similar
protein sequence coverage was obtained for unmodified and PIC modified protein digest
when “PIC N-term” was chosen as variable modification in Mascot parameter. The PyIC
modification had much lower sequence coverage when obtained MS/MS data were analyzed
using Mascot with parameter variable modifications set as “PyIC N-term”. For example,
protein sequence coverage of myoglobin reached 73% for PIC modification but only 62% for
PyIC modification. Moreover, identified peptides from both modifications did not
completely overlap. Several peptides identified for PIC modification were small peptides
with molecular weight less than 800. Because of the small size of those peptides, which were
less than 7 amino acids, the number of fragments generated from CID was not enough to
prevent false positive peptide identification191. Probably because of the poor quality of the
tandem mass spectra, those peptides were not in the sequenced peptide list for PyIC
modification. It seemed that PIC modification had difficulty in identification of large
peptides with few basic sites. Therefore, PIC may not be suitable for quantitative application
of hydrophobic proteins, such as membrane proteins, which contain a few basic amino acids
and produce large peptides by tryptic digestion. Large peptides such as peptide m/z 1175
(+3) were found sequenced when PyIC was used as labeling reagent.
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Figure 3.2. 4: Typical ESI ion trap MS/MS spectra of singly charged precursor ions of

unmodified peptide (a), and N-terminal modified by PIC (b), PyIC (c) and PEIC (d). Four
peptides (A-D) with sequence labeled were shown in this Figure. In each spectrum, bn and
yn ions are labeled and bn ions are highlighted. b-T ion represents b ion which lost the Nterminal isocyanate derivative tag. M* refers to the native form of the product ion and M**
means Isocyanate peptide product ion. M0 represents the native form of the product ion that
lost a water molecule.

127

128

129

Figure 3.2. 5 : Typical ESI ion trap MS/MS spectra of doubly charged precursor ions of
unmodified peptide (a), and N-terminal modified by PIC (b), PyIC (c) and PEIC (d). Four
peptides (A-D) with sequence labeled were shown in this Figure. In each spectrum, bn and
yn ions are labeled. New b ions or y ions that were not apparent in unmodified peptide
tandem spectra are highlighted. b-T ion represents b ion which lost the N-terminal
isocyanate derivative tag. M* refers to the native form of the product ion and M** means
Isocyanate peptide product ion. M0 represents the native form of the product ion that lost a
water molecule.
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Conclusion

In this study, we systematically studied both ESI characteristics and the fragmentation
pattern of N-terminal modified peptides with three typical isocyanates: PIC, PEIC and PyIC,
which represented aromatic neutral, aliphatic neutral and aromatic basic isocyanate,
respectively. We observed that isocyanate modification had effects on charge state
distribution of the peptides during ESI process. PIC and PEIC modification was found to
severely decrease the protonation of modified peptides, while PyIC modification maintained
and in some cases increased the protonation compared to unmodified counterparts. A
fragmentation study of each reagent modified peptides was carried out by comparison of
NFE and Ln(RN/I) values. In our experiments, PIC modified peptides produced the most
sequence product ions and had tendency to cleave at both urea bonds. Conversely, PyIC
modified peptides produced relatively fewer sequence product ions and were prone to cleave
at site 1 of the urea bonds. Compared to PyIC, PIC modification was better for protein
identification. One positive feature of the N-terminal modification by isocyanates was
shifting bn series ions to higher mass ranges and making b1 ion detectable in tandem MS.
Therefore N-terminal isocyanate modification has potential for enhancing de novo peptide
sequencing. Future efforts will be focused on designing new isocyanate reagent to
overcome, or at least minimize limitation of both PIC and PyIC. That is, modified peptides
by this reagent should have higher charge state distribution during ESI and produce more
abundant sequence product ions by CID fragmentation.
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Chapter 3.3
Fragmentation of N-terminal Modified Tryptic Peptides by 3-(Isocyanatomethyl)
Pyridine using Low-energy Collision-Induced Dissociation CID
Introduction

Our previous works showed that the adjustment of isocyanate structure changes both
ESI characteristic and the fragmentation pattern of isocyanate modified peptides. Phenyl
isocyanate (PIC), phenethyl isocyanate (PEIC) and pyridine-3-isocyanate (PyIC) were
chosen to carry out the investigation. PIC and PEIC modifications were found to severely
decrease the protonation of modified peptides during the ESI process, even though PIC
modified peptides produced the most sequence product ions by CID. On the other hand, PyIC
modification maintained and in some cases increased the protonation compared to
unmodified counterparts. However, PyIC modified peptides produced the fewest sequence
product ions among the three isocyanate modified peptides when subjected to CID. We
rationalized that the decrease of protonation of PIC and PEIC modified peptides results from
the neutral property of the both reagents. In addition, the structural characteristics of PyIC,
which were depicted as both electron-withdrawing feature of protonated PyIC and the
conjugation of pyridine ring with urea bonds once reacted with amino group, causes the
significant reduction of fragments when PyIC modified peptides were subject to CID.
To expand upon these prior studies, we designed a new isocyanate reagent called 3(isocyanatomethyl) pyridine (PyMIC) (Scheme 3.3.1), which had the same compound
structure as PyIC except a methyl group was introduced between the pyridine ring and the
isoyanate group. The methyl group was expected to act as a spacer to eliminate or at least
weaken the effect of electron-withdrawing feature of protonated pyridine ring on the two
urea bonds when reacted with amino group. In this study, we investigated the effect of the
PyMIC structure on peptide protonation and fragmentation pattern by comparing PyMIC
modified peptides with PIC and PyIC modified peptides. The results revealed that PyMIC is
a more appropriate reagent for quantitative proteomics applications compared to PIC and
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PyIC. In addition, to further characterize the fragmentation behavior of PyMIC modified
peptides, we have compared the tandem mass spectra for PyMIC modified and unmodified
tryptic peptides originating from standard proteins. Based on the results we obtained, the
application of PyMIC modification on de novo peptide sequencing is also discussed.
Experimental
Materials

Pyridine-3-isocyanate was obtained from Oakwood Products, Inc. (West Columbia,
SC). Phenyl isocyanate was acquired from Sigma-Aldrich Co. (St. Louis, MO). Proteins
including serum albumin (bovine), cytochrome c (horse), myoglobin, actin (bovine) and
carbonic anhydrase came from Sigma. Ammonium bicarbonate, Diphenylphosphoryl azide,
1,8-Diaminonaphthalene and 2-(pyridin-3-yl) acetic acid hydrochloride were purchaseed
from Sigma. Sequencing grade modified trypsin was supplied from Promega (Madison,
WI). Tetrahydrofuran (THF), triethylamine, HPLC grade acetonitrile (ACN), HPLC grade
water and formic acid were obtained from Fisher Scientific International Inc. (Chicago, IL).
The Synthesis of 2-(Pyridin-3-yl) Acetyl Azide (by Rong Hua Lu)

To a suspension of 2-(pyridin-3-yl) acetic acid hydrochloride (160 mg, 0.92 mmol) in
10 mL dry THF was added diphenylphosphoryl azide (DPPA) (0.22 mL, 1.0 mmol) on ice.
Triethylamine (0.2 mL, 1.42 mmol) was then added. After 2 h, the mixture was concentrated
under reduced pressure and the product was purified by flash chromatography (mobile phase:
50% ethyl acetate in 50% petro ether). Removal of the solvent under reduced pressure gave
60 mg (40% yields) of 2-(pyridin-3-yl) acetyl azide as colorless oil.
The Synthesis of 3-(Isocyanatomethyl) Pyridine (PyMIC) (by Rong Hua Lu)

2-(pyridin-3-yl) acetyl azide (20.0 mg) was dissolved in 0.5 mL benzene and heated
to 60°C for 3 hours. Before the heating and after the heating, the 1H NMR were taken. The
spectra showed the reaction went very well. All the starting materials were changed to the

133

product, no other byproducts formed. The synthesis of 3-(isocyanatomethyl) pyridine
(PyMIC) was shown in scheme 1.
N-terminal Labeling of Tryptic Peptides

Proteins including BSA, cytochrome c, myoglobin, actin and carbonic anhydrase
were digested with trypsin at a trypsin/protein ratio of 1:20(w/w) at 37°C overnight. The
resultant tryptic digest was diluted with the same volume of ACN. N-terminal modification
reactions were performed by mixing tryptic digests with 100 mM of 3-(isocyanatomethyl)
pyridine (PyMIC) in benzene at a peptide/isocyanate molar ratio of 1:150 and incubating at
37°C for 1hour. Solvent was removed by speedvac. PyMIC modified peptides were
dissolved in 0.1% formic acid for following analysis. PIC and PyIC modification was
performed as previously described. Tryptic digests were mixed with 100 mM of PIC or PyIC
in ACN at a peptide/isocyanate molar ratio of 1:150 and were incubated at 37°C for 1hour.
Reaction was terminated by adding 1µL of 88% formic acid.
LC-ESI-MS/MS Peptide Sequence

LC-ESI-MS/MS analysis was performed using a Hewlett Packard HPLC system
(1100 series) coupled with a Finnigan LCQ ion trap mass spectrometer. The reversed-phase
capillary HPLC column was laboratory fabricated by packing 5-µm C18 packing material
(macrosphere particle size: 300Å, Alltech Inc., Deerfield, IL) into a 350 um (I.D.) fused
silica capillary tubing and the final C18 column length was 15cm. The mobile phase
consisted of solvent B (0.1% formic acid in ACN), and solvent A (0.1% formic acid in HPLC
grade H2O). The column was first equilibrated with 95% solvent A and 5% solvent B at a
flow rate of 4µL/min. Once the sample was loaded onto the column, the mobile phase
composition was kept at 95% solvent A for 5 min, then was linearly changed from 95% to
90% over 10 min. Another linear gradient from 90%A to 45%A was performed in the next
90 min. Then solvent A was rapidly decreased to 10% in 10 min and kept the concentration
for additional 10 min. In the following 10 min, the solvent A was increased back to 95% and
held at 95% during the last 5 min.
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A data-dependent acquisition was employed for ms full scan and the selection of
precursor ions for the following tandem mass scan. The mass range of full MS acquisition
was set from 400 to 2000 m/z. The most intensive precursor ion was selected from the
previous full MS scan to undergo collision induced dissociation (CID). Once sampled, the
precursor mass was put on exclusion list and no CID was performed on this mass for the
following 0.5min. In all experiments, the parameters of collision induced dissociation (CID)
were set as follows: an activation Q of 0.250, activation time of 30 ms, and 35% normalized
collision energy (NCE).
Unmodified and isoyanate modified tryptic peptide sequences were identified by
using the in-house licensed MASCOT server, which searched tandem mass spectra of
unmodified or modified peptides against the NCBInr protein sequence database.
Results and Discussion
Fragmentation Characteristics of PyMIC Modified Peptides

The effect of PyMIC modification on the fragmentation of tryptic peptides was
investigated by LC-ESI-MS/MS. As indicated in scheme3.3.1, isocyanates react with the Nterminal amino group of a peptide to form a urea derivative. Previous work showed that one
striking characteristic of the fragmentation of N-terminal isocyanate modified peptide was
the dominance of two product ions in the tandem spectrum. One of the two product ions
resulted from the cleavage at site 1 (labeled in scheme 3.3.1) and the loss of the intact
isocyanate returning the native form of the peptide yn (scheme 3.3.1). The other major
product ion resulted from cleavage at site 2 (labeled in scheme 3.3.1) and the loss of the aryl
portion of the isocyanate returning a peptide isocyanate M**. The preference of cleavage at
the two sites depended on the structure of isocyanate employed. For example, phenylethanyl
isocyanate modified peptides are prone to cleave at site 2 while 3-pyridyl isocyanate
modified peptides incline to cleave at site 1. In order to investigate the characteristics of
fragmentation of PyMIC modified peptides, tryptic peptides from BSA, cytochrome C, actin
and myoglobin were reacted with PyMIC as described in experimental section. The resultant
modified peptides were subjected to LCQ for MS/MS analysis. Figure 3.3.1 shows typical
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tandem spectra of four doubly charged PyMIC modified peptides (a-d). We found that
similar to 3-pyridyl isocyanate, PyMIC modified peptides were observed to primarily cleave
at site 1 (labeled in bold line scheme 3.3.1) to produce yn fragment. In Figure 3.3.1, these yn
and M** ions are labeled with bold characters. It was observed that all presented spectra
showed relatively high intensities of yn ions. While M** ions produced from cleavage at site
2 were also present in tandem spectra, but the intensity of M** ions were tremendously low
compared to yn ions. In some cases, M** ion was not able to be detected. The predominant
yn ion was either singly charged or doubly charged depending on investigated peptide
sequence. Predominantly singly charged yn ions appeared in Figure 3.3.1a, b, and d whereas
double charged yn were dominant in Figure 3.3.1c. Another striking characteristic of
fragmentation of PyMIC modified peptides is that a mass tag with m/z 135, derived from
PyMIC portion during cleavage at the site 1 (scheme3.3.1), was observed in the tandem
spectrum of PyMIC modified peptide. In Figure 3.3.1, the mass tags present in all four
spectra were labeled as “T” in bold. Among all identified PyMIC modified peptides in the
experiment, fifteen of PyMIC modified peptides had molecular weight lower than 980, all
spectra of those peptides were observed m/z 135 mass tag. While the mass tag was not
detected in the tandem spectra for the remaining peptides with MW higher than 980 due to
the limited mass range of quadruple ion trap. The mass tag was below low mass cut-off
when such large peptides were subjected to the mass spectrometer. In addition, N-terminal
PyMIC modification caused all b ions had a 135 mass unit shift, making it possible to detect
low mass b ions in the tandem spectra. For example, b1 ions appeared in all the four spectra
in Figure 3.3.1.
Charge State Distribution Shifts of PyMIC Modified Peptides

Our previous work found that N-terminal modification of peptides with PIC
significantly decreases peptide protonation compared to corresponding unmodified peptides
during ESI process, while increases for peptide modified with PyIC. In order to
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Scheme 3.3. 1: A schematic of the fragmentation of N-terminal 3-(isocyanatomethyl)
pyridine (PyMIC) modified peptide. PyMIC modified peptides were observed to primarily

cleave at site 1 (labeled in bold line) to produce yn fragment.
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Figure 3.3. 1: Typical tandem spectra of four doubly charged PyMIC modified peptides
(a-d). a: PyMIC-IETMR, b: PyMIC-ATEEQLK, c: PyMIC-SEIAHR, d: PyMIC-LVTDLTK.

A mass tag with m/z 135 (labeled as “T” in bold), derived from PyMIC portion during
cleavage at the site 1 (scheme3.3.1), was observed in the tandem spectrum of PyMIC
modified peptide.
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evaluate protonation property for PyMIC, tryptic peptides from standard proteins including
BSA, cytochrome c., myoglobin, actin and carbonic anhydrase were chosen to react with PIC
and PyMIC, respectively. Then mass spectra of both PIC and PyMIC modified and
unmodified peptides were acquired as described in the experimental section. Considering that
various factors, such as elecrtrospray instrumental parameters182-184, solution pH values185, 186,
and solvent composition187, have influences on the observed charged state distribution of
analyte, all experiments were carried out with the same instrumental parameters and at the
same pH. A possible issue that may affect some of the experimental results is solvent
composition at the point of elution. The peptide hydrophobicity was increased in the order of
unmodified, PyMIC modified and PIC modified peptides. Thus the unmodified peptides
were eluted first from HPLC column, followed by the corresponding PyMIC modified
peptides. At last, the corresponding PIC modified peptides were eluted from HPLC. Since
high concentration of solvents with high volatility and high gas-phase basicity, such as
acetonitrile, increases observed average charge state of the same analytes187, the difference
of hydrophobicity among the three species may further lead to the increase of the observed
ACSs for PyMIC and PIC modified peptides.
A total of twelve pairs of PIC and PyMIC modified peptides were compared. The
sequences of investigated peptides are listed in Table 3.3.1. The charge state distribution of
each peptide was evaluated based on average charge state (ACS), which was previously
described in chapter 3.2:
N

ACS

=

∑

i=1

qi ∗ Ii
N

∑

i=1

Eqn. 3.2.1

Ii

Where qi represents the ith charge state present in the mass range from 400 to 2000, Ii
is the corresponding relative intensity and N is the number of observed charge states in mass
spectrum. Figure 3.3.2A shows a comparison of average charge states of PIC modified and
corresponding PyMIC modified peptides. It shows that all PyMIC modified peptides had
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Table 3.3. 1: The peptide sequences used for the study of charge state distribution shift

MW

peptide sequence

MW

peptide sequence

665

IETMR

1045

GTDVQAWIR

712

SEIAHR

1164

LVNELTEFAK

779

MIFAGIK

1482

LGEYGFQNALIVR

789

LVTDLTK

1568

DAFLGSFLYEYSR

818

ATEEQLK

1168*

TGPNLHGLFGR

922

AEFVEVTK

1496

EETLMEYLENPK

927

YLYEIAR

1248

FESNFNTQATNR

974

DLGEEHFK

1272*

LFTGHPETLEK

998

DLTDYLMK

1640*

KVPQVSTPTLVEVSR

1015

QTALVELLK

1582*

YAAELHLVHWNTK
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modified peptides had higher average charge states than corresponding PIC modified
peptides.
Multiply charged ions dominate the full MS spectra for PyMIC modified peptides,
while singly charged ions were observed to be dominant for PIC modified peptides,
especially in the case of small peptides. In Figure 3.3.2A, small peptides with MW 779, 789,
922 and 927 were observed to have very low ACS values when modified with PIC, while
protonations of those peptides were significantly improved by PyMIC modification. The
ACS values from PyMIC modified peptides were at least half unit higher that from
corresponding PIC modified peptides.
The protonation of PyMIC modified peptides was also evaluated by comparison of
The ACS values of PyMIC modified peptides with corresponding unmodified peptides
(Figure 3.3.2B). A total of 19 pairs of peptides were employed and their sequences are listed
in Table 3.3.1. ACS values of all modified peptides were higher than corresponding
unmodified peptides except peptides with MW 974, MW 1496 and MW 1582, which
unmodified forms had slightly higher ACS values than modified counterpart (Figure 3.3.2B).
Furthermore, N-terminal modification assisted the observed peptide m/z shifting to higher
values and made it possible to detect multiply charged peptides with low MW in the limited
mass range of ion trap. For example, Figure 3.3.2B shows four peptides with native peptide
MW 665, 712, 779 and 789. Since native form molecular weights of the four peptides were
less than 800, doubly charged ions could not be detected when the mass range of the mass
spectrometer was set from 400 to 2000. Thus ACSs of the four peptides for unmodified
forms were calculated only based on singly charged ion and produced values of 1. Nterminal PyMIC modification made the doubly charged ion of the modified peptide 67 mass
units higher relative to that of the unmodified ion. Doubly charged ions were able to be
detected under the same instrument condition and ACSs of the modified peptides were
calculated based on both singly and doubly charged ions. The largest ACS differences
between unmodified and modified forms were observed for the four peptides compared to
others showed in Figure 3.3.2B. The enhancement of protonation upon N-terminal PyMIC
modification may be explained by considering the following evidence. As we know, one of
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the most distinguishing characteristics of electrospray ionization is the tendency to form
multiply charged species. During the ESI process, peptides can be protonated at various sites
including N-terminal amino group, side chain groups and amides188. Of all those protonation
sites, basic side chains, such as arginine, lysine, and histidine, and the N-terminal amino
group are more easily protonated during the ESI process. The replacement of N-terminus
with neutral species like PIC reduced the possible protonation sites, while when substitute
with basic group like PyMIC maintained the possible protonation sites in peptide. In
addition, considered the structural characteristic of PyMIC, the charge delocalization on the
pyridine aromatic ring stabilized the protonated N-terminus to some extent. Therefore Nterminal modification of peptide with PyMIC increased the protonation during ESI process.
The CID Comparison of the Most Intensive Precursor Ions of N-terminal PyMIC
Modified Peptides with PIC and PyIC Modified Peptides Generated during the ESI
Process

As a result of the protonation enhancement for peptide modified by PyIC or PyMIC,
ion yield of multiply charged peptides was significantly increased. Multiply charged ions of
PyMIC and PyIC modified peptides were dominate in full MS spectra. In data-dependent
mode, mass spectrometer automatically selected the most intensive ion in full scan spectrum
to perform CID fragmentation. Therefore, multiply charged precursor ions from the two
isocyanates modified peptides had more chance to be subjected to CID fragmentation.
Figure 3.3.3 shows the comparison of full MS spectra and the following tandem spectra of
peptides modified with PIC (a), PyIC (b) and PyMIC (c) respectively. Three peptides,
YLYEIAR (Figure 3.3.3A), LVTDLTK (Figure 3.3.3B) and KVPQVSTPTLVEVSR (Figure
3.3.3C), were chosen to perform the study. As shown in Figure 3.3.3, for PIC N-terminal
modification, doubly charged ions for small peptides YLYEIAR (Figure 3.3.3A-a) and
LVTDLTK (Figure 3.3.3B-a), which had one basic residue in the sequences (labeled in
bold), were not detected in full MS scan, only singly charged ion were observed dominant in
the spectra for both peptides. Therefore, no tandem mass spectra from doubly charged ions
were obtained for both peptides.
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A

B

Figure 3.3. 2: Comparison of average charge states of 3-(isocyanatomethyl) pyridine

(PyMIC) modified peptides with phenyl isocyanate (PIC) modified peptides(A), and
unmodified peptides(B), respectively. The mass spectra for each unmodified and modified
peptides were obtained by averaging five microscans during the full MS scan experiments. *:
peptide with two basic amino acid residues.
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Even though the tandem mass spectra from singly charged ions were easily obtained in datadependent mode, fragments useful for peptide sequencing were observed in very low intense
in the spectra. On the other hand, doubly charged ions for both PyIC and PyMIC modified
YLYEIAR and LVTDLTK dominated the full scan spectra. Tandem spectra for both doubly
charged ions were achieved (Figure 3.3.3). However, PyIC modified peptides generated very
few sequencing useful fragments. Tandem spectra of PyIC-YLYEIAR and PyICLVTDLTK were shown in Figure 3.3.3A-b and Figure 3.3.3B-b, it can be seen that only y5
and y6 were detected for YLYEIAR, and b4, y5 and y6 found for LVTDLTK. While a series
of high intensive fragments were observed in the spectra when PyMIC-YLYEIAR (Figure
3A-c) and PyMIC-LVTDLTK were subjected to CID (Figure 3.3.3B-c). Peptide
KVPQVSTPTLVEVSR, which had two basic residues in the sequence, was also employed
for this study. The spectra were shown in Figure 3.3.3C. It was observed that both doubly
charged and singly charged ions for PIC-KVPQVSTPTLVEVSR were present in the full
scan spectrum, but singly charged ion still dominate the spectrum compared to doubly
charged. For PyIC and PyMIC modification, triply charged ions were detected, and doubly
charged ions dominated the spectra. Tandem mass spectra of doubly charged precursor ions
were obtained for all three modifications. It was found that PIC-KVPQVSTPTLVEVSR and
PyMIC-KVPQVSTPTLVEVSR generated similar fragment ions, while PyICKVPQVSTPTLVEVSR had much less fragments than PIC and PyMIC modification. Only
four y ions were detected and had very low relative intensities (Figure 3.3.3C-(b)).
Based on the above observations, we conducted a thorough investigation of the effect
of isocayanate structure on fragmentation of modified peptides. As described in our previous
work, Net Fragmentation Efficiency (NFE), which was used to measure the ion yield of
fragments that were useful for obtaining sequence information of peptide, was previously
defined as

NFE

=

(∑ I

I

− IM

∑

I

*

− IM

I
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Figure 3.3. 3: The comparison of full MS spectra and the following tandem spectra of

peptides modified with PIC (a), PyIC (b) and PyMIC (c) respectively. A: peptide YLYEIAR,
B: peptide LVTDLTK, C: peptide KVPQVSTPTLVEVSR.
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Where ΣII represented the total fragment ion intensity, IM* was native peptide ion intensity
and IM** was isocyanate-form ion intensity. A total of 19 tryptic peptides from standard
proteins were N-terminal modified with PIC, PyIC and PyMIC, respectively. Among the 19
peptides, six peptides contained one basic residue in their sequences. The singly charged
precursors ions of all three isocyanate modified peptides were selected to perform CID for
this study. The remaining 13 peptides, which were labeled by asterisks in Figure 3.3.4,
contained two or more than two basic residues in their sequences. Tandem mass spectra from
doubly charged ions of the three-isocynate modified peptides were collected for NFE
comparison. The result is shown in Figure 3.3.4. It was observed that PyMIC modified
peptides had NFEs equivalent to PIC when peptides contained two basic residues in the
sequences, more than half of PyMIC modified peptides obtained the highest NFE values in
contrast with corresponding PIC and PyIC modified peptides. While for peptides with one
basic residue, PyMIC modified peptides were observed to have highest net fragmentation
efficiencies in most of the cases except peptide with MW 922. Thus PyMIC modified
peptides produced more sequence fragments and were more appropriate for quantitative
proteomics than PIC and PyIC. A possible explanation for high NFE values of PyMIC
modification compared to PIC and PyIC involved the structural differences of the
isocyanates. For PyIC modified peptide, the protonation of the pyridine nitrogen greatly
increases the electron-withdrawing character of this group. In addition, due to the
conjugation of pyridine ring with urea bonds, protonated pyridine weaken both urea bonds,
especially urea bond on site 1 (scheme 3.3.1), which caused the relatively low NFEs
compared to PIC and PyMIC modified peptides during CID and the predominance of the
native peptide fragment in spectrum. While considering the feature of PyMIC structure, the
exist of methylene group between pyridine ring and two urea bonds broke the conjugation of
the two groups, thus the electron-withdrawing character of protonated pyridine ring was not
able to dramatically influence bond strengths of the two urea bonds. In consequence, PyMIC
modified peptides had higher NFEs compared to corresponding PyIC modified peptides. For
PIC modification, conjugation of the aromatic ring with urea bonds may stabilize both of the
two urea bonds, which led to produce relatively high NFEs compared to PyIC modified
peptides
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Figure 3.3. 4: The comparison of Net Fragmentation Efficiency (NFE) peptides modified

with PyMIC, PIC and PyIC respectively. The tandem mass spectra for each modified
peptides were obtained by averaging five microscans during the MS/MS experiments. *:
investigated peptides contain two or more than two basic residues in their sequences.
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during CID. PIC modified peptides have relatively high NFEs, however, the modification of
N-terminal amino group significantly decreased the protonation of peptide, especially for
peptide with one basic residue. PyIC modification can increase protonation of peptide, thus
making doubly charged ion dominant, however, the modified peptides have relatively low
NFEs. PyMIC overcome the drawbacks of both PIC and PyIC. On one hand, PyMIC
modified peptides produced multiply charged ions during ESI process, making it possible to
perform CID fragmentation for doubly charged precursor ions. On the other hand, the
fragmentation of PyMIC modified peptides generated enough fragments, so that peptide
sequence can be identified by either manually sequencing or searching against database using
searching algorithm like the MASCOT. Therefore, PyMIC is a more appropriate reagent for
quantitative proteomics applications compare to PIC and PyIC.
Comparison of Low energy CID Dissociation of Unmodified Peptides and PyMIC Nterminal Modified Peptides

To compare the fragmentation pattern of PyMIC modified peptides with their
corresponding unmodified peptides. Tryptic peptides from standard proteins were reacted
with PyMIC using the protocol depicted in experimental section. Then unmodified and
modified peptides were subjected to LC-ESI-MS. Tandem mass spectra of both unmodified
and modified peptides were collected. Figure 3.3.5 gave six examples of tandem spectra
obtained from doubly charged precursor ions of unmodified peptide (a) and PyMIC modified
peptide (b). Figure 3.3.5A-E shows five small peptides with native MW lower than 1020 Da
and Figure 5F shows one large peptide with native MW 1640 Da. Peptide sequences are
shown in the Figure 3.3.5. One of the most striking character of the N-terminal PyMIC
modification is the detection of complimentary product ions b1 and yn-1 for small peptides,
which caused by the enhanced cleavage of the N-terminal peptide bond. Those b1 and yn-1
ions were labeled with bold characters in Figure 3.3.5A-E. It can be seen that all small
peptides modified with PyMIC were observed y1 ions with relative high abundance. While
these y ions were either absent (Figure 3.3.5A, C, D, E) or in very low abundance (Figure
3.3.5B) for unmodified counterpart. Since ion trap mass spectrometers have limited MS/MS
mass range, low mass fragments like b1 ion usually were not detected in the tandem spectra
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even for small peptides. Adding the isocyanate on the N-terminal shifts the entire b-ion
series to higher mass range, making the detection of low mass fragments feasible. In Figure
3.3.5A-E, b1 ions were detected for every small peptides modified with PyMIC, while in
unmodified case, no b1 ions were observed in the corresponding tandem mass spectra. Figure
3.3.5F shows a MS/MS comparison of unmodified and PyMIC modified peptide with
sequence KVPQVSTPTLVEVSR to elucidate the fragmentation characteristic of PyMIC
modification for large peptides. Instead of cleavage enhancement of the N-terminal peptide
bond for PyMIC-KVPQVSTPTLVEVSR, PyMIC modification was observed to improve the
cleavage between Val and Pro, which caused the formation of complimentary product ions b2
and yn-2. For peptide KVPQVSTPTLVEVSR, since it had high molecular weight, even
considered the mass shift, the b1 ion was still below the mass range of the ion trap. The b2
ion was successfully detected for the PyMIC modified peptide, but not for corresponding
unmodified case. The yn-2 ion from PyMIC-KVPQVSTPTLVEVSR was also observed to
significantly increase in intensity compared to the unmodified counterpart.
In addition, when PyMIC modified peptides were subjected to CID, a greater number
of product ions were obtained compared to corresponding unmodified especially for small
peptides. At the same time, the relative intensities of product ions generated from PyMIC
modified peptides significantly increased compared to unmodified counterpart. Figure
3.3.5(a) shows tandem spectra of unmodified and PyMIC modified AEFVEVTK, when the
corresponding doubly charged precursor ions (m/z 462, +2 and m/z 529, +2) were subjected
into CID. CID of unmodified AEFVEVTK resulted in selective cleavage between Glu and
Phe. Consequently, complimentary product ions were observed to be dominant in the
spectrum and limited number of other product ions was generated. Product ions like y7+, b4+
and b1+ were not present in the tandem spectrum. N-terminal PyMIC modification changed
cleavage preference. As shown in Figure 3.3.5(a), besides the predominant ion yn, PyMICAEFVEVTK produced contiguous b and y ion series. All the product ions were in relatively
high intensities. Figure 3.3.5(b) shows the comparison of tandem spectrum of ATEEQLK
(m/z 410,+2) and PyMIC-ATEEQLK (m/z 477,+2). The predominance of M0++ product ion

in unmodified form indicated that unmodified ATEEQLK lost water in an easier manner than
fragment at peptide bonds. Also, few y serial product ions were observed and only one b ion
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was obtained. However, PyMIC modified ATEEQLK produced entire y+ and b+ ions and all
product ions were in high intensities. Similar results were obtained from Figure 3.3.5(c) to
Figure 3.3.5(e). It was proved that this phenomenon is common for all of the kinds of
peptides investigated. Figure 3.3.5(f) depicts the CID fragmentation of the unmodified and
PyMIC modified peptide KVPQVSTPTLVEVSR, which have two basic residues in the
sequence. It is apparent that PyMIC modified peptide produced similar number of product
ions as unmodified peptide even for large peptide like KVPQVSTPTLVEVSR. The results
can be explained that the bond strength of urea bonds in PyMIC modified peptides were
weaker than that of peptide amide bond, which caused the cleavage preference at site 1
(scheme 3.3.1) to form mass tag with m/z 135 or yn ion. In addition, the existence of urea
bonds decreased the differences of peptide amide bonds between various residues. In
consequence, the fragmentation patterns of modified peptides were changed and more
product ions present in tandem spectrum.
De novo Peptide Sequencing

The fragmentation characteristics of PyMIC modified peptides showed great promise
for de novo peptide sequencing. First, PyMIC modification changed the preferred
fragmentation pathway and caused the formation of complementary b1 and yn-1 fragment ion
pairs in CID experiments, which enabled to identify N-terminal residues during de novo
sequencing. Second, PyMIC modified peptides were able to produce contiguous series of b
ions and y ions under low energy CID, which helped to identify more residues in peptide
during de novo sequencing. In addition, since entire b ions in spectra shifted 135 mass units
once peptide modified with PyMIC, the comparison of tandem mass spectra of PyMIC
modified peptide with that of unmodified peptide can easily distinguish y ion series from b
ions, thus significantly simplifying the sequencing process. For example, tandem mass
spectra of the unmodified and PyMIC modified doubly charged ions of YLYEIAR were
acquired and are displayed in Figure 3.3.5 (d). By matching isobaric peaks in both spectra, it
is easily to assign m/z 246.3, 359.3, 488.3 and 651.4 in the spectra to y ion series. Also when
compared the spectra of PyMIC modified peptide with the unmodified, two new intensive
peaks with m/z 298.0 and 764.4 were found to appear in the spectra of PyMIC modified case.
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Figure 3.3. 5: A-F, examples of tandem spectra obtained from doubly charged precursor
ions of unmodified peptide and PyMIC modified peptide.
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And the sum of their masses equals to molecular weight of the modified peptide. So the two
peaks were easily recognized as b1 (m/z 298.0) and y6 (m/z764.4) ion. Peak with m/z 927.4
in PyMIC modified case was assigned as y7 since it is equal to the molecular weight of the
unmodified peptides. Therefore, the complete y ion series were identified except y1. Once yion series were conformed, b-ion series were also able to be identified by calculating and
matching the two spectra. Consequently, the entire sequence of this peptide was identified.
Conclusion

We designed a new isocyanate reagent, 3-(isocyanatomethyl) pyridine (PyMIC),
which had the same compound structure as PyIC except a methyl group was introduced
between the pyridine ring and the isoyanate group. The fragmentation characteristics of
PyMIC modified peptides was evaluated. First, we found that similar to 3-pyridyl isocyanate,
PyMIC modified peptides were observed to primarily cleave at site 1 (labeled with a bold
line scheme 3.3.1) to produce yn fragments. Another characteristic of fragmentation of
PyMIC modified peptides is that a mass tag with m/z 135, derived from PyMIC portion
during cleavage at the site 1 (scheme 3.3.1), was observed in the tandem spectrum of PyMIC
modified peptides. In addition, we investigated the effect of the PyMIC structure on peptide
protonation by comparing PyMIC modified peptides with PIC modified peptides and
unmodified peptides. This comparison shows that all PyMIC modified peptides had higher
average charge states than corresponding PIC modified peptides and unmodified peptides.
Multiply charged ions dominated the full MS spectra for PyMIC modified peptides. The
comparison of mass spectrometric properties of PyMIC modified with phenyl and pyridine
isocyanate modified peptides using LC-ESI-MS/MS was also performed. It was observed
that PyMIC modified peptides produced considerabley more sequencing useful fragments
compared to PIC and PyIC modified peptides, making it a more appropriate reagent for
quantitative proteomics applications. In addition, to further characterize the fragmentation
behavior of PyMIC modified peptides, we compared the tandem mass spectra for PyMIC
modified and unmodified tryptic peptides originating from standard proteins. PyMIC
modification was surprisingly observed to improve the cleavage of the peptides. New product
ions were observed when compared to unmodified peptides. In a nutshell, PyMIC is a more
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appropriate N-terminal labeling reagent for quantitative proteomic application compared
other isocyanate reagents.
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Chapter 3.4
Conclusion

Selection of appropariate labeling reagents is critical for quantitative proteomics
based on isotope labeling strategies. It directly affects total performance of the application
such as the identification of proteins and the accuracy of quantitative analysis. High-quality
labeling reagents, such as ICAT, can be widely applied to various quantitative proteomic
studies and extend the application of proteomics to new biological area 11, 154, 163. However,
currently there is no well-developed methodology for selecting ideal labeling reagents.
Researchers still use empirical method to find reagents that might suitable for quantitative
application. In this part of the dissertation, we developed a new methodology to choose an
isocyanate compound as an appropriate N-terminal labeling reagent for global labeling
strategy based quantitative proteomics.
Initially, three typical isocyanates: PIC, PEIC and PyIC, which represented aromatic
neutral, aliphatic neutral and aromatic basic isocyanates, respectively, were carefully chosen
for systematic study to investigate the effects of N-terminal labeling on peptide
fragmentation. Based on the structural and cleaving characteristics of N-terminal modified
peptides with various isocyanates, three concepts, average charge state (ACS), net
fragmentation efficiency (NFE) and the ratio of two major products ion intensities (RN/I)
were used to conduct the systematic study. The concept of average charge state was used for
a thorough investigation of the electrospray ionization characteristics of the N-terminal
modified peptides. Net fragmentation efficiency, which was originally used to study peptide
fragmentation mechanisms, was utilized to measure the ion yield of sequence-useful
fragments during CID. We also introduced the concept of the ratio of two major product ion
intensities (RN/I) to monitor the cleavage preference between two urea bonds formed during
N-terminal modification, as N-terminal modified peptide with various isocyanates was
subjected to CID fragmentation. Based on the average charge state invetigation, we
rationaled that isocyanate modification shifted the charge state distributions of modified
peptides during ESI process. PIC and PEIC modification was found to severely decrease the
protonation of modified peptides, while PyIC modification maintained and in some cases
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increased the protonation compared to unmodified counterparts. The decrease of protonation
of PIC and PEIC modified peptides results from the neutral property of the both reagents.
The modification also affects the fragmentation of modified peptides. PIC modified peptides
produced the most sequence product ions and had tendency to cleave at both urea bonds.
Conversely, PyIC modified peptides produced relatively fewer sequence product ions and
were prone to cleave at the urea bonds on peptide side. PEIC modified peptides were prone
to cleave at the urea bonds on isocyanate side. Compared to PyIC and PEIC, PIC
modification was better for protein identification.
Based on those results, we rationalized that the structure of isocyanate is the main
reason leading to fragmentation changes of the modified peptides. Since PIC reacts with the
N-terminus of the peptide to form two urea bonds, the conjugation of a benzene ring on PIC
with the two urea bonds can strengthen the two C-N bonds and make them have relatively
similar bond strengths. Therefore the PIC modified peptides have the highest NFE values and
could be cleaved at both sites to form both native peptide and isocyanate-form fragments.
While the structural characteristics of PyIC, which were depicted as both electronwithdrawing feature of PyIC and the conjugation of pyridine ring with urea bonds once
reacted with amino group, causes the significant reduction of fragments when PyIC modified
peptides were subject to CID. PEIC has an ethylene group between phenyl and isocyanate
moiety in its structure, which serves as a spacer to break any conjugation between the two
groups. Therefore, the two urea bonds are not as strong as that in PIC, and cause the decrease
of NFE values.
Combining the structural characteristics of the all three isocyanates of studied, we
designed a new isocyanate reagent, PyMIC, which has the same compound structure as PyIC
except a methyl group is introduced between the pyridine ring and the isoyanate group. The
methyl group was expected to act as a spacer to eliminate or at least weaken the effect of
electron-withdrawing feature of protonated pyridine ring on the two urea bonds when reacted
with amino group. When applying the new methodology we developed for monitoring the
mass spectrometric properties of modified peptides, we found that PyMIC modification
significantly increases protonation of peptides. Doubly charged peaks dominate the full scan
MS spectra. Furthermore, PyMIC modified peptides produce more sequence useful
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fragments compared to other investigated ioscyanate modified and unmodified peptides.
Therefore, we successfully found an isocyanate labeling reagent which is appropriate for
global coding strategy based quantitative proteomics applications.

Copyright © Ting Liu 2008
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CHAPTER FOUR
CONCLUSIONS

Since Marc Wilkins first used the term ‘proteome’ to represent the entire complement
of proteins expressed by the genome, proteomics has become the fastest-growing area of
biological research. By targeting systems and monitoring protein pattern changes rather than
single proteins, proteomics has allowed us to identify, characterize, and quantify proteins on
a massive scale and resulted in a fundamental change in biological and chemical approaches
to understanding proteins. To date, proteomics has been widely applied to immunology,
biology, biomedicine, almost every field related to proteins. The rapid progress of
proteomics in the last decade is based on the developments and innovations in four main
aspects: the completion of genome projects for humans or other species of interest; the
improvement of protein separation techniques; the development of mass spectrometry and
the establishment of bioinformatics. By developing and integrating new technologies, new
reagents, and new strategies into proteomics, it is possible that proteomics can be applied to
deeper and broader study areas.
The development of proteomics is bringing a revolution to its application areas such
as biomarker discovery, disease diagnosis and treatment. Currently, majority of biomarkers
are discovered by traditional linear, single event–based methods, in which research is driven
by previous knowledge. Early, accurate disease diagnosis, which offers the best chance to
treat and cure diseases, is still challenging for a varity of diseases. The odds of death caused
by lethal diseases like cencers remain adversely high, especially for those detected at an
advanced stage. Disease treatments are still basically "one size fits all", which means that the
same treatment is given based on the type of disease regardless of the individual biological
heterogeneity. With the potential of identifying protein pattern changes in a biosystem, one
can envision that proteomics could be applied to evaluation of the heterogeneity of cancer
patients, examination of alterations in disease progress research, identification of multiple
targets for new drug development. And one day in the future, individualized health care in
most of the medical areas will be realized.
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Parasitic diseases are the most common disease with world-wide distribution.
According to the World Health Organization, 3.5 billion people suffer parasitic diseases. The
symptoms of parasitic diseases can vary enormously from acute to chronic, from no
significant symptoms to death. So far, some medicines that treat parasitic infections are
available, but no vaccines for parasitic diseases are available yet. Therefore, the discovery of
effective vaccines is imperative to cure world-wide infected population and prevent futher
transmission. As one of the disease-causative parasite, T. gondii draws wide attentions due
to its ability to infect virtually all warm-blooded animals. After many years’ study and effort,
scientist cannot yet thoroughly elucidate state of the art of the parasite’s host-cell infection.
Because of its unique structure and localization, the Parasitophorous Vacuole Membrane
(PVM) has received a lot of attention for study of the mechanism of worldwide distributing
parasite’s survival. As such, it is an attractive target for discovery of novel vaccines and
drugs.
The first part of this dissertation described the development of LC-MS-based
methodologies for the qualitative analysis of the PVM proteome, which were enriched by
newly developed immunoprecipitation protocol by Sinai et. al. The goal of this project is to
identify as much as possible proteins in a proteome, especially low abundance proteins from
the challenging organelle. This was achieved through the development of novel protein
concentration and clean-up methods, followed by the integration of biological sample
preparation, protein concentration and 2D-LC-MS/MS steps. The invention of “Three-layer
Sandwich Gel Electrophoresis” (TSGE) protein concentration and clean-up protocol based on
the art of gel electrophoresis (which has been implanted in proteomics for years) makes
TSGE readily incorporate into the protein processing workflows. The example of analyzing a
whole cell extract of Toxoplasma gondii by the TSGE in combination with 2D-LC-MS/MS
demonstrates TSGE is suitable for high-throughput proteomic analysis of complex protein
mixtures. With significant high protein recovery and efficient concentration and salt removal
ability for challenging samples, one can envision that the TSGE method will easily adapt to a
wide range of diverse studies and have broad applications.
The application of the developed sample concentration method (TSGE) coupled with
2D-LC-MS/MS methodology to characterization of the T. gondii Parasitophorous Vacuole
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Membrane (PVM) proteins clearly demonstrates the power of LC-MS-based proteomics in
subproteome research. One can envision this methodology will have extensive application to
similar subproteome studies in the future. The proteins from the established PVM proteome
will be considered as attractive targets for discovering novel vaccines and drugs against the
parasite, dramatically narrowing down the investigation range from thousands of proteins
present in T. gondi. Therefore, it will dramatically accelerate the drug discovery process. Of
course, further biological techniques like immunoflourescence assays for each identified
protein will be needed to offer more direct information on those proteins’ localization. The
studies of protein-protein interaction for interested protein in PVM proteome using similarly
designed immunoprecipitation-TSGE-LC-MS methods can provide a clearer understanding
of the functions of those proteins in the PVM. Targeted gene disruption technique such as
gene knockouts or transgenic models for interested proteins can also be used for
determination the importance of a gene implicated in a particular pathway or phenotype. In a
nutshell, the establishment of the PVM proteome by using developed qualitative proteomic
methodology provides a solid foundation for elucidation of protein functions in the PVM and
parasite activities associated with the PVM, which will pave the way to entirely
understanding the mechanism of T. gondii’s host-cell infection and discovering novel drugs
and vaccine.
One major goal of proteomics is to systematically identify and quantify proteins in a
given biosystem. The PVM proteome characterization example discussed above
demonstrates the power and importance of method development on proteomics for
qualitative application. Indeed, an ideal proteomic method is expected to be capable of
identifying low abundant proteins in a complex sample and obtaining high proteome
coverage for challenging biosystems. Beyond that, proteomic technologies also are expected
to be reliable, sensitive and accurate for the need of quantification application to ensure
minute quantity of proteins and slight changes between samples in a verity of biosystems can
be detected. However, by using traditional proteomic approach like 2D-SDS-PAGE, it is
very difficult to sufficiently capture the entire proteome for a given biological system due to
its limited ability to handle proteins with the vast diversity of properties such as molecular
sizes, charge state, hydrophobicity, protein conformational states and post-translational
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modifications. The development of new reagents for gel-free based strategies that have the
ability of analyzing broader range of proteins and more complex samples is critical for the
extension of the quatification applications in a verity of biological research. A well-known
example is the introduction of the LC-MS-based ICAT reagent. It has been widely applied to
various research areas.
Stable isotope labeling utilized in LC-MS-based quantitative methods holds greater
promise for accurate and large-scale quantitative analyses due to its ability to simultaneously
identify and quantify proteins. For developing novel stable-isotope-labeling reagents,
evaluation of the electrospray ionization property and fragmentation of the reagent-labeled
peptides is nessessary and important, since these features directly influence on protein
identification. As with the PVM study in Part 1, careful method design and reagent candidate
choice proved to be highly beneficial in achieving the desired goals. In this part, we
carefully selected three typical isocyanates, phenyl isocyanate (PIC), phenethyl isocyanate
(PEIC) and pyridine-3-isocyanate (PyIC) to carry out the investigation. The systematic study
revealed that basicity of labeling reagent severely impacts ESI efficiencies, while the
electronic effect of labeling reagents directly affects the net fragmentation efficiencies and
the sequencing-useful fragments during CID process. A thorough understanding of the effect
of isocyanate structure on mass spectrometric properties of labeled peptides is helpful in
directing the design of a new isocyanate, with which labeled peptides are expected to have
better ESI and CID properties. The novel isocyanate (PyMIC) labeled peptides proved to
have high ESI efficiency and better fragmentation compared to other isocyanates and even
natural tryptic peptides. Therefore, PyMIC has valuable potential to be exploited as a
labeling reagent for both quantitative proteomics applications and peptide de novo
sequencing.
The systematic study of the three isocyanate reagents presented here offered a
foundation for understanding the structure impact of isocyanate on mass spectrometric
properties of N-terminal labeled peptide, the alternative examination on bond strength using
quantum calculation will surely provide a deeper appreciation of the underlying mechanisms
for this phenomenon. Also, in this study we provided a promising labeling reagent for
quantitative proteomics, futher preparation of 13C labeled PyMIC will be definitely necessary
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for application. A thorough examination of the completeness and the specificity of the
modification reaction between PyMIC and various peptides will make it closer to the actual
quantitative applications.
Method development in both qualitative and quantitative proteomics along with
application of developed methodology on establishment of the PVM proteome described in
this dissertation clearly demonstrates the power of innovations in the proteomic technology.
A well thought-out integration of modifications and innovations in each component of
proteomics shows its capability to extend new research areas. Further improvement in this
fast-growing field will continue to revolutionize many fields, such as drug discovery, clinical
diagnostics, disease prevention, basic biological research, and biotechnology. With the
potential that proteomics carries, it will not be too far in the future that proteomic
technologies will play key role in those areas. Proteomics has proved and will continue to
demonstrate its potential to improve quality of life. Our work described in this dissertation is
only one individual contrbution to the progress of proteomic technology and it is high-speed
evolving everyday.

Copyright © Ting Liu 2008
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Appendix
Table1: Proteins in T. Gondii identified based on multiple peptides
protein description

1
2
3
4
5
6
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7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

elongation factor 1-alpha, putative/
elongation factor 1-alpha,
putative
heat shock protein 70, putative
protein disulfide isomerase, putative
lactate dehydrogenase
heat shock protein 70, putative
enolase, putative/ enolase,
putative
heat shock protein 90
elongation factor 2, putative
bi-functional aminoacyl-tRNA
synthetase, putative / prolyl-tRNA
synthetase,putative
ATP synthase beta chain, putative
actin
hypothetical protein
ribosomal protein L23a, putative
myosin A, putative
hypothetical protein
phosphoglycerate kinase, putative
pyruvate kinase, putative
nucleoside-triphosphatase I/
nucleoside-triphosphatase II
p36 protein
fructose-1,6-bisphosphate aldolase
glyceraldehyde-3-phosphate
dehydrogenase

Accession
No.

database source

MW
(Da)

score

sequence
coverage
(%)

No. of
peptides

76.m00016/
83.m00013

http://toxodb.org/download/release-3.3/Genome/pep

48974/
48974

1048/
1048

41/41

15/15

688
614
537
518

30
38
38
26

14
15
9
14

453/ 348

20/4

6/2

448
401

18
14

11
15

583.m00009
27.m00003
44.m00006
59.m00003
59.m03410/
59.m03411
80.m00001
20.m03912

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

73208
52769
35525
72834
52080/
48311
81882
106504

38.m00021

http://toxodb.org/download/release-3.3/Genome/pep

80380

337

12

6

55.m00168
25.m00007
80.m02161
49.m00008
46.m00001
42.m00026
641.m00193
55.m00007
65.m00001/
65.m01111
49.m00048
46.m00002

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

59879
41881
47892
36412
93260
220725
44647
57493
69112/
82332
37644
46930

304
293
292
290
286
284
258
257

21
25
16
5
12
2
26
18

8
9
5
2
7
5
8
8

253/ 34

7/1

3/1

251
244

18
30

5
12

238

27

6

80.m00003

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
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36605

22
23
24
25
26
27
28
29
30
31
32
33
34
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35
36
37
38
39
40
41
42
43
44
45
46

tubulin alpha chain
heat shock protein 90, putative
acid phosphatase, putative
tubulin beta chain, putative/ tubulin
beta chain / tubulin beta chain,
putative
proteasome PCI domain-containing
protein
40S ribosomal protein S7, putative
profilin-related
toxofilin
rhoptry protein, putative / protein
kinase domain-containing protein
adenosylhomocysteinase, putative
14-3-3 protein, putative
major surface antigen p30
glyceraldehyde-3-phosphate
dehydrogenase
40s ribosomal protein S14, putative
glutaminyl-tRNA synthetase, putative
tudor domain-containing protein /
staphylococcal nuclease homologue
domain-containing protein
60S ribosomal protein L8, putative
2,3-bisphosphoglycerate-dependent
phosphoglycerate mutase,
(phosphoglycerate mutase), putative
60S ribosomal protein L7a, putative
heat shock protein 60
ADP/ATP carrier, putative
rhoptry antigen, putative
eukaryotic translation initiation
factor 3 subunit 3, putative
40s ribosomal protein S6, putative
hydroxymethyldihydropterin
pyrophosphokinase-dihydropteroate
synthase

583.m00022
49.m00060
38.m01061
41.m00036/
57.m00003/
28.m00301

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

37.m00775

http://toxodb.org/download/release-3.3/Genome/pep

49.m00013
83.m00017
33.m02185
20.m03896

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

50081
96763
46577
50005/
50041/
50020

233
231
224

16
11
9

5
5
4

209/ 209/
104

13/ 13/ 6

5/ 5/ 2

66008

206

5

2

22573
17544
26772
62626

189
184
182
175

33
20
21

4
2
4

42.m00008
55.m00015
44.m00009

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

51777
37150
34709

171
171
169

11
13
32
25

4
3
7
6

59.m00091

http://toxodb.org/download/release-3.3/Genome/pep

53495
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10

3

55.m00221
37.m00743

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

16292
95468

162
162

22
7

3
4

49.m00009

http://toxodb.org/download/release-3.3/Genome/pep

103977
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3

2

20.m00388

http://toxodb.org/download/release-3.3/Genome/pep

28237

157

17

3

113.m00016

http://toxodb.org/download/release-3.3/Genome/pep

30027

157

22

4

55.m00280
50.m00006
50.m00009
83.m02145

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

31012
60875
35233
103803

153
152
151
149

12
14
16
4

5
7
4
4

50.m03396

http://toxodb.org/download/release-3.3/Genome/pep

65672

146

6

2

27.m00119

http://toxodb.org/download/release-3.3/Genome/pep

28938

143

20

3

55.m00011

http://toxodb.org/download/release-3.3/Genome/pep

82633

143

6

3
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47
48
49
50
51
52
53
54
55
56
57
58
59
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60
61
62
63
64
65
66
67
68
69
70
71
72
73
74

TCP-1/cpn60 family chaperonin,
putative
importin beta-3 subunit, putative
ribosomal protein L5, putative
60S ribosomal protein L18a, putative
elongation factor 1-beta, putative
myosin light chain (TgMLC1)
malate dehydrogenase, putative
TCP-1/cpn60 family chaperonin,
putative
60s ribosomal protein L13a, putative
asparaginyl-tRNA synthetase,
putative
serine-threonine phosophatase 2C
hypothetical protein
RNA recognition motif domaincontaining protein
small heat shock protein, putative /
bradyzoite-specific protein, putative
phosphate carrier protein, putative
ATP synthase alpha chain, putative
eukaryotic translation initiation
factor 4A
dense granule protein 5 precursor,
putative
rhoptry antigen, putative
porin, putative
nucleolar phosphoprotein (nucleolin),
putative
hypothetical protein
60S acidic ribosomal protein P2,
putative
elongation factor 1-gamma, putative
hypothetical protein
DEAD/DEAH box helicase, putative
threonyl-tRNA synthetase, putative
peroxidoxin 2

20.m03910

http://toxodb.org/download/release-3.3/Genome/pep

60575

141

9

2

44.m02525
641.m00186
55.m05004
42.m00069
55.m00021
641.m00168

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

133597
35320
21317
36026
24108
50335

139
136
135
131
131
130

3
7
26
10
13
7

2
2
4
2
2
2

77.m00088

http://toxodb.org/download/release-3.3/Genome/pep

59295

128

10

4

80.m00062

http://toxodb.org/download/release-3.3/Genome/pep

32728

127

14

3

59.m03518

http://toxodb.org/download/release-3.3/Genome/pep

74957

125

8

6

44.m00037
583.m00019

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

36767
286259

124
124

11
1

3
4

645.m00319

http://toxodb.org/download/release-3.3/Genome/pep

49454

122

5

2

44.m02755

http://toxodb.org/download/release-3.3/Genome/pep

20253

117

11

2

65.m00005
20.m00382

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

53058
61073

117
116

7
6

2
3

50.m05680

http://toxodb.org/download/release-3.3/Genome/pep

46644

115

11

4

76.m00004

http://toxodb.org/download/release-3.3/Genome/pep

12831

115

17

2

551.m00238
55.m08198

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

60933
31332

115
114

20
22

6
2

80.m02340

http://toxodb.org/download/release-3.3/Genome/pep

73075

113

3

2

42.m08072

http://toxodb.org/download/release-3.3/Genome/pep

27317

112

9

2

583.m00610

http://toxodb.org/download/release-3.3/Genome/pep

11761

112

27

2

145.m00003
42.m03584
46.m00027
145.m00604
583.m00002

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

44011
57998
59930
95838
24446

110
107
106
105
105

6
6
11
4
20

2
2
4
3
4

167

75
76
77
78
79
80
81
82
83
84
85
86

168

87
88
89
90
91
92
93
94
95
96
97
98
99

phosphoenolpyruvate carboxykinase,
putative
glycyl-tRNA synthetase, putative
NAD-specific glutamate
dehydrogenase, putative
KH domain-containing protein
phosphofructokinase, putative
eukaryotic translation initiation
factor 2 gamma subunit, putative
cell division protein 48, putative
cytosol aminopeptidase
SAG1-related sequence 2
60S ribosomal protein L13, putative
actin depolymerizing factor
nascent polypeptide-associated
complex alpha chain, putative
peroxiredoxin
60S ribosomal protein L14, putative
purine nucleoside phosphorylase,
putative
hypothetical protein
ubiquitin / ribosomal protein CEP52
fusion protein, putative/
polyubiquitin, putative
ROP8, putative
gbp1p protein (RNA bindiong
protein), putative
eukaryotic translation initiation
factor 3, putative
rhoptry antigen, putative
54-kDa antigen, partial
malate:quinone oxidoreductase,
putative
40S ribosomal protein S13, putative
tryptophanyl-tRNA synthetase,
putative

80.m00002

http://toxodb.org/download/release-3.3/Genome/pep

75294

104

3

2

55.m04665

http://toxodb.org/download/release-3.3/Genome/pep

86319

103

5

3

50.m00072

http://toxodb.org/download/release-3.3/Genome/pep

125469

101

3

2

35.m00901
42.m00123

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

100033
131279

100
96

4
2

2
3

46.m00024

http://toxodb.org/download/release-3.3/Genome/pep

50476

95

8

2

59.m03661
80.m00088
44.m00010
55.m00189
39.m00001

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

88267
59804
39094
35678
12914

94
94
93
93
91

8
5
6
3
10

4
3
2
2
3

20.m03918

http://toxodb.org/download/release-3.3/Genome/pep

650452

91

0

2

37.m00001
57.m01833

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

21708
15452

85
85

16
18

2
2

583.m00630

http://toxodb.org/download/release-3.3/Genome/pep

33022

83

9

2

25.m02949

http://toxodb.org/download/release-3.3/Genome/pep

50170

81

7

3

80.m02240/
38.m01076

http://toxodb.org/download/release-3.3/Genome/pep

14676/
34429

79/ 79

27/ 11

5/ 5

80.m02343

http://toxodb.org/download/release-3.3/Genome/pep

57575

79

5

2

55.m00241

http://toxodb.org/download/release-3.3/Genome/pep

31740

78

5

2

83.m01278

http://toxodb.org/download/release-3.3/Genome/pep

49703

77

10

2

33.m01398
63.m00146

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

66706
42334

76
75

3
11

2
3

80.m00006

http://toxodb.org/download/release-3.3/Genome/pep

60342

73

5

2

59.m03516

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

17166

71

29

4

52781

69

4

2

80.m00063

168

100
101
102
103
104
105
106
107
108
109
110

123

aconitate hydratase, putative
40S ribosomal protein S3a, putative
apical membrane antigen 1, putative
hypothetical protein
60S ribosomal protein L9, putative
40S ribosomal protein S16, putative
thioredoxin, putative
60s ribosomal protein L19, putative
60s ribosomal protein L4, putative
40S ribosomal protein S8, putative
60S ribosomal protein L3, putative
cAMP-dependent protein kinase
regulatory subunit, putative
60S acidic ribosomal protein P0
60S ribosomal protein L22, putative
multisynthetase complex auxiliary
component p43, putative
ribosomal protein L27, putative
hypothetical protein
glycine hydroxymethyltransferase,
putative
alanyl-tRNA synthetase, putative
asparagine synthase, putative
26S proteasome subunit 4, putative
60S ribosomal protein L10a, putative
chaperone protein dnaK, putative /
heat shock protein 70, putative
ribosomal protein L22, putative

124

histone H3.3 variant/ histone H3

125
126
127
128
129
130

WD-40 repeat-containing protein
18 kDa cyclophilin
myosin D, putative
succinyl-CoA ligase, putative
60S ribosomal protein L10, putative
hypothetical protein

111
112
113
114

169

115
116
117
118
119
120
121
122

42.m03524
44.m02744
55.m00005
80.m00049
76.m00009
55.m05028
42.m03331
80.m02220
583.m00619
50.m00067
42.m00084

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

114813
29352
62980
48042
21410
25289
68905
22146
45720
23547
44028

68
67
66
65
63
63
63
61
60
58
54

4
8
2
10
10
8
4
11
13
12
10

2
3
2
2
2
2
2
3
4
2
5

49.m00003

http://toxodb.org/download/release-3.3/Genome/pep

34988

52

9

3

38.m00002
49.m05661

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

34136
15064

52
51

7
18

2
3

41.m00027

http://toxodb.org/download/release-3.3/Genome/pep

73990

50

2

2

55.m05006
50.m03261

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

16791
54249

49
47

13
6

2
2

46.m01590

http://toxodb.org/download/release-3.3/Genome/pep

54518

45

4

2

38.m01067
52.m00010
57.m03106
33.m01368

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

113338
65826
49090
24587

43
42
41
41

2
4
4
13

2
2
2
3

50.m00085

http://toxodb.org/download/release-3.3/Genome/pep

78202

41

6

3

583.m00016
38.m00006/
55.m00013
583.m05430
41.m00001
55.m00020
583.m00592
80.m00017
20.m07752

http://toxodb.org/download/release-3.3/Genome/pep

16334
15404/
15393
142765
19592
102104
53355
24785
56874

38

14

2

36/ 36

13/ 13

3/ 3

36
35
35
35
34
33

1
11
2
6
16
3

2
2
2
2
3
2

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

169

131
132

40S ribosomal protein S11, putative
histone H2B variant 1

42.m00125
25.m00008

http://toxodb.org/download/release-3.3/Genome/pep
http://toxodb.org/download/release-3.3/Genome/pep

170

170

18665
13723

30
29

14
15

2
2

Table 2: Protein identified based on single peptide
protein description

83.m01295

http://www.toxodb.org

143536

573

69.m00139

http://www.toxodb.org

34746

211

5

1

3

N-glycosylase/DNA lyaserelated
conserved hypothetical
protein
hypothetical protein

sequence
coverage
(%)
2

41.m00022

http://www.toxodb.org

41634

115

6

1

4

thioredoxin, putative

50.m00069

http://www.toxodb.org

46946

114

6

1

5

fructose-1,6bisphosphatase, putative
cleft lip and palate
transmembrane protein
1-related
mitochondrial processing
peptidase beta subunit,
putative
nucleolar RNA helicase,
putative
ribosomal protein S23,
putative
RNA binding motifcontaining protein
lysophospholipase,
putative
40S ribosomal protein
S18, putative
40S ribosomal protein
S12, putative
ubiquitin carboxylterminal hydrolase,
putative
conserved hypothetical
protein
ribosomal protein L35,
putative
seryl-tRNA synthetase,
putative
inhibitor-1 of protein
phosphatase type 2A
translation initiation
factor eIF-2B epsilon

50.m00005

http://www.toxodb.org

42370

110

4

1

129.m00256

http://www.toxodb.org

71224

102

3

1

46.m01692

http://www.toxodb.org

58618

101

3

1

TQLLGHLDST
TAVAEDIGR

999.27, 2+

0.51

101

1

583.m05295

http://www.toxodb.org

91836

100

2

1

100

1

http://www.toxodb.org

15792

96

13

1

-0.37

92

2

80.m02342

http://www.toxodb.org

84218

96

1

1

1069.64,
2+
1091.83,
2+
500.79, 2+

0.35

44.m02556

SEEASEETDTP
ETVEAQSAK
DGSLNYIDEND
EVLVAGFGR
AAAAAAAAVSAR

0.03

66

3

76.m01665

http://www.toxodb.org

107177

95

2

1

95

1

http://www.toxodb.org

17712

94

7

1

1246.73,
2+
567.35, 2+

0.31

42.m00037

GLTPQTMYTQIAH
GIDSAMDDAR
AGELTADEISK

0.12

57

3

20.m03903

http://www.toxodb.org

15389

92

19

1

68

2

http://www.toxodb.org

64018

92

2

1

1008.98,
3+
791.08, 2+

0.45

83.m01263

KVVGASCVCVTDFG
EESEALTFLQNHIK
TPAPSPSAAAV
SAPQTK

0.32

92

1

583.m00625

http://www.toxodb.org

64938

91

2

1

843.19, 2+

0.53

67

3

50.m03373

http://www.toxodb.org

20056

85

2

1

TGQPAPAAAAPG
YQTQR
FALIA

534.22, 1+

-0.11

32

6

50.m00020

http://www.toxodb.org

54082

82

3

1

828.70, 2+

0.56

82

1

59.m03592

http://www.toxodb.org

31912

81

6

1

955.79, 2+

0.55

81

1

59.m03731

http://www.toxodb.org

88756

81

1

1

SVPVSNDEV
NNQVVR
TLELTDNHISG
GLEALVK
DQGDDSAFASEIR

706.15, 2+

0.69

81

1

1
2

6
7

171

8
9
10
11
12
13
14
15
16
17
18
19

Accession
No.

database source

MW
(Da)

protein
score

171

No. of
peptides
1

peptide sequence

LSVVVDDALGTVD
AINALATHVVGAVK
LGDDDMFSTDLTEE
ELSR
TLTPLLVDITTMG
DKLPGVAAWNK
GDFSQESINTFLT
QLLAGKAPISELPK
LLYEANPMAF
LAEQAGGK
SVSSPSASEA
SVSETGNSR

precursor
m/z,
charge
1324.32,
2+
1037.19,
2+
1277.59,
2+
1453.10,
2+
1922.47,
1+
920.19, 2+

mass error
observed
(Da)
0.17

highest
peptide
score
79

muitiple
observations

0.48

102

3

-0.21

92

2

0.67

114

1

-0.5

72

2

0.53

102

1

14

subunit-related
20

hypothetical protein

44.m06355

http://www.toxodb.org

104123

81

2

1

21

translationally-controlled
tumor protein, putative

50.m03408

http://www.toxodb.org

19160

80

19

1

22

MA3 domain protein

76.m00019

http://www.toxodb.org

58932

79

4

1

23

DNA-binding protein
HU, putative
facilitative glucose
transporter, putative
28 kDa antigen

42.m00103

http://www.toxodb.org

25173

73

8

1

33.m00002

http://www.toxodb.org

61648

72

2

1

SLYGGIANTLETP
FADSEAVAK
GAEDYGIADNSEED
GGGVDSTSETVVD
VVDAFR
LVGDVDDYSLDNP
DVYYLLAK
TGEQLTVPATTFP
TFSFSK
GVSDDLTKGTEVV

42.m00015

http://www.toxodb.org

19792

72

5

1

AAHVPVPDFSQ

35.m00002

http://www.toxodb.org

35125

71

5

1

IWDLENKNVLSEI
TPEK

86.m00361

http://www.toxodb.org

39715

71

7

1

49.m00035

http://www.toxodb.org

48493

70

3

1

49.m03152

http://www.toxodb.org

27919

69

4

1

55.m11049

http://www.toxodb.org

20303

69

10

1

49.m00030

http://www.toxodb.org

72191

69

3

1

583.m05469

http://www.toxodb.org

61497

68

3

1

20.m00373

http://www.toxodb.org

97179

68

3

1

24
25
26
27
28
29

receptor for activated C
kinase, RACK protein,
putative
UV excision repair
protein rhp23, putative
hypothetical protein

1127.67,
2+
1688.51,
2+

81

1

0.56

80

1

0.18

62

2

0.28

73

1

-0.17

47

3

0.54

59

2

1014.86,
2+

0.66

71

1

AAAESALFTGPQL
EETLTHLVAMGFPR
AAANALGSDAVDE
YAK
KAQELQAEEQAP

1429.59,
2+
1565.58,
1+
671.48, 2+

0.72

71

1

-0.16

70

1

0.3

47

2

GAGAGGMNFDTS
LITPEMLR
NVLLEKEYGPPMI
VNDGVTIAR
AEGEGVSGEAATS
QDTR
GLSLISASSSPAADS
TPAVTDLLMPSLSP
SLK

1019.75,
2+
1214.69,
2+
832.90, 2+

0.52

69

1

0.08

69

1

0.05

68

1

0.54

68

1

1194.17,
2+
1030.16,
2+
1319.50,
1+
584.56, 2+

34

proteasome subunit
alpha type 4, subunit
NAC domain containing
protein
TCP-1/cpn60 family
chaperonin, putative
serine/threonine protein
phosphatase, putative
biotin requiring domaincontaining protein / 2-oxo
acid dehydrogenases
acyltransferase catalytic
do
peroxisomal catalase

44.m00005

http://www.toxodb.org

57262

68

2

1

FSTVAGESGSADTR

693.07, 2+

0.5

68

1

35

protein kinase 3

57.m00024

http://www.toxodb.org

44440

67

7

1

67

1

60S ribosomal protein
L17, putative
pyridine nucleotidedisulphide
oxidoreductase domaincontaining protein
hypothetical protein

129.m00402

http://www.toxodb.org

22255

67

9

1

-0.38

67

1

25.m00219

http://www.toxodb.org

71114

66

1

1

1500.55,
2+
1093.91,
2+
684.57, 2+

0.55

36

LPSGGPLPELFTFSQ
LELQNMSPAAQVK
NLDVDNLVIEHIQV
NRAPK
FLADQSEFALAR

0.44

66

1

49.m03169

http://www.toxodb.org

44683

66

4

1

66

1

http://www.toxodb.org

140861

65

0

1

1095.93,
2+
534.39, 2+

0.62

55.m04747

EIPTVAGFVQKYV
LAAQLSR
DSAGVYAQTR

0.27

65

1

541.m00133

http://www.toxodb.org

29317

64

4

1

SPYQEWSDYLAR

758.19, 2+

0.68

59

2

30

172

0.22

31
32
33

37

38
39
40

DNA-directed RNA
polymerase II subunit
40S ribosomal protein S2,

172

1557.59,
2+

putative
41

20.m00365

http://www.toxodb.org

54315

62

3

1

42

nucleolar protein NOP5,
putative
hypothetical protein

38.m01037

http://www.toxodb.org

132202

62

1

1

43

hypothetical protein

645.m00330

http://www.toxodb.org

40637

61

5

1

44

hypothetical protein

583.m00626

http://www.toxodb.org

24692

61

8

1

45

hypothetical protein

41.m01274

http://www.toxodb.org

35433

56

4

1

46

113.m00802

http://www.toxodb.org

24138

56

10

1

46.m00022

http://www.toxodb.org

46231

56

2

25.m02955

http://www.toxodb.org

7583

55

20.m05985

http://www.toxodb.org

59027

35.m00899

http://www.toxodb.org

51

dense-granule antigen
DG32, putative
signal peptide peptidase
domain-containing
protein
40S ribosomal protein
S28, putative
RNA-binding protein,
putative
conserved hypothetical
protein
hypothetical protein

28.m00590

52

hypothetical protein

53

ribosomal protein L32,
putative
40S ribosomal protein
S17, putative
peptidyl-prolyl
isomerase, putative
GTPase-related

47
48
49
50

173

54
55
56
57
58
59
60

61
62

importin-alpha reexporter, putative
conserved hypothetical
protein
TCP-1/cpn60 family
chaperonin, putative
eukaryotic translation
initiation factor 3 subunit
6 interacting protein,
putative
40S ribosomal protein S4,
putative
hypothetical protein

RNFVQGEENEENVE
QTFGVR
LFQYIAPGGLDEEKA
EEL
LVELDTGVASPVFAR

1837.70,
1+
1290.46,
1+
1191.33,
2+
1011.72,
2+
787.48, 2+
1259.70,
2+
624.49, 2+

0.01

56

1

1

GVGEHIGGTPVDLVL
NDLYPLIVK
QNEVDEVTGEK

0.41

56

1

19

1

VTFMADETDLAGR

-0.05

55

1

55

1

1

TAGDLIQEAR

1425.62,
1+
537.52, 2+

0.48

55

1

45089

55

4

1

907.40, 2+

0.79

55

1

http://www.toxodb.org

28880

53

6

1

976.81, 2+

0.73

53

1

41.m02358

http://www.toxodb.org

61478

52

2

1

SVELTRPQAVLGAV
GMGK
TGSSENNEVLPSFQD
AEK
VALSSLTTQPAEISK

-0.28

52

1

57.m00005

http://www.toxodb.org

15607

52

7

1

SARLDTAEDE

0.78

52

1

25.m00216

http://www.toxodb.org

15219

52

9

1

ISEEVAVIPSKR

1544.57,
1+
1107.28,
1+
664.55, 2+

0.34

52

1

76.m00007

http://www.toxodb.org

55554

52

2

1

LGEFSEAIEQTTK

-0.08

52

1

20.m00340

http://www.toxodb.org

72779

51

3

1

0.38

51

1

52.m01606

http://www.toxodb.org

120810

51

1

1

0.71

51

1

59.m00041

http://www.toxodb.org

55768

51

2

1

SATSPARTEPPAAS
AGAASGEVSR
IAETDLPLDWPTLLP
ELSQK
VAALAGPSPVAK

-0.05

51

1

20.m00349

http://www.toxodb.org

58580

50

5

1

1452.64,
1+
1114.74,
2+
1140.47,
2+
1080.59,
1+
1570.81,
2+

0

50

1

59.m00055

http://www.toxodb.org

75026

50

2

1

966.64, 2+

0.33

50

1

25.m00221

http://www.toxodb.org

30152

49

4

1

GVPALITHDGR

568.26, 2+

-0.11

49

1

27.m00846

http://www.toxodb.org

59296

49

2

1

VAALRPNVVYGQ
AR

757.25, 2+

-0.37

49

1

173

NVELSPLLPDEIAA
EVK
SVEEAADAAAASAK

VVGGGGSAELAA
AIAVENEADKIPGV
EQYAVR
FINPATPSFEDPQA
LER

0.7

47

2

-0.16

48

2

0.55

61

1

0.43

61

1

0.1

56

1

63

hypothetical protein

583.m05652

http://www.toxodb.org

89288

49

3

1

64

eukaryotic translation
initiation factor 3 subunit
9, putative
formate/nitrite
transporter-related

41.m00006

http://www.toxodb.org

88336

49

1

1

25.m02951

http://www.toxodb.org

44261

49

7

1

44.m02716

http://www.toxodb.org

33936

48

3

1

GNPGTNPPSKSPE
SSATGGTGAAASP
TATS
YLGPESSVPHR

65
66

hypothetical protein

GAASSPASSSVFFA
TSPLSEAEKEELSV
LPR
AALLDDFDEIVGR

67

histone H2A, putative

55.m04926

http://www.toxodb.org

13621

47

7

1

AGLQFPVGR

68

eukaryotic translation
initiation factor 3 subunit
10, putative
proteasome A-type and
B-type domaincontaining protein
hypothetical protein

20.m03667

http://www.toxodb.org

119053

47

2

1

72.m00688

http://www.toxodb.org

30247

46

4

1

SADAPVLPGQGL
GDLDSVADSPED
LLLSTLQIEVR
TAHQYAALLSR

69
70
71
72

174

73
74
75
76

77
78
79
80
81
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